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Abstract 
Many ocular diseases result in visual impairment often leading to blindness with disease 
progression, one such example is Retinitis pigmentosa (RP). The underlying cause for 
blindness is often due to the degeneration of photoreceptors and supporting cells in the 
retina. Photoreceptors are responsible for the conversion of light signals into electrical 
impulses which are processed by the brain to form a visual image. Unlike other cells, 
photoreceptors cannot be regenerated by the body. For this reason current treatment for 
many ocular diseases aims to preserve what little vision patients hold. The only way 
such diseases could be cured is by regenerating photoreceptors and transplanting them 
into patients to replace lost cells and function.  
The differentiation of retinal cells from human embryonic stem cells (hESCs) is a 
difficult process. Current strategies produce low efficiencies of retinal cells which could 
not supply cells in a clinical environment. It is evident that the key lies within the tight 
control of the microenvironment of these cells at various stages of the differentiation 
process.  
In this study various optimisation avenues were investigated in order to increase the 
yield of retinal cells. By investigating the impact of various dissociation reagents and 
enzymes it was found that, the dissociation of cells using TrypLE Express significantly 
increased retinal gene expression. Using this reagent resulted in over a 100 fold increase 
in expression of photoreceptor precursor marker Nrl in comparison to the mechanical 
dissection with Collagenase IV (the control). In this investigation it was also found that 
the dissociation of cells during the process, in order to reduce cell densities is highly 
detrimental. 
The investigations were successful in finding some changes to the published protocols 
that optimised the differentiation process of pluripotent Shef3 hESCs into retinal cells. 
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1 Introduction 
The eye although a comparatively small structure of the human anatomy, in history, has 
been the centre of many conflicting theories for centuries. Famous scholars including 
Plato and Aristotle have all contributed to the discussion of its process.  
In summary, it is a complex system capable of rapidly processing light into electrical 
impulses to produce the important sense of vision; and the underlying cause of ocular 
diseases is often degeneration, damage or loss of one or more of the components 
involved in this system. 
Loss of vision has become widely accepted as “the norm” in the aging population with a 
whole subset of ocular diseases shown to be more prevalent with ageing. Examples of 
diseases from this subset are macular degeneration and retinitis pigmentosa, resulting in 
partial or total blindness respectively, due to damage in components associated with 
light processing. These components are known as photoreceptors and reside in the back 
of the eye in the retina.  Degeneration of photoreceptors can be both inherited or 
acquired. 
The discovery of stem cells has taken science and therapy to new horizons with the 
potential to be used in therapy for many age-related ocular diseases.  Before these cells 
become clinically available however, there are several hurdles to overcome concerning 
the efficiency, reproducibility and safety in the production of these cells. Once key 
hurdles have been conquered, the transplantation of photoreceptors to replace 
degenerate photoreceptor cells could be the answer to the restoration vision in suffering 
patients.  
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1.1 Eye Development 
The development of the human eye begins around day 22 of embryogenesis lasting 
several months until completion (Sernagor, 2006). It is structured using three tissue 
types: the neural ectoderm, mesoderm and the ectoderm. The retina and retinal 
pigmented epithelium (RPE) is formed from the neural ectoderm, whilst the sclera and 
cornea are formed from the mesoderm. Lastly the lens is formed from the ectoderm. 
During the developmental process, optic vesicles which form from the neural tube, form 
the two eyes (Sernagor, 2006).   
The development of the eye results from the contact of the optic vesicle with the 
ectoderm. This induces the thickening of the ectoderm, producing a lens placode which 
in turn pushes into the optic vesicle leading to its invagination and formation of the 
optic cup, lens and vesicle (Sernagor 2006).  This is connected to the central nervous 
system by a stalk which later becomes the optic nerve. The outer surface of the optic 
cup later becomes the retinal pigment epithelium (RPE), whilst the inner surface 
becomes the retina (Figure 1.1)  (Wawersik and Maas 2000; Sernagor 2006). 
Several important eye field transcription factors have been found to hold important roles 
in the formation of the eye. These include the following: ET, Rx1, Pax6, Six3, Lhx2, tll 
and Six6 which are all expressed at the neural plate (Zuber et al., 2003). 
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Figure 1.1: Development of the eye. (a): Optic vesicles from the neural tube form the two eyes. (b): 
The lens placode is produce as a result of the contact between the surface ectoderm and optic 
vesicles. (c): The invagination of the lens placode results in the formation of the optic cup. (d): The 
outer surface of the optic cup later becomes the retinal pigment epitheilum and the inner surface 
the retina. (e): The mature eye and location of the retina. Image retrieved from Sernagor 2006. 
 
 
Pax6 especially, has been found to play a prominent role in the early development of the 
eye. The expression of Pax6 has been found to be present in the head ectoderm and 
optic vesicle. This has then found to later become restricted in the lens placode prior to 
ectoderm thickening, suggesting a regulatory role of Pax6 expression by the optic 
vesicle.  
The importance of Pax6 in eye development is clear from studies that have found 
mutations resulting in a range of severe ocular diseases including: aniridia, a disease 
resulting in the absence (complete or partial) of the iris and anophthalmia, a disease 
resulting in the absence of the eye structure affecting either one or both eyes.  
 Other studies have also found that homozygous mutants for Pax6 fail to form the lens 
placode, whilst chimera studies have highlighted a cell autonomous role for Pax6 in 
retina development (Wawersik and Maas 2000). 
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 There are several transcription factors that have been identified to play an important 
role in and also mark the various stages of photoreceptor differentiation. 
1.2 Anatomy of the adult eye 
The complex system of the eye is compacted into a slightly irregular spheroid with a 
diameter of approximately 24mm and weighs an estimated 8g. Structurally it is divided 
into three layers (i) fibrous tunic- the outer layer, (ii) vascular tunic- the intermediate 
layer, and (iii) the neural tunic (retina)- the inner layer (Figure 1.2) (Martini et al. 2009). 
 
 
Figure 1.2: A simplified horizontal section of the eye. Image taken from Martini et al., 2009. 
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1.2.1 Fibrous Tunic 
The fibrous tunic is the outermost layer containing the sclera and cornea. The majority 
consists of the sclera. This structure is a strong layer of connective tissue made up of 
collagen and elastic fibres that functions as (i) a protective shield for internal structures 
that are more delicate, (ii) an attachment point for extrinsic muscles and (iii) contains 
structures involved in focussing.  
Towards the anterior section of the eye, the surface closest to the entrance of light, the 
sclera becomes more curved in structure and transparent to form the cornea. The cornea 
consists of dense collagen layers organised not to impede on the path of light entering 
the eye (Figure 1.3) (Martini et al. 2009; Tortora and Nielsen 2009). In contrast to the 
sclera, the cornea does not contain any blood vessels. Epithelial cells absorb oxygen and 
nutrients from the free flowing tears across the eye instead. It also has a limited ability 
for self-repair, maybe owing to the lack of blood supply. Damage could therefore easily 
result in blindness, although intrinsic structures are fully functional.  
The advantage of lacking a capillary network is that it remains one of the few 
transplantation procedures readily carried out without danger of immunorejection, as no 
white blood cells are present to initiate an immune response (Martini et al. 2009). 
Corneal transplantation is a common procedure with approximately 3615 successful 
procedures resulting in the restoration of sight carried out in the UK last year 
(2012/2013)(NHSBT,2013). 
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Figure 1.3: A detailed horizontal section of the right eye. (Martini et al. 2009). 
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1.2.2 Vascular Tunic 
The vascular tunic is the middle layer of the eye and regulates the lens shape, aqueous 
humor volume, quantity of light entering the eye and supplies blood and nutrients to the 
eye (Martini et al., 2009). This layer is primarily made up of three main components: 
iris, ciliary body and the choroid. 
The iris is positioned between the cornea and the lens, morphologically shaped like a 
donut, with the opening referred to as the pupil and the ring made up of two groups of 
smooth muscle (Martiniet al., 2009). The pupillary constrictor located towards the inner 
ring (i.e. closest to the pupil) and the pupillary dilator located towards the outer ring 
(Figure 1.4) (Martini et al. 2009). As the names suggest, these are involved in regulating 
the diameter of the pupil depending on the intensity of entering light in the eye. Melanin 
producing cells (melanocytes) also reside in the iris, the density of which governs eye 
colour. A dense organisation of melanocytes restricts the quantity of light reflecting 
back from the pigmented epithelium. This results in a brown eye colour, whereas a less 
dense organisation allows more light to be reflected from the pigmented epithelium 
giving the appearance of blue eye colour. 
 The iris is firmly attached to the ciliary body, a thickened region of the sclera at the 
corneal junction. The ciliary body is made up of smooth muscle (ciliary muscle) which 
regulates lens shape. The epithelium of ciliary muscle are organised into folds referred 
to as ciliary process and fibres (suspensory ligaments), the lens attach to the ciliary body 
from these folds. Contraction and relaxation of the ciliary muscles affects the tension on 
the suspensory ligaments which in turn alters the lens shape (Martini et al. 2009; 
Tortora and Nielsen 2009).  
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Figure 1.4: Diagram of pupillary muscles during decrease and increase of light intensity.   
(Martini et al.  2009).  
 
Separation of the vascular tunic and the fibrous tunic is provided primarily by the 
choroid. The choroid is equipped with a capillary network which is used to supply 
nutrients and oxygen to the retina. It also contains melanocytes giving this structure a 
dark brown appearance. The melanin absorbs lights rays entering the eye and restricts 
reflection of the rays within the eye so that a sharp image is cast on the retina.  
 
1.2.3 Neural Tunic (Retina) 
The retina is the innermost layer of the eye made up of a pigmented layer and a neural 
layer. A single sheet of epithelial cells containing melanin constructs the pigmented 
layer and runs over the ciliary body and iris. The role of the melanin remains the same 
as that in the choroid. In contrast to the pigmented layer, the neural layer is a multi-
layered structure constructed of three distinct layers of neurons: (i) photoreceptor layer, 
(ii) bipolar cell layer and (iii) ganglion cell layer, which only continues as far as the 
ciliary body (Martini et al. 2009; Tortora and Nielsen 2009) (Figure 1.5). 
 In addition to these neurons the retina also contains a number of other supporting 
neurons, including horizontal cells and amacrine cells which are involved in modulation 
of the activity of the three primary neurons (Snell and Lemp 1998). 
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Figure 1.5: Detailed diagram of the retina. (Tortora and Nielsen 2009).  
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1.3 The Retina 
1.3.1 Photoreceptors 
This layer is located closest to the pigmented layer of the retina and is packed with 
numerous photoreceptors- as the name suggests! Photoreceptors, in short, are sensory 
receptors capable of detecting light. There are two types of photoreceptors: rods 
involved in dim vision and cones involved in colour vision. The latter is responsible for 
producing sharper and clearer images. Rods, approximately 120µm in length, are more 
sensitive to light and produce vision when light is sparse, but cannot distinguish colours 
in contrast to cones. There are three types of cones, each approximately 75µm in length, 
and colour perception is dependent on the combination of which of the different types 
are stimulated.  
The distribution of rods and cones are by no means equal within the retina. The 
population of cones are by far outweighed by that of rods. An estimated 125 million 
rods are distributed in the periphery of the retina gradually decreasing in density 
towards the centre of the retina. In contrast, there is an estimated 6 million cones with 
the highest concentration lying at the fovea, the central point of the macula lutea, the 
region where most distinct vision occurs. Both rods and cones appear as narrow cells 
and are constructed of three parts: (i) an outer segment responsible for the detection of 
light, (ii) an inner segment and (iii) a synaptic terminal (Figure 1.6) (Snell and Lemp 
1998; Martini et al. 2009).  
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Figure 1.6: Structure of a rod and a cone. Image retrieved from Snell and Lemp 1998. 
 
The shape of both photoreceptors in the outer segment, the region responsible for light 
detection, is what lends its name to the receptors. Rods take the shape of a rod-like 
structure whilst cones take the shape of a cone. The outer segment of both rods and 
cones have an elongated region of the photoreceptor containing thousands of individual 
discs; in cones however, as this region lies within the folding of the plasma membrane, 
the outer segment tapers to a point producing the characteristic cone shape which 
distinguishes cones (Figure 1.6) (Martini et al. 2009; Tortora and Nielsen 2009). 
 In both photoreceptor types the discs contain visual pigment which absorbs light 
photons, the first step light detection. This is known as photoreception. In rods this 
visual pigment is called rhodopsin, synthesised from vitamin A, whilst in cones the 
      
 
26 
 
pigment is called iodopsin (Figure 1.7 A and B). Both are made up of the pigment 
retinal, bound to the protein opsin. In cones however, the retinal is bound to different 
forms of opsin which defines the light wavelength that can be absorbed (Martini et al. 
2009; Tortora and Nielsen 2009). This is the underlying basis of colour vision.  
There is ample evidence showing the continual renewal of the outer segment with discs 
assembled at the base of the outer segment slowly moving to the tip of the outer 
segment (Young 1967; Snell and Lemp 1998; Martini et al. 2009). After approximately 
ten days discs become phagocytosed by pigmented epithelial cells reconverting retinal 
into vitamin A which the pigmented cells store (Young 1967; Snell and Lemp 1998; 
Martini et al. 2009). The outer segments of photoreceptors are connected to the inner 
segment via connecting stalks which in fact have been shown to be modified cilia (Snell 
and Lemp 1998). 
 
 
Figure 1.7: Detailed structure of rods and cones. (Martini et al., 2009). 
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The inner segment is made up of two main areas: (i) the ellipsoid and (ii) the myoid. 
The ellipsoid was first described by Sjöstrand in 1953 and covers the area closest to the 
outer segment. It also contains numerous mitochondria. The myoid is located towards 
the synaptic layer of the photoreceptor. It contains many important organelles such as 
Golgi apparatus, free ribosomes and endoplasmic reticulum to perform the vital role of 
providing ATP for the renewal of visual pigment and synthesis of parts of the outer 
segment (Ishikawa and Yamada 1969; Iwasaki and Inomata 1988; Snell and Lemp 
1998). 
The remaining compartments of photoreceptors consist of a 1µm wide outer fiber that 
connects the inner segment to the cell body. An inner fiber in turn connects the cell 
body to the spherule in the case of a rod; and the pedicle in the case of a cone (Snell and 
Lemp 1998). The spherule and pedicle contain many pre-synaptic vesicles and 
microtubules, which form synapses with dendrites of bipolar cells (Snell and Lemp 
1998; Martini et al. 2009). This region is known as the synaptic terminal. 
Approximately six million neurons form synapses with both types of photoreceptors and 
these neurons are known as bipolar cells (Snell and Lemp 1998; Martini et al. 2009).  
 
1.3.2  Bipolar cells 
Bipolar cells form synapses with photoreceptors at one end and ganglion cells at the 
other. The input received from photoreceptors are delivered to ganglion cells through 
horizontal cells located at the base of photoreceptors, and are involved in the inhibition 
of bipolar cells  producing sharpened contrast and spatial resolution (Snell and Lemp 
1998). There are specific bipolar cells for both rods and cones so that a single bipolar 
cell will never receive input from both rods and cones (Masland, 2001). The number of 
cone-driven bipolar cells outnumber that of rod-driven cells. Approximately 9-11 
varieties of cone-driven bipolar cells have been identified in mammals, most likely due 
to the fact that more rods converge to a single bipolar cell whereas many single cones 
converge to a single bipolar cell although there are also bipolar cells that connect many 
cones to ganglion cells (Snell and Lemp 1998; Masland, 2001).  
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1.3.3  Ganglion cells 
Ganglion cells are neuronal cells that form synapses with bipolar and amacrine cells 
within the retina. Amacrine cells are excited by bipolar cells which in turn excite 
ganglion cells. Ganglion cells have long axons which extend to form the optic nerve 
leading to the brain. They are involved in transporting information from photoreceptors 
to the brain. Largely, a single layer of ganglion cells occupy the retina but the layers 
increase from the periphery of the retina to the macula (Snell and Lemp 1998). Up to 10 
layers can be found to be present in areas containing multi-layered ganglion cells, 
decreasing towards the fovea (Snell and Lemp 1998).  
From what has been discussed, it is easy to see why diseases causing damage or 
degeneration to components such as photoreceptors in the retina can have detrimental 
effects on vision. The importance of the role of photoreceptors in producing visual 
images can also be appreciated. 
 
1.4  Photoreceptor Dystrophies 
Photoreceptors are light sensing cells located in the outer nuclear layer (ONL) of the 
retina. These cells absorb light and transform these into electrical signals, the process 
known as phototransduction. This process makes up the initial stage of the visual cycle. 
These signals are then transported and interpreted by the brain to produce a visual 
image. 
 There are two types of photoreceptors: rods, involved in phototransduction in dim light 
and cone which are involved in phototransduction of colour vision. The healthy function 
of both types of photoreceptors is key for normal vision. 
There are many devastating ocular disease which can grossly effect visual clarity and 
often result in blindness. Some of these include age-related macular degeneration 
(AMD), retinitis pigmentosa (RP) and cone-rod dystrophy (CRD) (Nag and Wadhwa, 
2012).  
AMD is a disease affecting the choroid and RPE, the photoreceptor support system. 
Lesions form on the choroid and ingrowth of vessels in the choroid can lead to visual 
impairment (Nag and Wadhwa 2012). The choroid is the layer located between the 
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retina and the sclera and provides oxygen and other nutrients to the retina for its 
maintenance. RP and CRD affect the function of photoreceptors directly. 
Of the photoreceptor dystrophies mentioned above, RP is the more prevalent of ocular 
diseases and is discussed in further detail in the following chapter. 
 
1.5  Retinitis Pigmentosa 
Pigmentary retinopathies are a classification of ocular diseases as a result of the loss of 
photoreceptors and retinal pigmented deposits. This is also the classification under 
which retinitis pigmentosa (RP) appears. In contrast to some other ocular diseases, RP is 
both genetically and clinically heterogenetic. It has also become the most common 
subtype of retinal degeneration related diseases in the world, with 1 in 4000 individuals 
being affected (Petra-Silva and Linden, 2013). A defect in any one of over 60 genes can 
result in RP which can be inherited (Petra-Silva and Linden, 2013). Characteristic to 
RP, alterations occur in the retinal pigmented epithelium resulting in the deposits of 
pigments (Anasagasti et al., 2012). These pigments are predominantly deposited in the 
peripheral retina often with initial degeneration of rod photoreceptors followed by the 
secondary degeneration of cones (Hamel, 2006). In light of this, it is no surprise that 
sufferers often experience the loss of night vision initially, eventually leading to visual 
impairment and often blindness with progression of the disease. The disease progression 
evolves over several decades (Hamel, 2006). In some cases the cone function is lost 
first, leading to the loss of central vision (Petra-Silva and Linden, 2013). 
All RP are progressive but the rate of deterioration varies greatly. Even in the case of 
the same gene mutation resulting in RP can still result in varied symptoms which can 
also be affected by the environment (Petra-Silva and Linden, 2013). There are two 
forms of RP that exist: syndromic and non-syndromic. 
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1.5.1 Non syndromic RP 
Non-syndromic RP is inherited in most cases and is the term given to RP where only the 
eye is affected with no other non-ocular diseases are associated (Anasagasti et al., 
2012).  In rare cases, RP can also be caused due to mutations in mitochondrial DNA 
(Mansergh et al., 1999). The course of RP can easily be divided into 3 stages: early, mid 
and late. Diagnosis of RP during early stages of the disease is difficult. This is because 
night blindness is often the main symptom of the disease with minimal or no defects 
during day light. For this reason it is often ignored by sufferers (Figure 1.8 B). 
Additionally, fundus examination may appear as normal as deposits are rarely present 
(Hamel 2006). A key test is that of the electroretinogram (ERG) which can expose the 
presence of the disease by the characteristic decrease in the b-wave amplitude. It must 
be noted however, that the ERG may seem normal although the retina is partially 
affected (Hamel 2006). 
 By the mid stage of the disease symptoms are clearly obvious with night blindness and 
loss of peripheral vision during day light. Sufferers may become photophobic and also 
suffer a decrease in visual accuracy; pigmented deposits also become clearly evident in 
fundus examinations by this stage of the disease (Figure 1.8 C). Additionally, the optic 
disc may appear pale with a narrowing of retinal vessels (Hamel, 2006).  
At this stage of the disease the ERG is often not recordable with flickering responses 
and various yearly assessments are mandatory in order to keep records of the 
progression of the disease (Hamel, 2006).  
By the end stage of the disease, patients lose all autonomous movement due to loss of 
peripheral vision often termed tunnel vision (Figure 1.9B). Reading remains extremely 
difficult without the aid of magnification glasses and photophobia becomes more 
intense. Fundus examinations exhibit widespread pigmented deposits spreading as far as 
the macular (Figure 1.8 D) and retinal vessels become more narrow with the optic disc 
becoming even more pale (Hamel, 2006). Disease progression at this stage is still slow, 
with patients able to read short passages for several years although unable to move. This 
is only lost once central visual fields also become affected and lost (Hamel, 2006). 
      
 
31 
 
 
 
Figure 1.8: Images of the fundus. (A) Image of fundus from an individual with normal vision. 
(B)Fundus image of early stage retinitis pigmentosa (RP) patient. (C) Image of fundus from mid 
stage RP patient. (D) Fundus image from end stage RP sufferer. Retrieved from (Hamel 2006). 
 
 
 
Figure 1.9: Visionary field. (A) Normal visionary field. (B) RP visionary field. Retrieved from 
(http://www.retinitis-pigmentosa.com.au/ 2009). 
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The inheritance of RP can be divided into three groups: autosomal dominant, autosomal 
recessive and X-linked. 
 
1.5.1.1  Autosomal Dominant RP 
Autosomal dominant RP is generally the least severe of RPs with the onset of the 
disease generally seen later and it also maintains fairly good vision (Chang et al.,2011). 
Approximately 30-40% of RP is autosomal dominant RP 
(http://www.patient.co.uk/doctor/retinitis-pigmentosa). There are three main genes 
where mutations can result in autosomal dominant RP, and these are: rhodopsin (Rho), 
oxygen-related proteins (RP1) and peripherin (RDS) (Chang et al.,2011). 
Rhodopsin is a photo-pigment found in rod photoreceptors and is involved in the 
absorption of light and is responsible for phototransduction (Chang et al.,2011). This 
transmembrane makes up 85% of the total protein content in rods and with rods being 
made up with three domains, mutations have been identified in all three domain (Chang 
et al.,2011).  
As the name suggests, RP1 is regulated by oxygen levels in the retina and has been 
found to play an important role in the correct stacking of photoreceptor outer segments 
(Chang et al.,2011). Over 50 mutations that cause the disease have been identified in 
this gene and most commonly in those suffering from dominant RP these mutations are 
usually a frameshift or nonsense mutations in a region located on the exon 4 of this gene 
(Siemiatkowska et al.,2012). 
Peripherin is found abundantly in the outer segments of photoreceptors and is extremely 
important in maintaining the structure and stability of photoreceptors (Chang et 
al.,2011). 
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1.5.1.2 Autosomal Recessive RP 
Autosomal recessive RP is one of the most common inherited forms of the disease 
although associated genes are very rare. This disease often has an early onset of the 
disease with more severe symptoms (Chang et al.,2011). Approximately 50%-60% of 
suffers of RP are affected by this type (Patient.co.uk). The most common gene 
mutations that result in the disease include: ABCA4, RPE65, PDE6A and PDE6B, and 
USH2A amongst others that are common to other ocular disease (Chang et al.,2011). 
ABCA4 is a photoreceptor specific ATP-binding cassette transporter gene. This protein 
is found in the outer segments of photoreceptors and is responsible for the breakdown of 
N-retinylidene-PE into vitamin A which is involved in the visual process (Chang et 
al.,2011). This mutation has also been found to be present in other ocular disease 
including age related macular dystrophy and cone rod dystrophies to name a few 
(Chang et al.,2011). 
RPE65 is also involved in the breaking down of retinoids, mutation in which results in 
the disease. Both PDE6a and PDE 6b play important roles in the rod photoreceptor 
visual transduction cascade and hold vital roles in the correct function and maintenance 
of photoreceptors (Sakamoto et al., 2009).  
USH2A is found in two isoforms in the body; a short and long form, the latter of which 
is predominantly found in the retina (Mèndez-Vidal et al., 2013). This gene produces 
multidomained proteins called usherins which are involved in the delivery of 
substituents from the inner segments of photoreceptors to the outer segment. Thus they 
play important roles in the maintenance of photoreceptors (Mèndez-Vidal et al., 2013). 
 
1.5.1.3 X-linked RP 
X-linked RP causes the most severe forms of the disease with an early onset and also 
fast disease progression (Chang et al., 2011). This has also been found to account for 
6%-20% of RP (Petrs-Silva & Linden, 2013). This disease affects males more severely 
than females, caused by a random X-inactivation (Chang et al., 2011). Mutations in two 
genes: RPGR/RP3 and RP2 have been found to be responsible for the majority of X-
linked RP (Chang et al., 2011). 
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The protein produced by the gene RP3 is imminent for cell viability and is localised in 
the base of photoreceptors and cilia bodies. This protein also possibly plays important 
roles in protein transportation and organisation of microtubules (Petrs-Silva & Linden, 
2013).  Almost 70% of X-linked RP is caused by a mutation in this gene (Petrs-Silva & 
Linden, 2013).  
It is very clear that in the majority of cases, RP is caused by the failure of vital 
components to function as normal. This occurs either in photoreceptors or supporting 
components which in some way affect the normal functioning of photoreceptors.  
Currently there is no cure for RP and existing treatment only aid in preserving what 
little vision is left using visionary aids. Some treatments aim at treating various 
symptoms of RP such as photophobia, by reducing the effect of photophobia. Other 
treatments include the supply of antioxidants such as vitamin A and E to protect and 
prolong the life of existing photoreceptors, although studies have shown that the supply 
of vitamin A may not be suitable for sufferers of RP due to specific mutations 
(Mansergh et al. 1999). 
 
1.5.2  Syndromic Retinitis Pigmentosa 
Syndromic RP refers to a number of other syndromes that have been associated with 
retinopathies. This chapter only discusses the two most common syndromes associated 
with RP: Usher syndrome (USH) and Bardet Biedl syndrome (BBS). 
 
1.5.2.1 Usher syndrome 
This syndrome is characterised by retinitis pigmentosa, loss of hearing and in some 
cases vestibular dysfunction and is often a disease that is inherited in an autosomal 
recessive manner (Ferrari et al., 2011). This syndrome is the most common syndrome 
affecting deaf-blind individuals and accounts for approximately 50% of these 
individuals (Ferrari et al., 2011). Approximately 10%-30% of all cases of autosomal 
recessive RP are sufferes of Usher syndrome (Ferrari et al., 2011).  
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 This syndrome can be divided into three categories with the severity of deafness 
defined by the syndrome type. Type 1 (USH1) is profound and thus the most severe of 
the three types. In USH1 the onset of RP is pre-pubertal (Ferrari et al., 2011).  Type 2 
(USH2) is mild or moderate in comparison with USH1 with a later onset of RP 
progression (Ferrari et al., 2011). In type 3 (USH3), deafness can occur within the first 
decade worsening with disease progression (Boughman et al., 1983; Hamel 2006). The 
onset of RP is also variable in this type of the sydrome (Ferrari et al., 2011). 
 Unfortunately, there is no treatment available to cure this syndrome. Detection for the 
syndrome has been greatly aided by the discovery of mutations of specific genes 
associated with the disease. Currently five genes have been identified to be associated 
with USH1 and three associated with USH2 (Ferrari et al., 2011). In the case of USH3, 
this is a very rare form of the disease, with the prevalence seen only in certain 
populations (namely Finns and Ashkenazi Jews) (Ferrari et al., 2011). 
 
 1.5.2.2 Bardet Biedl syndrome (BBS) 
Bardet Biedl syndrome (BBS) is less frequent than usher syndrome, affecting 1 in 
150,000 people (Hamel 2006). Similar to Usher syndrome, this is another syndrome that 
is inherited in an autosomal recessive manner (Ferrari et al., 2011). Characteristics of 
this syndrome include child obesity, mental retardation or mild psychomotor delay and 
renal abnormalities leading to renal failure amongst sufferers (Hamel 2006). A major 
cause of morbidity and mortality in this syndrome has been a result of renal failure 
(Ferrari et al., 2011). 
 Although sufferers of this syndrome are usually born with a normal birth weight, a 
continuous substantial weight gain is often observed within the first year; this then later 
becomes a fighting battle throughout adult life (Ferrari et al., 2011). Night blindness in 
many sufferers is usually observed by the age of seven, with blindness often diagnosed 
by the age of 15 (Ferrari et al., 2011).  
Some population have a higher incidence of this syndrome than others, such as some 
population of Newfoundland where 1 in 13000 is affected. A total of 14 genes have 
been associated with BBS which again is useful for diagnosis purposes although 
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approximately 20% of sufferers have gene mutation that have not yet been identified 
(Ferrari et al., 2011). Again, as of yet, there is no current cure for sufferers of BBS. 
 
 
1.6  Potential Treatment for retinal dystrophies 
1.6.1 Gene Therapy 
Gene therapy is currently the most promising treatments for many ocular diseases. In a 
short summary, this form of therapy involves the transportation of normal genes into an 
area of mutated genes causing disease to correct the disease. This type of therapy often 
requires the use of retroviral vectors for the transplantation stage. These then infect cells 
of the patient to correct the mutation and thus aid in treatment of the disease. 
One of the most popular types of vectors to transport genes into ocular cells is the 
recombinant adenoassociated virus (rAAV) (Petrs-Silva and Linden, 2013). The AAV 
vector is relatively smaller in size in comparison to other available vectors and thus 
holds a great advantage in that it is capable of tranducing to a range of retinal cells, both 
dividing and single cells (Petrs-Silva and Linden, 2013). 
One ocular disease which has had success in clinical trials via gene therapy is the 
treatment of Leber’s congenital amaurosis (LCA). LCA is one of the most severe forms 
of inherited ocular diseases with severe loss of vision detected at early infancy and 
childhood. Although the disease can be caused as a result of mutations in any one of 13 
genes, a mutation in the retinal pigment epithelium (RPE65) causes approximately 6% 
of all cases of LCA (Maguire et al., 2009). 
 Maguire and his group carried out phase 1 clinical trials for the treatment of LCA. In 
this investigation 12 sufferers of various ages were injected with the recombinant vector 
(AAV2-hRPE65v2) containing the sequence of a normal RPE65 gene in the subretinal 
space. Three doses of low, medium and high were administered to patient. The AAV2-
hRPE65v2 vector was well tolerated by all patients with increased visual acuity 
observed in children and benefits of the trial was sustained at the 2 year follow-up 
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investigation. The study also found that the high dosage of the vector (1.5x10
11
) may be 
edging towards the limit of toxicity and thus will be omitted in following investigations. 
This provides great hope for young suffers as the greatest level of benefits were 
observed in children. 
1.6.2 Cell Therapy 
As the name suggests, cell replacement therapy is the transport of healthy cells into an 
organ in order to restore functionality of deteriorated or damaged cells. This type of 
treatment is especially convenient for treating photoreceptors dystrophies as the 
intraocular space is in fact immunoprivilaged. As the subretinal space has also been 
found to hold this property, it is immediately protected by the harmful effects of 
immunological inflammatory responses which can lead to blindness (Masli & Vega, 
2011). 
 For this type of treatment to become successful, this requires initially the transplanted 
cells to survive in the retina and then become integrated as part of the ONL of the host 
retina where it can then form synaptic connections for transmission. 
Carr et al., 2009 readily differentiated iPS cells from human foetal lung fibroblast cells 
and differentiated these cells into RPE cells. The iPS-RPE was then injected into the 
subretinal space of 22-23 day old dystrophic rats. The disease progression in untreated 
rats is such that the ONL is usually diminished along with the reduction in the 
photoreceptor outer segment layer. 
 Transplantation however, found that 13 weeks post-transplantation the structure of the 
retinal was well preserved with a significant increase in visual acuity. This provided 
great potential for the treatment of AMD.  
A partnership between UCL and Pfizer has now been formed. This partnership has been 
approved to begin phase 1 clinical trials for the treatment of wet AMD in March 2014. 
In this trial patients over 60 years of age, suffering with wet AMD, whereby the blood 
vessels are affected in the retina resulting in a rapid progression of AMD are to be 
investigated. The trial will involve the transplantation of hESCs derived RPE cells, 
which will be immobilised on a polyester membrane, into the eye 
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(http://clinicaltrials.gov). If successful, this will provide a cure for sufferers as the 
procedure is intended to be life-long. 
Current times are extremely exciting times in terms of the development of therapies for 
some retinal dystrophies, although there are far more ocular diseases where no treatment 
is currently available, like for example RP. It is clear that for some ocular diseases such 
as RP, the way forward would be to develop a means by which target cells such as 
photoreceptors could be delivered in a safe, secure and permanent manner. The 
possibility of using hESCs to reach this target definitely holds great potential.  
 
1.7  Stem cells 
During early stages of mammalian embryo development cells are capable of existing in 
an undifferentiated state for an indefinite period of time. They also have the capability 
of differentiating into various cell types of the 3 germ layers: (i) endoderm, (ii) 
mesoderm or (iii) ectoderm, a term commonly defined as pluripotency. These early 
developmental cell types are what became known as stem cells.  
 
1.7.1 The Discovery  
Using mouse-derived cells Thomson and his group defined that for a cell to be defined 
as a stem cell, it must exhibit the following characteristics: (i) it must be derived from a 
peri-implantated or pre-implanted embryo, (ii) it must be able to proliferate in an 
undifferentiated state for a prolonged period and (iii) that it must demonstrate potential 
to form derivatives of all three germ layers, and only then can a cell be defined as a 
stem cell (Thomson et al., 1998). 
Using donated fresh/frozen cleavage stage embryos intended for use in, in vitro 
fertilization,embryos were cultured into a blastocyst stage. Thomson and his group 
(1998) then isolated 14 inner cell masses from the blastocyst and they obtained 5 
embryos from which 5 stem cell lines (H1, H13, H14, H7 and H9) were derived. These 
cell lines produced characteristic morphology to stem cells such as, a high nucleus to 
cytoplasm ratio, prominent nucleoli and colony morphology to stem cells (Figure 1.10).  
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Figure 1.10: Derived H9 cell. (A) H9 colony, scale bar 100µm. (B) H9 colony , scale bar 50 µm. 
Modified from Thomson et al. (1998) 
 
Of the five cell lines derived by Thomson and his group (1998), 4 cell lines were stably 
cultured in an undifferentiated state for 5-6 months before being cryopreserved. The last 
cell line, H9 was stably cultured for 8 months (32 passages) in an undifferentiated state, 
fulfilling the second characteristic of a stem cell discussed earlier.  
When telomerase activity was investigated by this group, it was found that all cell lines 
exhibited high telomerase activity. Telomerase is an enzyme that functions to add G-
rich repetitive sequences to the ends to chromosomes (Yang et al., 2008). This action 
protects the chromosomes from degradation and end-to-end fusion (Yang et al., 2008). 
The activity of telomerase to maintain telomere length has readily been associated with 
cell immortality in cancer cells, germ line cells and embryonic stem cells (Hiyama and 
Hiyama 2007). 
 Given the infinite, undifferentiated, proliferative nature of stem cells, it would be 
rational to assume that stem cells must have some way of maintaining telomere length. 
They therefore must express telomerase highly in order to be capable of proliferating 
(undifferentiated) infinitely. The fact that high telomerase activity was recorded in all 5 
cell lines isolated by Thomson et al., 1998 is further evidence that these cell lines were 
in fact stem cells. 
 It is however also important to note that other studies have found low expression of 
telomerase activity in human stem cells (Hiyama and Hiyama 2007). An up regulation 
of telomerase acitivity has also been observed in cells which rapidly expand, such as 
committed haematopoietic progenitor cells (Hiyama and Hiyama 2007). In the case of 
cells isolated by Thomson however, these cells are embryonic stem cells and not adult 
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stem cells and therefore these finding are in line with other research into telomerase 
activity in stem cells. 
After being injected to severe combined immunodeficient (SCID) mice, all cell lines 
produced teratomas of all three germ layers (Figure 1.11), exhibiting the third property 
of a stem cell, although only images for three of the cell lines are shown. 
 
 
Figure 1.11: Teratomas formed by human ES cell lines after injection onto 4 week old SCID mice. 
(A) Gut-like structures from H9 cell line. Scale bar, 400mm. (B) Rosettes of neural epithelium from 
H14 cell line. Scale bar, 200mm. (C) Bone from H1 cell line. Scale bar, 100mm. (D) Cartilage from 
H9 cell line. Scale bar, 100mm. (E) Striated muscle from H13 cell line. Scale bar, 25mm. (F) 
Tubules interspersed with structures resembling foetal glomeruli from H9 cell line. Scale bar, 
100mm. Image retrieved from Thomson et al., 1998. 
 
Stage-specific embryonic antigen 3 (SSEA3), stage-specific embryonic antigen 4 
(SSEA4), TRA160 and TRA181 are all markers of pluripotency originally developed 
from human embryonic carcinoma cells. These markers are also recognised in human 
embryonic stem (hESCs) cells, which were shown to be present in all cells isolated by 
Thompson and his group (1998). This provided even further evidence for the nature of 
these derived cells. 
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 It is important to note that conflicting research emerged, suggesting SSEA3 and 4 were 
invalid markers for pluripotency as it was not essential (Brimble et al., 2007). The 
international stem cell initiative, which compared characteristics of 59 hESCs cell 
derived from 17 laboratories worldwide found that in fact the expression of these 
antigens were valuable markers of pluripotency in hESCs (Adewumi et al., 2007). 
The cells isolated by Thomson and his group in 1998 clearly fulfilled all the defined 
characteristics of stem cells with ample evidence.  This protocol has since been widely 
used to isolate many more stem cell lines through the years of stem cell history. A list of 
current stem cells approved by the National Institutes for Health (NIH) can be found on 
their website (http://grants.nih.gov/stem_cells/registry/current.htm). 
 
1.7.2 Human Embryonic Stem Cells (hESCs) and Mouse Stem 
cells 
Although mouse models provide a reliable source for medical research in the field of 
stem cell research it has been found that mouse development is considerably different to 
human development. One such difference is the timing of gene expression in developing 
embryos.  
An investigation was carried out by Braude et al., 1988, where human pre-embryos 
were inseminated and gene expression analysed at various time points. This 
investigation found that unlike mouse gene expression which was known to be detected 
in the mid two-cell-stage of development, in human development gene expression was 
not detected until between the four-cell and eight-cell stage (Braude et al., 1988). In the 
case of hESCs, as discussed earlier, there are also major differences in surface makers. 
Stage-specific antigens 3 (SSEA3) and 4 (SSEA4), glycoproteins TRA-1-60 and TRA-
1-81 and GCTM2 are not detected in mouse stem cells while they are readily detected in 
human stem cells (hESCs) (Thomson et al., 1998; Reubinoff and Pera et al., 2000). 
 In the case of mouse stem cells, surface marker Stage-specific antigen 1(SSEA1) is 
readily detected as a marker for pluripotency but remains undetected in human stem 
cells (Solter and Knowles, 1978). 
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Major differences in the culture methods between mouse and hESCs also exist. The 
primary difference being that in order to maintain hESCs in a state of pluripotency, a 
feeder layer of mouse embryonic fibroblasts (MEF) is required. MEFs are known as 
“feeder cells” and provide hESCs with important growth factors, which still remain 
unknown, and play important roles in the maintenance of pluripotency in culture.  
The introduction of animal cells however raises many safety concerns especially in 
terms of cross-contamination for intended clinical use. The use of MEFs in culture 
systems introduces potential non-human pathogens which could then be transfer into 
human if the same hESCs are used in a clinical environment. The introduction of non-
human pathogens in humans could have devastating effects on the health of patients. 
Additionally, non-human pathogens can evoke immune responses in recipients and thus 
alter hESCs therapeutic capacities (Kibschull et al., 2011). For these reasons, all animal 
constituents are used with caution in research, especially when intended for use in 
therapy. 
 For this reason MEFs are best avoided when investigating hESCs for the purpose of 
regenerative medicine increasingly so at the point of clinical trials. In order to avoid 
issues of contamination, technology has since evolved from the original procedure of 
hESCs culture. Currently many commercial products are available which mimic the role 
of MEFs using a range of extracellular matrices (ECMs) without the introduction of 
animal counterparts. 
 One such product is Matrigel (BD Biosciences) for example, containing components 
such as collagen IV, laminin, heparin sulphate proteoglycans and entactin, amongst 
others, are now available to overcome this issue of cross contamination (Thomson et al., 
1998; Loring et al., 2007).  
Using such products to culture hESCs is termed a “feeder-free” culture system. In the 
past the transition from a feeder culture system to a feeder-free culture system was a 
gradual process but with time this has also become a fairly easy process (Loring et al., 
2007). Cells are now almost instantaneously changed between the two culture systems  
Unlike hESCs, mouse stem cells do not require co-culturing with a feeder layer and can 
be easily be maintained in the same manner as normal mammalian cell culture (Loring 
et al., 2007).  
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In mouse stem cell (ES) culture, Leukaemia inhibitory factor (LIF), a cytokine from the 
interleukin family (IL-6) is required for the proliferation of mouse ES (Burdon et al., 
2002; Conley et al., 2004). LIF has been found to block differentiation in mouse ES by 
stabilising the LIF receptor (LIFR) and gp130 cytokine receptor heterodimer complex. 
This results in the activation of the Janus-associated tyrosine kinases (JAK) / signal 
transducer and activator of transcription (STAT3) cascade resulting in the translocation 
of STAT3 into the nucleus (Burdon et al., 2002; Conley  et al., 2004). In the nucleus 
STAT3 binds onto essential ES self-renewal locations on the DNA (Figure 1.12) 
(Burdon et al., 2002; Conley et al., 2004). 
 In the case of hESCs however, the presence of LIF seems to have no effect in 
sustaining the cells in an undifferentiated state. Research has shown that differentiation 
takes place both in the presence and absence of LIF in hESCs (Thomson et al., 1998). 
 
Figure 1.12: LIF-dependent activation of STAT3 blocks ES cell differentiation and promotes self-
renewal. Leukaemia inhibitory factor (LIF) stabilizes the association of LIFR and gp130 cytokine 
receptors activating JAK kinases, causes the recruitment, tyrosine phosphorylation and 
dimerization of STAT3 resulting in the translocation of STAT3 into regions of the DNA in the 
nucleus to important controls of self-renewal transcriptional genes. Image modified from (Burdon, 
Smith et al. 2002). 
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1.7.3 Adult Stem Cells 
Pluripotent stem cells exist in adults in various tissues and organs. These cells are 
known as adult stem cells (ASCs) or somatic stem cells. The purpose of these cells is to 
repair and maintain damaged cells or tissue in organs through the lifetime of the 
organism. These cells lie in a state of activity or quiescence within their location until 
they are required to repair or maintain damaged cells (Li & Clevers, 2010; Maguire & 
Friedman, 2014). ASCs have been found in various locations in the body, with the list 
of locations increasing with research; some of these locations include (but is not by any 
means exclusive): hair, bone marrow, gut, skeletal muscle and the brain (Li &Clevers., 
2010). 
 When damage has occurred in the body, there are many stem cell types which migrate 
to initiate a healing response (Maguire & Friedman, 2014). ASCs migrate from various 
locations in the body and release a pool of stem cell released molecules (SRM) at the 
site of damage (Maguire & Friedman, 2014).  These SRMs are specific to some degree 
to each stem cell type with some level of overlap between pools released (Figure 1.13) 
(Maguire & Friedman, 2014).  
These pools of SRM are made up of a range of molecules including (but not exclusive): 
cytokines, growth factors, chaperone molecules, microRNA and antioxidants (Maguire 
& Friedman, 2014). All these molecules are collectively referred to as SRMs. When two 
pools of SRMs are released from two different ASCs they are referred to as S
2
RM 
(Maguire & Friedman, 2014). As is obvious, all these molecules play important roles in 
the healing and maintenance process of cells. 
Studies have found that although ASCs are extensively capable of repair and 
maintenance of damaged tissue, the mere transplantation of ASCs from a young adult 
into an older adult may not reach optimal results regarding tissue regeneration and age-
related conditions (Maguire & Friedman, 2014). This is because stem cells must come 
from similar stem cell niches in order to keep their optimal regenerative properties 
(Maguire & Friedman, 2014).  
Other studies have found that the life style of an individual can have an important 
impact on the health of ASCs in the body as this can have an impact on the telomerase 
activity (Maguire & Friedman, 2014). Some research has shown that exercise, low 
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calorie intake and low stress could all contribute to extending the life span of ASCs or 
increase the lifespan of stem cell renewal activity (Maguire & Friedman, 2014). 
 Initially it was thought that ASCs were multipotent cells. The term ‘multipotent’ refers 
to the capability of cells to specialise into a limited number of cells that are closely 
related. This idea however, has since changed with various researches exhibiting the 
differentiation of ASCs into various specialised cells generated from both the same 
embryonic germ layer as well as different germ layers (Mundra et al, 2013). 
Differentiation is still however, restricted in terms of lineage in comparison to 
embryonic stem cells (Mundra et al, 2013).  
This capability of ASCs to differentiate into other specialised cells of other embryonic 
germ layers is referred to as “transdifferentiation”. These findings have opened new 
doors for the potential exploitation of ASCs in the clinical environment. The added 
advantage of ASCs for use in therapy is that, unlike embryonic stem cells (ESCs), ASCs 
do not form teratomas in the body and thus holds great potential in regenerative 
medicine.  
One example of ASCs that has received tremendous amounts of attention is a type of 
ASCs derived from bone marrow. There are two types of ASCs found in the bone 
marrow: Mesenchymal stem cells (MSCs) and Hematopoietic stem cells (HSCs) 
(Mundra et al, 2013).  
MSCs were discovered by Friedenstein and his colleagues over 40 years ago. This 
group found that a small population of cells resident in the bone marrow were adherent 
to tissue culture surfaces and were capable of differentiating into osteoblasts, 
chondrocytes, and adipocytes- cells of the mesoderm germ layer (Prockop et al., 2003). 
Following the discovery of MSCs, a number of other investigations have shown the 
differentiation of MSCs into muscle cells, neural cells as well and cardiomyocytes 
(Prockop et al., 2003). Such investigations showed that MSCs were in fact, capable of 
differentiating into specialised cells from other germ layers other than that of their own. 
This factor had therefore caused interest in MSCs for use in therapy for many diseases.  
One disease of particular interest is type 1 diabetes (T1D). T1D is an autoimmune 
disease whereby insulin-producing pancreatic β cells are identified and destroyed by an 
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autoreactive immune system. This complicates the treatment and therapy for sufferers of 
this disease. 
Current methods of treatment for T1D only provides short term treatment as it focuses 
on raising antibodies against T cells (Wu & Mahato., 2014). The complication of this 
treatment is that antibodies are unable to differentiate between autoreactive T cells and 
those that are required for the healthy maintenance of the immune system (Wu & 
Mahato., 2014). This, for obvious reasons causes many complications, as the treatment 
results in the depletion of healthy T cells that are required for the maintenance of a 
healthy immune system.  
The advantage of MSCs is that they are hypoimmunogenic, due to the lack of specific 
surface markers and additionally are attracted to injured mesenchymal tissue for repair 
(Wu & Mahato., 2014). At the target location, they can then transport soluble proteins 
to autoreactive T cells more specifically rather than affecting the whole immune system 
as a whole (Wu & Mahato., 2014).  
One group has been successful in injecting bone marrow stem cells (BMSCs) into the 
liver into order to reduce levels of anti- islet cell antibodies (ICA) and anti- glutamic 
acid decarboxylase antibodies (GAD); two important antibodies the presence of which 
has been detected in approximately 90% of cases of T1D (Wu & Mahato., 2014; 
Mesples et al., 2013). In this clinical study, 2 patients were treated with autologous 
BMSC transplantation through the liver with one patient being treated using 
conventional treatment and thus acted as the control subject. It was found that, 12 
months after the treatment, those patients treated with the BMSCs had a significant 
reduction in anti-ICA and anti-GAD levels. Results from this study provided great 
potential for the use of MSCs for an easy and effective treatment for T1D. 
The ease of which ASCs can be harvested gives good potential for the use of these cells 
in a clinical environment. Especially in terms of yield and cost as a small sample could 
easily be harvested and then potentially be expanded for use for treatment.  
Potentially, ASCs from patients needing treatment could be harvested from their own 
body; differentiated into specialised cells and transplanted back into the patient- a term 
referred to as “autologous transplantation”. This has the advantage of ruling out almost 
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all autoimmune reactivity that may be associated with this type of treatment, as the 
patient’s immune system is unlikely to reject cells from its own body.  
The disadvantage of these types of stem cells is however that the differentiation 
potential is somewhat still limited in comparison to other stem cell types. Additionally, 
the extent to the capability of these cells to differentiate into other functionally mature 
cells of other embryonic germ layers is yet to be understood. More research is still 
required before these cells can comfortably be brought from the bench to the bedside as 
many safety issues still remain unanswered. Furthermore, the potential of the use of 
APSCs would be greatly increased once issues concerning environmental niches 
surrounding these cells have been resolved. This could open new doors to the concept of 
donors which would have a significantly, positive effect in terms of cell therapy and 
regenerative medicine. 
 
Figure 1.13: A diagram of adult stem cell (ASC) healing response to damage. The image was taken 
from Maguire & Friedman., 2014. 
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1.7.4 Induced Pluripotent Stem Cells 
In 2006, Takahashi and Yamanaka showed that by exposing somatic cells to 
transcription factors Oct3/4, Sox2 as well as tumour-related factors c-Myc and Klf4, the 
differentiation commitment could be reprogrammed to produce cells with a pluripotent 
nature. These cells were named induced pluripotent stem cells (iPSC). Initially a panel 
of 24 genes that played important roles in maintaining pluripotency was transfected into 
MEF cells using a retrovirus. Other investigations have used other delivery systems 
using adenoviruses to avoid potential introductions of mutations, but with a significant 
decrease in yield (Stadtfeld et al., 2008). These cells were then exposed to a 
combination of factors Oct3/4, Sox2, c-Myc and Klf4. By culturing cells in ES 
conditions, somatic cells were reprogrammed to become cells resembling those in an 
embryonic state (Figure 1.14). Further research has found that other combinations can 
be used to substitute c-Myc and Klf4 to produce both mouse and human iPSCs 
(Nishikawa et al., 2008).  
The method of creating iPSCs since its origin has become a robust and practically 
straight forward process. The major advantage of this process is that it takes away the 
ethical issues surrounding the use of original stem cells, as these involve invasive 
methods of cell collection from the inner cell mass of a blastocyst of a pre-implanted 
embryo. It also opens up great potential for regenerative therapy and customised 
therapy. This is because this technology has potential to de-differentiate cells from a 
patient and to re-direct differentiation of these cells to replace degenerate cells from the 
same patient, overriding many difficulties facing autoimmune rejection. 
iPSCs could also provide vast information on disease pathways at a cellular level which 
could be used to gain a better understanding of some diseases providing great human 
models for research purposes. For example, cancer is an extremely prevalent disease 
many types for which, a lack of understanding stands in the way of treatment. It is well 
known that along with many other factors, epigenetic programming plays an important 
role in cancer formation (Nishikawa et al., 2008).  
By de-differentiating cancerous cells and allowing cancer derived iPSCs to form cells of 
its original state, a better understanding of the epigenetic changes that take place in the 
progression of cancer could be gained.  This could aid immensely in the treatment of 
many cancers. 
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An example of the use of iPSCs is a proof of concept study carried out in 2007, by 
Hanna and her group, for a mouse model for sickle-cell anaemia (Tahashi & Yamanaka, 
2013). This study involved the harvest of mouse fibroblasts from a humanised sickle 
cell anaemic mouse, which were then de-differentiated to create iPSCs. The genetic 
mutation causing β sickle cell anaemia was then corrected and the cells were then 
differentiated into haematopoietic progenitor cells and transplanted back into the mouse 
(Hanna et al., 2007).  
Such investigations provide great scope for potential therapy but in more realistic terms 
such customised approaches will be extremely costly. In addition to this, if only cells 
from the patient is used in this technology for treatment of disease, it could be very time 
consuming, which for some diseases such as spinal cord injury will not be a feasible 
approach in terms of treatment regimes. 
Another advantage of these cells is that because they can be produced from any human 
cells. Any side effects caused from specific drugs or even the lack of effectiveness 
could be well investigated using these iPSCs and thus has potential to provide an 
essential tool in monitoring drug safety in drugs that are already on the market 
(Nishikawa et al., 2008). 
Whilst hurdles are still to be overcome in terms of use in therapy, iPSCs could also be 
an important tool to gain vital information concerning the progression of diseases. This 
may in turn aid profusely in the develop treatment for diseases where little is still 
known. 
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Figure 1.14: The process of reprogramming between embryonic stem cells (ES) and somatic cells. 
The diagram depicts that all differentiated cells (somatic cells) in the body are derived from 
pluripotent ES cells. Somatic cells can then be reprogrammed into iPSC cells using a combination 
of transcription factors, the successful combinations of which are shown in the indicated box. The 
question mark represents that the lack of understanding between ES cells and iPSCs. Image taken 
from Nishikawa et al., 2008. 
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1.8  Differentiation of Human Stem Cells 
One of the major challenges of human stem cell culture is to find an efficient protocol to 
direct hESCs into specific lines of differentiation; and although various methods exist 
for the differentiation of mouse ES cells, variations in success have been found when 
these same methods have been applied to hESCs. There are 2 main methods of 
differentiation in hESCs: embryoid-body (EB) protocol and monolayer protocol.  
 
1.8.1 Differentiation of Human Stem cells through EBs 
Mouse ES cells can simply be differentiated by dissociating the culture into single cells, 
a process that has been found to be fairly detrimental to hESCs. 
 It has been found that by dissociating hESCs into smaller, free-floating aggregates 
termed embryoid bodies, cells can be directed into different lineages. The route of 
differentiation hESCs take is dependent on the type of chemically defined media these 
aggregates are cultured in and the time period (Loring et al., 2007). Aggregates can be 
directed down various lines of differentiation.  
For example, cardiomyocytes have been formed by plating EBs onto gelatin coated 
dishes after a culture period of 7-10 days in suspension (Kehat et al., 2001).  Of the 
examined EBs approximately 10% exhibited contracting areas which stained positive 
for cardiac-specific proteins (Kehat et al., 2001).  
The formation of EBs has also been used to drive differentiation of hESCs into 
derivatives of endothelial cells. One such study formed EBs from the H9 hESCs clone 
and analysed RNA extracted from different time points of the differentiation protocol. 
This study tested for known endothelial markers PECAM1 (CD31), vascular 
endothelial-cadherin (VE-cad and CD34) and vascular endothelial growth factor 2 
(VEGFR-2/Flk-1/KDR) amongst others (Levenberg et al., 2002). This investigation 
found that maximum gene expression of PECAM1, VE-cad and CD34 occurred during 
day 13-15 of EB formation, suggesting that these cells had been directed towards the 
differentiation of endothelial cells during this period (Levenberg et al., 2002). It is 
important to note however, that although this protocol produced cells exhibiting the 
phenotype and specific markers of endothelial cells, the method is not an efficient 
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process, as only 2% of grown cells were capable of organising into structures indicative 
to blood vessel formation (Levenberg et al., 2002). 
Although only two cell types have been discussed above which use the EB protocol to 
direct differentiation of hESCs, this protocol has been successfully used to direct 
differentiation of hESCs into various other cell derivatives including pancreatic cells, 
neural cells and photoreceptor precursors amongst others (Conley et al., 2004). 
Although differentiation can be directed to a certain extent by forming EBs, 
differentiation of hESCs has also been found to occur spontaneously. Spontaneous 
differentiation has been found to occur in cells cultured in serum-free conditions as well 
as serum supplemented media; but the during spontaneous differentiation it is often very 
difficult to direct the differentiation of hESCs down a specific lineage.  
The original differentiation process through EBs remained a fairly unpredictable and in 
most cases inefficient system. This is largely due to the fact that EB sizes were beyond 
control and left to the course of nature. Depending on the size of cells mechanically 
removed from an original culture source, which is by no means a uniform process, 
would then govern the size of aggregates formed in suspension. A single suspended 
culture system could therefore hold a number of EBs in varying sizes.  
This heterogeneity in cultures then leads to inefficient and uncontrollable 
differentiation. Additionally, any single cells remaining in suspension that had not 
conformed to an existing aggregate is then vulnerable to waste. Eventually during 
culture maintenance processes which may include media change processes, these cells 
would then eventually be discarded. This can result in the loss of a large cell population, 
leading to a major reduction in efficiency of the differentiation process.  
Whether the size of aggregates can contribute to directing pluripotent hESCs down 
specific lineages remains unclear. A heavy importance is given to uniformity and 
creating a homogenous population of cells. Creating uniform EBs would only be 
beneficial for investigative purposes. 
 In light of this, recent advances in technology have now addressed this very issue. 
Currently, Stem Cell Technologies have produced plates called AggrWell in order to 
address the issue of heterogeneity amongst EB differentiation. These plates have a 
number of microwells (Figure 1.15A), each specified to a dimension which is dependent 
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on the plate size. As expected, a larger sized microwell would therefore produce larger 
aggregates.  
A suspension of cells is then added to these plate types and centrifuged in order to 
distribute cells evenly across the whole plate and are cultured for a minimum period of 
24 hours to allow the formation of aggregates in each microwell. This creates a more 
uniform population of EBs in comparison to the original approach in creating EBs 
(Figure 1.15 B&C). 
 EBs formed using this technology are more uniform in terms of size and shape and thus 
aids in the standardisation of protocols, which was not possible prior to such 
technologies.  
By standardising such methods of differentiation, any results of investigations using 
such technologies can confidently express results.  
 
Figure 1.15: Image of AggrWell plates from Stem Cell Technologies. Image of a magnified 
AggrWell plate. B) Image of heterogeneous population of EBs formed using traditional methods. C) 
Image of a more uniform population of EBs formed using an AggrWell plate. Images taken from 
http://www.stemcell.com/~/media/Technical%20Resources/9/29146MAN_3_0_0.pdf 
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1.8.2 Monolayer Differentiation of hESCs 
The term monolayer differentiation refers to a process of differentiation whereby EBs 
are not cultured in a suspended culture system. Instead, in the same way as hESCs are 
cultured in a monolayer to retain pluripotency, cells are differentiated whilst still 
attached to a monolayer. 
 Researchers have found that by culturing undifferentiated hESCs in serum-free media 
as normal on mouse embryonic fibroblasts and co-culturing with either mouse bone 
marrow stromal cells or mouse yolk-sac endothelial cells for 17 days, hESCs can be 
directed to differentiate into hematopoietic cells with differentiated cells being cultured 
in 20% serum supplemented media (Kaufman et al., 2001). Of the isolated 
differentiated cells however, only 1-2% exhibited positivity for CD34
+
, a known early 
hematopoietic cell marker suggesting a small percentage of differentiated cells were 
successfully directed into hematopoietic-like cells (Kaufman, Hanson et al. 2001). 
 This method of differentiation can also be referred to as monolayer differentiation as no 
formations of EBs is required and cells are continually grown on a monolayer. 
This type of differentiation has been readily used to direct differentiation of hESCs into 
cardiomyocytes, trophectoderm and neural cells amongst others with varying degrees of 
success. 
Although both EB and monolayer differentiation process have been successful in 
differentiating pluripotent hESCs into specific cells types, the differentiation of higher 
order structure  remains to be a challenge (Liu et al., 2013). 
 The issue with differentiation of pluripotent hESCs is the maintenance of viability of 
cells as well as creating a homogenous population-which in most cases is almost near 
impossible using current technologies. 
Although protocols have been produced to differentiate hESCs into different cell lines 
the efficiency and success of these methods require a large amount of optimisation and 
remains a difficult hurdle in the world of stem cell research, more so for some lineages 
than others. 
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1.9  Retinal Differentiation of pluripotent hESCs 
As discussed previously, it is extremely difficult to direct hESCs down specific lines of 
differentiation. The differentiation of photoreceptors has not been found to be an easy 
process either! There are a number of protocols that have been developed and have 
shown to direct hESCs into eye field precursors with varying efficiencies. Currently 
however, no methods to date have been shown to efficiently produce required retinal 
cells with a pure population. Therefore the struggle to produce a perfect protocol for 
purposes of treatment for degenerative eye diseases is still present. 
 Some of the currently available protocols are discussed later in this chapter. One of the 
hurdles lies within establishing an environment that mimics the retinal environment 
during embryogenesis.  Many pathways have been found to play important roles in the 
differentiation process of photoreceptors in nature and thus complicating the issue of 
creating optimal environments for this process in vitro. One such pathway which holds 
great importance in the differentiation of photoreceptors is described in the following. 
 
1.9.1  Wnt signalling 
Wingless (Wnt) has been found to be play an important role in many processes of 
embryonic development and adult tissue. Controlled Wnt signalling has been found to 
play an extremely important role in forebrain patterning with disruptions resulting in 
adverse effects on the formation of the eye.  
Wnt binds a cell-surface receptor complex made up of Frizzled and low density 
lipoprotein receptor-related protein (LRP) which activates the dishevelled (Dsh) protein 
which in turn inhibits a large degradation protein complex, made up of three main 
proteins: glycogen synthase kinase-3β (GSK3β) which phosphorylates and marks the 
protein for ubiquitylation, adenomatous polyposis coli (APC) which promotes affinity 
of the degradation complex to β- and Axin which acts as a scaffold protein holding the 
complex together.  
As a whole this degradation complex functions to phophsphorylate and ubiquitinise β-
catenin, therefore the inhibition of this complex result in the accumulation of 
unphosphorylated β-catenin in the cytoplasm. This accumulation, results in the 
translocation of the β-catenin into the nucleus where it displaces the Groucho in the 
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Groucho/Lymphoid enhancing factor 1 (LEF-1)/T cell-specific transcription factor 
(TCF) complex (Alberts et al., 2002). This induces transcription of Wnt target genes 
(Alberts et al., 2002). 
 In the absence of Wnt, β-catenin is readily phosphorylated and degraded. This pathway 
is referred to as the canonical Wnt pathway. 
Wnt signalling can also takes place via the non-canonical pathway in a β-catenin 
independent manner. Although Wnt is clearly required for the formation of the eye 
field, overexpression has been found to result in a decrease in eye size while in contrast 
Wnt antagonists such as dickkopf 1 (dkk1) and Secreted Frizzled related proteins 
(SFRP) are capable of increasing and expanding eye size and eye field marker 
expression (Shinya et al., 2000; Esteve et al., 2004).  
To add to the confusion, Wnt signalling through non-canonical and canonical pathways 
can also have opposite effects on eye formation. For example, in zebra fish, whilst the 
canonical pathway inhibits eye field specification the non-canonical pathway promotes 
eye field formation (Cavodeassi et al., 2005).This suggests that both canonical and non-
canonical signalling of Wnt is a highly controlled process, where different signalling 
pathways are induced at different stages for the correct development of the eye and is in 
fact a puzzle within its self, within the world of eye development research. 
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1.9.2 Current Methods of Photoreceptor Differentiation of Stem 
Cells 
There are currently several protocols available with varying degrees of success to 
differentiate hESCs into photoreceptors. Each holds its own specific advantages and 
disadvantages, although no single protocol to date has successfully produced a fool 
proof method of converting hESCs into photoreceptors with 100% efficiency. 
Although not many protocols exist for the differentiation of photoreceptors when 
comparing differences in methods it is clear that practically not many differences exist. 
All protocols include the formation of EBs (or EB-like aggregates) as the primary stage 
followed by a period of free-floating maintenance; a plating stage to adhere cells to a 
monolayer differentiation system followed by maintenance of cells in chemically 
defined media for a set period of time. What appear to be minor changes between 
protocols however may hold the key to success.  
The formation of EBs (or EB like aggregates), being the primary stage of photoreceptor 
differentiation, is one of importance. It is apparent that in the case of EB formation, 
groups are divided between formation in serum enriched media and the use of a serum 
replacement, the later method referred to as serum-free culture.  
Serum-free culture of EBs involves either culturing cells in suspension for a period of 4 
days substituting knockout serum for a commercially available knockout serum 
replacement (at 20% final volume of media) or culturing in suspension in decreasing 
concentrations of serum replacement (Meyer et al., 2009; Osakada et al., 2009).  
The latter method involves the culture of EBs in an initial concentration of 20% (final 
volume) for a period of 6 days, proceeding to a concentration of  15% of (final volume) 
for a further 9 days, down to 10% (final volume) for the rest of the protocol leading to 
an extended period of EB maintenance of approximately 20 days. EB-like aggregate 
formation using serum enriched media however, requires no gradual reduction in serum 
concentration and is only maintained in suspension for a period of 3 days (Lamba et al., 
2006; Osakada et al., 2009).  
The reason behind the gradual decrease in serum replacement is not clear. This is 
because, if constituents of the serum replacement resulted in a negative effect on hESCs 
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differentiation or hESCs cell proliferation then it would be assumed that this would be 
discussed in studies omitting this stage. On the other hand, the same discussion would 
be expected if this process had a positive effect towards committing hESCs. The fact 
that some groups such as Meyer et al., (2009), which have successfully shown to direct 
differentiation of hESCs into photoreceptors using a serum-free approach without 
gradual reduction to EB-like aggregate formation, suggests that the incorporation of a 
gradual reduction in serum replacement, as shown by Osakada et al.,(2009), is not an 
essential part of the process. Especially as this step requires an increased volume of 
consumables and takes a longer period. On the other hand, the extended time period of 
EB culture may or may not contribute to the success of the differentiation protocol.  
As none of the currently available protocols comment on the number of aggregates 
produced it is difficult to conclude the success of discrete variations between protocols. 
From a personal perspective, although long period of suspension culture of EB will 
essentially allow more time for differentiation to take place within the aggregate 
conformation, it must be noted that it may not necessarily result in the differentiation of 
target cells.. This is an important factor that must be taken into consideration when 
directing hESCs into photoreceptor. 
Another difference in protocols is the need to remove feeder cells from the 
undifferentiated population of hESCs. Whilst some groups direct differentiation of 
photoreceptors in a mixed population of hESCs and feeder cells, others include steps to 
create a pure population of hESCs to carry forward with the differentiation. 
 From a practical perspective, feeders are inactivated cells and therefore should not 
interfere with any hESCs activity. The removal of these cells from the population 
however, results in the elimination of any potential interference that may be caused by 
these cells. Additionally, with any potential therapy, animal contaminants are highly 
unfavourable therefore removing contaminants early on in the investigation can only be 
beneficial. 
Following the EB formation, common to all current protocols, is the attachment of cells 
onto a growth surface usually covered in a coat of extracellular matrix (ECM) proteins. 
Although a common procedure, there is wide variation in the preference of ECM 
proteins used. It is not surprising that ECM proteins are commonly used during the 
      
 
59 
 
attachment stage of the differentiation protocol as the attachment surface has an 
influence on many cellular pathways such as cell spreading, proliferation ect.  
Peptide recognisers known as integrins are responsible for the regulation of intercellular 
signalling, cell-to-cell signalling as well as surface attachment;  the signal regulation is 
dependent on which peptide the integrin recognises (Hidalgo-Bastida and Cartmell, 
2010). As ECM proteins are made up of various different sequences they can be readily 
used to mimic the cellular micro-environment to encourage processes such as 
differentiation.  
In light of this fact, although initially the variation in ECM proteins used in various 
protocols of photoreceptor differentiation may have been a fairly small factor to be 
considered, it is now clearer that these ECM proteins may in fact hold an important role 
in the direction of photoreceptor differentiation. 
 While some groups have used a single ECM protein such as laminin, others have opted 
for a combination of laminin and fibronectin.  Some have preferred a commercially 
available feeder replacement such as Matrigel, discussed earlier in this chapter, as a 
substitute for feeder cells.  
As a matter of opinion, the combination of ECM proteins may greatly impact the 
process of differentiation. This is due to the fact that they can be used to create a closer 
match to the natural micro-environment of cells during photoreceptor development. 
Further investigations are however required to identify whether or not a single ECM 
protein can significantly increase the efficiency of a specific protocol or whether a 
combination of ECMs would be more beneficial. If so, which combination would create 
an optimal environment to efficiently direct differentiation of hESCs into 
photoreceptors. The use of Matrigel however, is not encouraged, as the constituents of 
this product remain undefined. This therefore creates many safety concerns for potential 
use in a clinical environment for therapy.  
The culture of cells after attachment in a chemically defined media seems to play an 
extremely important role in the differentiation process of hESCs into photoreceptors, as 
all current protocols include this step. Common to all protocols the chemically defined 
media seem to include an enriched source of neural growth supplements such as N2 
supplement and B27 supplement (increases long-term viability of neurons), to steer 
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hESCs down the retinal lineage with varying concentrations. This is clearly a necessity 
for the differentiation of photoreceptors. It must be noted however that whilst some 
positive results has been recorded with only a single addition of a supplement to the 
chemically defined medium, others have recorded success using a combinations of both 
neural supplements mentioned above. 
Whilst every effort must be made to create an environment as close to the natural 
environment,, the cost of therapy must also be taken into consideration. In the case of 
supplement additions, if reduced additions of supplements could still achieve the 
successful direction of hESCs into photoreceptor precursors, then it is wise to add fewer 
supplements, purely in terms of cost effectiveness. 
Additions of inhibitors of Wnt signalling during the EB formation and maintenance are 
a common procedure in many protocols attempting to drive differentiation down the 
photoreceptor lineage. The addition of dickkopf 1 (dkk1), a known Wnt inhibitor is 
commonly added to the chemically defined media - although at different concentrations 
depending on the protocol. The importance of the absence of endogenous Wnt3A and 
bone morphogenetic protein (BMP) 4, especially during early stages of this process 
holds great importance. The inhibition of both Wnt3A and BMP is known to result in 
the generation of retinal progeny in blastomeres. The importance of this is more so 
evident from an investigation carried out by Meyer and his group in 2009. This study 
showed that the addition of Wnt3A to cultures during the first 10 days of culture, during 
and briefly after suspension culture of cells, in fact resulted in the abolishment of Pax6 
and Rx expression in cells (Figure 1.16) (Meyer et al., 2009). 
 
 
      
 
61 
 
 
Figure 1.16: qPCR of cells treated with and without (control) endogenous Wnt3A and BMP4 
during the first 10 days of differentiation process of eye field cells. Addition of Wnt and BMP4 
resulted in loss of Pax6 and Rx expression in comparison to cells treated without endogenous 
Wnt3A and BMP4. Image retrieved from Meyer et al., 2009. 
 
The absence of endogenous Wnt and BMP is evidently important for the differentiation 
process of photoreceptors. It is however, questionable whether this requires the addition 
of inhibitors such as Dkk1, as commonly used. This is because the protocol developed 
by Meyer et al., in 2009, does not at any point in the protocol add inhibitors such as 
Dkk1 to the chemically defined media. However, this protocol continued to produce a 
high percentage of eye field-like cells. Additionally although Meyer et al., 2009, added 
N2 supplement in the chemically defined media, no other neural inducers such as 
noggin (used by Lamber et al., 2006) or nodal inhibitors such as LeftyA (as used by 
other groups) are included. This protocol still remained to successfully produce 
photoreceptor precursor-like cells. This again questions the necessity of these additions 
(Osakada et al., 2008;Hirami, Osakada et al. 2009; Osakada et al., 2009).  
It must be noted that in the protocol produced by Lamba et al., 2006, the addition of 
combinations of IGF1, Dkk1 and noggin to attached cultures for a week, resulted in a 
clear increase in many of the eye field transcription factors (EFTFs) (Figure 1.17). 
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Figure 1.17: QPCR analysis of eye field transcription factors after 1 week culture with combination 
of IGF1, Dkk1 and noggin. (Lamba et al., 2006). 
 
Retinoic acid has been shown to play an extremely important role in retinal 
development as has taurine. Retinoic acid has been shown to increase cells that later 
developed into photoreceptors in a dose-dependent manner when added exogenously in 
mice (Figure 1.18). This also resulted in having teratogenic effects at high 
concentrations, clearly reflecting the importance of this acid in eye field development 
(Kelley et al., 1994; Sernagor and Lemp, 2006).  
Investigations have also shown that the deletion of the gene expressing taurine (Taut) 
results in severe retinal degenerations through photoreceptor apoptosis, again reiterating 
the importance of the role of taurine (Heller-Stilb et al., 2002). In light of this, the 
reason behind the addition of retinoic acid and taurine is evident in the differentiation of 
photoreceptors. Although many groups have included these additions other groups have 
again, also succeeded in producing photoreceptor precursors without these additions or 
any replacements. 
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Figure 1.18: Response of mouse embryonic stem cells cultured in varying concentrations of retinoic 
acid. Image retrieved from Kelley et al., 1994. 
 
In summary, these protocols can be grouped into three main protocols: (1) serum culture 
and neural growth supplements and only includes a 3-day EB formation protocol as 
produced by Lamba et al., (2006), (2) serum free culture of EBs in a gradual decrease of 
serum replacement followed by many groups and (3) the serum free culture without a 
gradual reduction in concentration as produced by Meyer et al., (2009). 
The results obtained by the main groups that have reported successful differentiation of 
photoreceptors is summarised in Table 1.1. 
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Table 1.1: A summary of the main photoreceptor differentiation protocols with results. 
 
(i) Cells not aggregates 
(ii) Note cell line 201B6 did not express Crx or Rho 
(iii) Percentage of expressing cells 
 
When comparing results obtained by various groups together with the main differences 
between groups it is evident, in my opinion, that the increased number of inducers and 
extended period of gradual reduction in serum replacement is not reflected highly in the 
results. 
 The protocol devised by Osakada and his group (2009) requires many inducers with the 
addition of Y-27632, a Rho-associated kinase inhibitor which aids to stop cell death 
associated with dissociation. During the extended EB culture, the production of neural 
retinal progenitor cells and photoreceptor precursors does not match the higher 
percentages produced by other protocols. 
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It must also be noted that whilst groups incorporating the serum replacement reduction 
stage they report results as a percentage of aggregates formed. This does not include the 
number of cells that are actually expressing specific genes, which would be a more true 
representation of results. In this case, in extreme circumstances, whether 2 cells or 100 
cells in an aggregate expressed a certain gene, this aggregate would be recorded as a 
“positively expressing” aggregate. This form of analysis has the potential of results 
being misconstrued.  
When comparing protocols it is evident from Table 1.1 that the highest percentage of 
neural retina progenitor cells have been reported by Lamba et al.,(2006) (Figure 1.19 A 
and B) and Meyer et al., (2009) (Figure 1.20 ). Whilst Lamba and his group use 
knockout serum and the addition of other inhibitors, Meyer and his group use serum 
replacement without reduction of serum replacement, inducers or inhibitors. 
Additionally these two protocols also require the shortest time periods in comparison to 
the five protocols discussed.  
Although Lamba et al., (2006) have produced the shortest of all protocols with the 
whole process only lasting 21 days. A good correlation was found in EFTF expression 
between 91 days (after conception) human foetal retinal cells and differentiated hESCs 
(Figure 1.21). This builds confidence in this method as a potential therapeutic process 
although this time period is still a fairly prolonged process. 
 In the case of photoreceptors production however, it is also important to note that 
Lamba and his group (2006) were not successful in producing photoreceptor-like cells. 
This is because expression of opsin and rhodopsin was only recorded in less than 0.01% 
of cells, a result that would not be satisfactory or feasible for use in therapy. 
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Figure 1.19: Expression of retinal markers from retinal induced hESCs. A) Expression of Chx10 in 
induced hESCs. Arrows indicate cells that expressed Chx10 (red) but not Pax6. (B) Expression of 
Pax6 (green) in induced hESCs. Modified from Lamba et al., 2006. 
 
 
 
 
 
 
 
 
 
Figure 1.20: RT-PCR of gene expression during first 16 days of eye field differentiation of hESCs. 
Retrieved from Meyer et al., (2009). 
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Figure 1.21: QPCR analysis of various genes between cells from a 91 day human foetal retina and 
hESCs after a 3 week culture condition. (Lamba et al., 2006). 
 
In the case of the protocol produced by Meyer et al., 2009, in comparison to other 
protocols, the production of photoreceptor-like cells is significantly improved.  In terms 
of use of protocols for the purpose of production of cells for therapy; the protocol 
produced by Meyer and his group is still extensive. It could however, be argued that 
from a cost perspective, as this protocol uses minimal reagents in comparison to other 
protocols, costs may be recuperated from the loss of time endeavoured by the extensive 
process.  
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1.10 Retinal Co-culture with hESCs and Photoreceptor Differentiation 
 
Interestingly, it has been found that co-culture of early retinal progenitor cells with 
mature retinal cells efficiently enhances differentiation of these cells into 
photoreceptors. Firstly developed in mouse ES cells (mES), rhodamine labelled mES 
cells (1x104 cells) was cultured in a serum free EB culture system for 5 days. The 
chemically defined medium had additions of inhibitors such as Dkk1, LeftyA and 
activin (SFEB/DLFA), a known photoreceptor inducer. These cells were then co-
cultured with GFP labelled mouse retinal cells (1:50) for 12 days in chemically defined 
media (Ikeda et al., 2005; Kanno et al., 2009). This co-cultured medium had the 
addition of serum (Figure 1.22A) (Ikeda et al., 2005; Kanno et al., 2009). This culture 
was found to have induced mES cells into expressing photoreceptor genes (Ikeda et al., 
2005; Kanno et al., 2009). 
 This process resulted in 36% of labelled ES cells to be identified in enriched areas of 
embryo-derived photoreceptors cells (which formed clusters). These clusters of cells 
were observed to express rhodopsin and recoverin. Interestingly it was also noted that 
mES cells that were not present near the photoreceptor cluster did not express 
photoreceptor markers (Figure 1.22 B and C). This suggests that the microenvironment 
of the immediate vicinity of exogenous photoreceptors may hold an important role in 
directing differentiation of mES cells towards the photoreceptor lineage (Ikeda et al., 
2005).  
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Figure 1.22: Generation of photoreceptors from mES cell co-culture with mature retinal cells. 
(A)Schematic of mES cells (red) co-culture with mature retinal cells (blue). (B) Rhodamine 
expressing SFEB/DLFA mES cells (red) were cultured with GFP expressing retinal cells. 
Rhodopsin (blue) expressing mES cells (red) did not express GFP in C. Modified from (Ikeda et al., 
2005).   
 
Following a  similar method in hESCs, groups have found that by coculturing hESCs 
derived progenitor cells with  retinal extracts from GFP expressing mice (6 days) these 
progenitor cells readily integrate into mice retinal extracts with a majority of these cells 
expressing Pax6 (Lamba et al., 2006). Interestingly, hESCs were co-cultured with both 
wild-type and mutant mice retina. The later was found to result in photoreceptor 
degradation, and it was found that hESCs derived retinal progenitor cells expressing 
recoverin readily integrated into the mouse retina and cells resembling photoreceptors 
were  observed (Figure 1.23) (Lamba et al., 2006). 
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Figure 1.23: hESCs derived retinal progenitor cell co-culture with Aip1-/- GFP mice retina labelled 
with human nuclear marker (blue) and recoverin (red). Image retrieved from Lamba et al., 2006. 
 
These results are encouraging and give hope that progenitor cells produced by these 
protocols capable of integrating into the correct part of the retina. It must however, be 
noted that, to ensure these progenitors are functionally normal, assays are required to 
stipulate whether this integration does in fact repair visibility in the mice and if so to 
what extent. 
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1.11 Retinal Transplantation 
Transplantation of brain and retinal derived stem cells have been shown to be 
unsuccessful in the integration of the outer nuclear layer of the retina failing to 
differentiate into photoreceptors (MacLaren et al., 2006). An exciting investigation 
however has found that via transplanting retinal cells taken at the height of rod genesis, 
into the outer nuclear layer of the retina, these cells are capable of integrating in the 
correct location with >95% in the correct orientation (MacLaren et al., 2006). 
In this particular investigation carried out by MacLaren and his group in 2006, retinal 
cells from transgenic mice were extracted at postnatal day 1. These cells contained a 
GFP reporter gene and at this time point cells were at the peak of rod genesis. These 
cells were then injected to the outer nuclear layer of the retina (~2x10
5
 cells) of wild-
type littermates. Three weeks later approximately 10-200 cells (in each eye) were 
observed integrate into the correct position with morphological characteristics similar to 
that of mature photoreceptors (Figure 1.24) (MacLaren et al., 2006).  
 
 
Figure 1.24: Transplantation of P1 transgenic retinal cells into immature wild type littermate (3 
weeks post transplantation). Image retrieved from MacLaren et al., 2006. 
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In order to identify whether this transplantation was only successful in immature retinas, 
the same population of cells were also transplanted into adult wild-type retina (~8x10
5 
cells). Contrary to other research it was found that these cells again successfully 
integrated into the outer nuclear layer (~300-1000 cells) as observed in immature retinas 
and taken the form of rod photoreceptors (Figure 1.25). The fact that the majority of 
transplanted cells had taken form into rod-like structures is not surprising, given the 
transplanted population of cells was taken at a time point which was at the peak of rod 
genesis. 
 The majority of the cells within this population must have been in the differentiation 
process of rod photoreceptors resulting in the further differentiation into rod-like 
structures after transplantation. This integration was also not due to fusion between host 
and transplanted cells as DNA labelling confirmed that cells only contained one nucleus 
from the donor. 
 
Figure 1.25: Transplantation of P1 cells from transgenic mice into wild-type mature retina. Image 
retrieved from MacLaren et al., 2006. 
 
As the transplanted population within this investigation contained a mixture of cells at 
different stages of the differentiation process, in order to identify which specific 
population was most successful in integrating into the retina cells were extracted at 
different time points. The first time point of extraction began with embryonic day 11.5 
(E11.5), where the majority of cells would consist of progenitor cells; E16.5 and 
postnatal day 1 (P1)-P15. These populations extracted for transgenic mice were 
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transplanted into wild-type adult mice and interestingly it was found that cells that cells 
extracted between P1-P7 had the highest number of integrated cells in comparison to all 
other ages of cells. The highest cell integration of cells was found between P3-P5, 
where most cells would have been at the precursor stage (Figure 1.26) (MacLaren et al., 
2006). 
 
Figure 1.26: A chart of the number of integrated cells from each population of transplanted cells. 
(MacLaren et al., 2006). 
 
As a large population of viable cells were obtained from each of the transplantations it 
is apparent that in earlier aged populations, the lack of integration was not due to the 
lack of cell survival. This was more due to the fact that cells have a higher probability of 
integration when transplanted at the precursor stage and not at the progenitor or late 
differentiation stage. This was evident as cells transplanted from an adult retina also did 
not integrate successfully into the host. Additionally when transplanted cells were tested 
in rho
-/-
 mice, which do not have functional rod photoreceptors, transplanted mice 
showed a response to light in comparison to un-injected mice. This suggests that 
transplanted cells also exhibited functionality, an exciting finding for the therapy of rod 
regeneration. 
The investigation described above clearly shows the successful integration of 
transplanted rod precursor cells into the retina with cells exhibiting specialised 
morphologies similar to mature photoreceptors. Although this in itself, this is exciting in 
the world of regenerative medicine for the treatment of many ocular diseases, it still 
remains unclear whether transplanted cells are capable of improving vision. Without the 
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actual improvement of these cells after transplantation, this line of research could 
potentially be rendered useless in terms of clinical therapy for sufferers of ocular 
diseases. 
Currently no reports of photoreceptor transplantation have actually been found to 
improve vision. This could possibly be due to the low numbers of transplanted cells, as 
typically, less than 1000 cells have been transplanted (Pearson et al., 2012). In order to 
identify whether transplanted rod-precursor cells result in any improvement to vision, 
Pearson and his group constructed a study in 2012. In this study, rod-precursor cells 
were tagged with GFP (Green fluorescence protein) under the control of the Nrl 
promoter. 
 Nrl is a transcription factor and marker for rod precursors. Transplanted donor cells 
could then be identified by the GFP. Approximately 200,000 donor cells were 
transplanted into wild type mice, a vast increase in the number of transplanted cells by 
most groups. These cells were then injected into the retina of wild type mice and 
although integrated cells were found to be predominantly located at sights of injection a 
distribution of donor cells were also found to cover approximately 50% of the retina as 
a whole.  
In order to investigation the functionality of donor cells, rod-precursors were also 
transplanted into a Gnat1
-/- 
mouse model. This mouse model was chosen as these mice 
lack α-transducin (Gnat1), which plays an essential role in rod phototransduction. Thus 
these mice lack any rod function or behavioural response to stimuli. Although these 
mice lack rod function it is important to note that they do not lack cone function. In fact, 
these mice have full functional cones, with both histology and behavioural response to 
visual stimuli.  
Transplantation of recombinant rod-precursors, in this study found donor cells to 
integrate in the outer nuclear layer of the retina (Figure 1.27A). This integration was 
found to be to similar in numbers as the wild type control exhibiting morphologies also 
similar to wild type rods. Additionally, integrated donor cells were found to co-express 
α-transducin. During normal vision, α-transducin is translocated depending on the type 
of light present; in dim or dark light α-transducin is expressed in the outer segment of 
the retina whilst in bright light it is found to be expressed in the inner and synaptic 
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segments (Kerov et al., 2005). Pearson et al., 2012, found that integrated rod-precursor 
cells also displayed the correct translocations in dim a bright light (Figure 1.27B). 
 
Figure 1.27: Transplantation of rod-precursor cells in Gnat1-/-  mice. A: Image of integrated 
recombinant rod-precursor cells (green) in Gnat1-/-  mice. B&C: Image of Translocations of 
integrated donor cells (in green) in dark light (B) and bright light (C). Image retrieved from 
Pearsons et al., 2012. 
 
All the results at this point in this investigation give evidence of successful integration 
of donor cells into the expected regions of the retina. In addition to this, translocation 
data further showed the correct functioning of these cells in vision. In order to 
investigate whether the transplantation of these cells had a significant improvement on 
vision, Pearson and his group then went onto take optomotor head response readings. 
These readings were taken both before and after transplantation had been carried out in 
order to give a true reflection of the results of transplantation.  
It was found that before transplantation, no responses were made in Gnat1
−/−
 mice in 
scotopic light levels (dim light). This was as expected as these mice lack α trasducin 
which therefore renders the functionality of rod photoreceptors, which are only function 
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in dim light. After 4-6 weeks post-transplantations readings were only recorded in mice 
where the transplantation had been carried out, although visual acuity was found to be 
poorer in animals in dim conditions than photopic condition.  
No change in readings under photopic conditions were found, again an expected results 
as cone functionality remained unaffected in these models. Mice were also subjected to 
visually guided water-maze test which would require cognitive processing of visual 
images. In these tests post-transplantation mice were found to have completed the maze 
in 70% of trials. Additionally, it was found that mice that mice who had an integration 
of cell in clusters rather than a wide distribution performed better at completing tasks. 
This investigation was successful in the transplantation of rod-precursor cells and also 
found that transplantations could not only mimic mature cell functionally but could also 
improve vision. Additionally, results discussed clearly highlight the importance of cell 
numbers for successful transplantations and also the importance of integrated cells to be 
in close proximity of one another which may also have a significant effect on improving 
vision (Pearsons et al., 2012).  
Studies described above have shown successful integration of donor photoreceptor 
precursor cells along with the functionality and improvement of these cells to vision. 
The next stage of the process of taking such cells from bench side to bedside involves 
the investigation of transplantations in many more models as well as the study of the 
success rate of transplantations at varying degrees of retina degeneration. By investing 
the later of these issues a better idea as to the potential breath of application could be 
gained to provide a more realistic target for the use of such therapies for blindness in 
particular. 
Transplantation of cells into normal retinal tissue is somewhat different to that of 
degenerating retina. The reason behind this is that often, degeneration in the retina 
results in glial scarring as a result of reactive gliosis (Barber et al., 2013). This scarring 
acts to inhibit many cellular processes within the retina including cell migration and 
regeneration. Photoreceptor death can also result in reactive gliosis which again result in 
more scaring and can prevent the migration of transplanted cells within the retina by 
creating a physical barrier (Barber et al., 2013). Additionally, the death of 
photoreceptors results in the reduction of the interphotoreceptor matrix (IPM) which 
impedes on normal barrier functionality (Barber et al., 2013). This in turn affects the 
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integrity of the outer lining membrane (OLM) located on the outer edge of the outer 
nuclear layer (ONL) of the retina (Barber et al., 2013). 
In light of this knowledge it is clear that there are three main issues which require 
investigation before transplantation techniques could be employed in a clinical 
environment. These issues include: the extent of retinal degeneration, the extent of 
gliosis and integrity of OLM), all of which could potentially have a significant effect on 
the success of transplantation. 
A study carried out by Barber and her group set out to investigate these very issues and 
published their findings in 2013. 
This study investigated six mouse models all of which resulted in the progressive loss of 
photoreceptors. A range of progressive loss of approximately 10% over a 12 month 
period (Gnat
-/-
) to almost complete loss of rod photoreceptors (PDE6β) in 3 weeks were 
covered by the chosen mouse models (Table 1.2). These models therefore represented a 
good variation in retinal degeneration.  
 
 
 A standard time point of 6–8 wk was included to provide information about each model at a time when the 
 retina could be defined as “adult” (boldface, italics). Other stages defined as: early = ONL at >70% 
 thickness of wild-type; mid = 30–70%; and late = <30%. —, not examined. 
 *Exceptions were Gnat1−/−, which is still 90% of wild-type at 1y and PDE6β rd1/rd1, which is ∼90% of 
 wild-type at postnatal day 10 but reduced to 20% by postnatal day 21. Crb1 rd8/rd8 undergoes focal 
 degeneration, the extent of which broadly follows the criteria above. 
 
Table 1.2: Classification of early-, mid- and late- stage retinal degeneration mouse models used. 
Table retrieved from supplementary information from Barber et al., 2013. 
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In these mouse models the retina only reach a stage of maturity during the period of 6-8 
weeks. For this reason, murine retinas were only examined 6-8wks, once retinal 
maturity had been reached. By this timeframe the stage of retinal degeneration was 
already varied as models used in this study had varied degenerations periods.  
 (Barber et al., 2013). The most poignant of results recorded from the study carried out 
by Barber et al., (2013) was that although efficiency of integration of donor cells varies 
amongst various stages of degeneration, it was prominant to note that integration was 
still possible in late-stages of retinal degeneration. In most cases integration was found 
to be comparable to that of wild type controls and thus shows that robust integration of 
donor cells even at mid-and late-stage retinal degeneration is possible. This is a 
promising finding that builds confidence for this line of research that endeavours to 
bring this type of research into use in a clinical environment as it can potentially aid 
thousands of sufferers irrespective of rate or extent of retinal degeneration. 
 Investigations concerning the morphology of integrated cells found that all 
environments tested were capable of forming segment and synaptic formations to some 
degree (Barber et al., 2013).  
The morphology (both segment and synapse) of transplanted cells is however heavily 
impacted by causes of specific gene defects for each disease, which also has an effect on 
the number of donor cell integration .Barber and her group also found that the integrity 
of OLM and glial scarring also has a great impact on transplantation efficiencies. It was 
interesting to note that in this study, the rate of gliosis and OLM integrity is not have a 
specific correlation patterns. The increase or decrease of gliosis and OLM integrity with 
disease progression was dependant on the disease type.  
The disease itself can heavily affect the efficiencies of transplantations which if 
understood could be overcome by manipulating barriers and optimising transplantation 
cell numbers. By increasing integration of cells transplantation could very well be used 
to treat and cure many levels of blindness irrespective of the extent of retinal 
degeneration. 
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1.12 Summary  
Photoreceptor degeneration is the underlying cause of many ocular diseases leading to 
partial or complete blindness. Current treatments of such diseases aid in preserving as 
much vision as possible but unfortunately no permanent cure is currently available to 
completely reverse the effects of these diseases. Many ocular diseases result in 
progressive loss of vision due to the degeneration of photoreceptors. Unfortunately, 
photoreceptors cannot repair themselves so that once they are lost there is no way to 
replace them or their vital function. This results in blindness for many sufferers which 
in some cases are inevitable depending on the disease type. The only possibility of a 
permanent cure for such diseases is the permanent replacement of degenerate 
photoreceptors artificially.  
hESCs can potentially be derived into any cell type of the body. The pluripotent nature 
of these cells holds great potential for cell based therapy for a broad range of degenerate 
diseases. For example, RP results in progressive blindness as a direct result of 
photoreceptor degeneration and studies have shown successful differentiation of 
pluripotent hESCs into retinal cells (Lamba et al., 2010). Additionally, studies have 
shown that precursor cells have a better ability to integrate into recipients and that 
transplantations success is possible despite the extent of retinal degeneration (Barber et 
al., 2013). 
Current methods only produce target cells with low efficiencies which are far too small 
to be exploited in a clinical environment. The key therefore lies in the optimisation of 
protocols in order to increase target cell production. A large contributing factor may be 
due to the production of EBs which results in the loss of a large proportion of the cell 
population which could potentially be differentiated into photoreceptor progenitor cells. 
By initially creating a protocol which omits the EB stage of photoreceptor 
differentiation could potentially make a vast increase in efficiency of target cells. 
  Current protocols have not been successful in creating vast numbers of Chx10 ineural 
retinal progenitor cells and have the tendency to create higher numbers of other early 
eye field progenitor cells expressing markers such as Pax 6 Lamba et al., (2006). A 
protocol that could also be used to create larger populations of late eye field cells such 
as Nrl positive photoreceptor precursor cells would be extremely beneficial.  
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 An optimised protocol whereby small variants of compounds such as ECM proteins 
and dissociation buffers and also create a protocol which omits the creating of EBs 
would be ideal. By achieving this goal a milestone would be reached in the 
differentiation process of photoreceptors and a platform created with potential of 
automation to be used for the manufacture of late photoreceptor progenitor cells.  
Although at this stage, only part of the goal would have been achieved, once a 
successful protocol has been identified and used to create a large population of late 
photoreceptor progenitor cells, the next stage of the system could be investigated in 
more detail. With co-culture systems with retinal extracts proving to produce functional 
photoreceptors, investigations can then be made to identify prime factors released by 
these mature retinal extracts which encourage photoreceptor progenitor cells into mature 
photoreceptors.  
Precursor cells have been proven to be capable of transplanting and maturing into cells 
that mimic mature photoreceptors and thus once an appropriate protocol has been 
established cells could possibly then de directly used and tested in transplantations 
studies. Once key components of the microenvironment are identified, these can then be 
exploited to artificially mimic the whole differentiation process of photoreceptor 
progenitor cells and create a breakthrough in therapy for the treatment of blindness 
caused by the degeneration of photoreceptors. 
In general the potential for curative measures for blindness with the use of pluripotent 
stem cells is theoretically a very viable process. What remains to be difficult is the 
creation of an efficient protocol that could be used to establish a line of target cells with 
high efficiency. Once this hurdle has been overcome great potential will be unlocked for 
the future. 
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2 Aims and Objectives 
Current methods of differentiation of hESCs into retinal cells remain suboptimal. 
Improvements to the differentiation process could be made by (i) identifying the best 
dissociation conditions before cells are entered into the differentiation process and (ii) 
creating a monolayer differentiation system to make the process more efficient.  
This study aims to optimise current photoreceptor differentiation protocols to make an 
improvement to the efficiency of the protocol. In order to investigate various avenues 
for optimisation this study has been divided into three sections. 
Characterisation of hESCs. This chapter investigates the characterisation of Shef3 
hESCs using popular pluripotent markers and capabilities of cells to form EBs along 
with karyotyping analysis. 
Differentiation of Shef3 hESCs using current photoreceptor differentiation protocols via 
EBs. This chapter investigates differentiation capacity of Shef3 hESCs following an 
already established protocol.  
Optimisation of dissociation methods using an EB method of differentiation. This 
chapter investigate the impact of three different dissociation buffers on the 
differentiation protocol. 
Monolayer differentiation method. This protocol investigates the possibility of a 
monolayer differentiation method and also explores the impact of various ECMs. 
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3 Materials and Methods 
3.1  Human Pluripotent Cell Culture 
Undifferentiated  human pluripotent Shef3 cells (obtained from the UK Stem Cell bank) 
were cultured on mouse embryonic fibroblast (MEF) feeder cells inactivated with 
Mitomycin-C (1mg/ml, Sigma-Aldrich, Poole, UK) and maintained  in hESC media 
(80% (v/v) Knockout DMEM, 20%(v/v) knockout serum, 1mM Glutamine, 1% (v/v) 
nonessential amino acids (NEAA), 100mM β-mercaptoethanol, 4.4ng/ml basic human 
fibroblast growth factor (bFGF) (all Invitrogen, Paisley, UK). Cells were cultured in a 
Sanyo IncuSafe incubator (Sanyo, MCO-18AIC, Leicestershire, UK) at 37
O
C and 
5%(v/v) CO2 with an exchange of media every 48 hours. 
Non-adapted cells were dissected into smaller colonies using a Fine Tip Mini Pastette 
(Alpha Laboratories, Hampshire, UK) every 3-4 days after incubation with 0.025mg/ml 
Collagenase Type IV (Invitrogen, Paisley, UK) at 37
O
C for 3 minutes and transferred 
onto newly inactivated MEF feeder cells. Adapted cells were dissociated with TrypLE 
Express (Invitrogen, Paisley, UK) after incubation at 37
0
C for 5 minutes. 
 
3.2  Isolation of Mouse Embryonic Fibroblasts 
Mouse embryos from day 13 post conception (p.c) were separated from the placenta 
using sterile tweezers and the brain and dark organs removed using fine surgical 
scissors. The embryos were then finely minced and incubated with 2mls Trypsin 
(Invitrogen) at 37
o
C for 15 minutes. The supernatant was then resuspended in 2ml MEF 
media ( DMEM, 10% (v/v) Foetal bovine serum (all from Invitrogen, Paisley, UK) and 
1% (v/v) nonessential amino acids (NEAA) (Gibco)) and centrifuged at 1200 rpm for 3 
minutes.  The supernatant was discarded and the pellet resuspended in MEF media 
before being plated out in a T75 (Nunc) flask. This new batch of cells was denoted as 
“P0”. 
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3.3 Feeder Preparation 
Once MEF cells had reached a confluency of approximately 70% cells were inactivated 
with Mitomycin C (Invitrogen, Paisley, UK) for 2 hours at 37
o
C, 5% O2. Cell were then 
washed with Dulbecco’s phosphate buffered saline (DPBS) three times and for 10 
minutes at 37
o
C, 5% O2. Cells were then neutralised with MEF media and centrifuged 
for 3 minutes at 1200rpm. The pellet was then resuspended in MEF media and counted 
using a haemocytometer. Cells were then plated onto 0.1% Gelatin (Sigma, Dorset, UK) 
diluted in sterile H2O) coated T25flasks at 250,000 cells/cm
2
.   
 
3.4 Retinal Differentiation of Human Pluripotent Stem Cells 
3.4.1 Embryoid Body Differentiation of Human Pluripotent Stem 
Cells 
The differentiation of human pluripotent stem cells was based on a previously published 
protocol (Lamba et al., 2006). In accordance with this protocol, undifferentiated human 
pluripotent stem cells are dissected into smaller clumps with a Fine Tip Mini Pastette 
(Alph Laboratories) and cultured in suspension as embryoid bodies in a non-adherent  
30mm bacterial grade culture dish (Sterilin, Caerphilly, UK). The EBs are maintained 
for 3 days in EB media (DMEM:F12, Kockout serum replacement (Both Invitrogen, 
Paisley, UK), GlutaMAX, B27 Supplement (PAA, Somerset, UK), Noggin (1ng/ml), 
DKK1 (1ng/ml), IGF-1 (5ng/ml)( All R&D Systems, Abingdon, UK). On day 4, EBs 
were plated onto a 6-well plate pre-coated with Matrigel (BD Bioscience, San Diego, 
CA) and maintained in differentiation media until day 21 (DMEM:F12, GlutaMAX, 
B27 Supplement, N2 supplement (All PAA, Somerset, UK), Noggin (10ng/ml), DKK1 
(10ng/ml), IGF-1 (10ng/ml) and bFGF (5ng/ml) (All R&D Systems, Abingdon, UK). 
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3.4.2 Optimisation of Dissociation Buffer For EB Retinal 
Differentiation 
Undifferentiated Shef 3 (P63) cells were induced into early neural retinal differentiation 
using the protocol described above.  To investigate and optimise the dissociation buffer 
type, one flask of pluripotent hESCs was dissociated with one dissociation buffer or 
enzyme. One flask of pluripotnet hESC was dissociated by incubation with Collagenase 
Type IV (Invitrogen, Paisley, UK) for 3 minutes, another flask of pluripotent hESCs 
was dissociated with TrypLE Express for 5 minutes and another flask with  Accutase 
(Both Invitrogen, Grand Island, NY) for 5 minutes at 37
o
C. The remainder of the 
differentiation protocol was carried out as outlined above. 
3.4.3 Monolayer Retinal Differentiation  
Shef 3 (P52) cell line were maintained in EB media (DMEM:F12, Kockout serum 
replacement (Both Invitrogen, Paisley, UK), GlutaMAX, B27 Supplement (PAA, 
Somerset, UK), Noggin (1ng/ml), DKK1 (1ng/ml), IGF-1 (5ng/ml) (All R&D Systems, 
Abingdon, UK) for 3 days in a T25 culture flask on MEF feeders (250,000 cells per 
flask). The media was then completely replaced with differentiation media 
(DMEM:F12, GlutaMAX (Invitrogen, Paisley, UK), B27 Supplement, N2 supplement 
(Both PAA, Somerset, UK), Noggin (10ng/ml), DKK1 (10ng/ml), IGF-1 (10ng/ml) and 
bFGF (5ng/ml)(All R&D Systems, Abingdon, UK)) and maintained in culture until day 
21 with media changes given every 2-3 days. Cells were passaged on day 7 and 14 with 
samples taken and pelleted for further investigations. On day 20, cells from one T25 
flask were plated into two 12-well-plates (12-wp). Each row was coated in one of the 
following extracellular matrix proteins (ECM):  PDL (4µg/cm
2
), Laminin (2 µg/cm
2,
), 
Fibronectin (5µg/cm
2
, ( All Sigma, Dorset, UK)), 0.1% Gelatin, Matrigel (diluted 1:3 in 
serum free basal media, BD Biosciences 354230) and one row left uncoated (blank). 
These 12-wp were then cultured in differentiation media for a further 6 days. It must be 
notes that for the investigation using Shef 3 cells, bFGF was omitted from the 
differentiation media. 
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3.5 Immunocytochemistry 
All cells were fixed using 2ml 4% (w/v) paraformaldehyde (PFA) for 20 minutes at 
room temperature followed by several washes with DPBS and stored at 4
o
C in DPBS. 
For intracellular staining, cells were permeabilised in permeabilisation solution (DPBS 
and 0.25% (v/v) Triton X-100 Sigma T8787) for 10 minutes at room temperature, 
followed by two washes with DPBS (note for extracellular staining the permeabilisation 
stage was omitted). Blocking solution (PBS, 0.25 % Triton and 2% Goat serum Sigma 
G9023) was then added to the cells and incubated at room temperature for 30 minutes. 
The blocking solution was then removed and the primary antibody (diluted in blocking 
solution) then added to the cells and incubated at 4
o
C overnight. 
 The primary antibodies used were as follows: monoclonal mouse anti- SSEA1(1:200) , 
monoclonal mouse anti- SSEA3 IgM (1:200) (Both kindly donated by Peter Andrews, 
Sheffield), monoclonal mouse anti -OCT4 IgG  (Invitrogen 1:400), Β-III-Tubulin 
(Sigma, Dorset, UK), Chx10 (Millipore, Watford, UK), Pax6 (Millipore, Watford, UK). 
Cells were then washed several times with DPBS before the addition of the secondary 
antibody either Alexa Fluor 555 goat anti-mouse IgG (H+L) 2mg/ml, Alexa Fluor 488 
goat anti-mouse IgG (H+L) (Both Invitrogen, Paisley, UK) and incubated at room 
temperature for 2 hours.  
 After several washes with DPBS,  4',6 Diamidino-2-phenyl-indole, dihydrochloride 
(DAPI) (Invitrogen, Paisley, UK) was then added to the cells and incubated for 2 
minutes before being discarded. After a final wash with DPBS cells were then analysed 
using a fluorescence microscope. 
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3.6 RNA Extraction and cDNA Synthesis 
All RNA extractions were achieved using the protocol by the Qiagen  RNeasy kit 
(Qiagen, West Sussex, UK). In short, pelleted cells were resuspended in buffer RLT 
(guanidine thiocyanate buffer)and homogenized via aspiration through an RNase-free 
syringe using a 18G needle 5 times. Following the manufacturer’s protocol the DNase 
digestion was also followed and finally the RNA was eluted with 40µl RNase-free water 
after centrifugation at 10,000 rpm for 1 minute. The concentration of the eluted RNa 
was measured using a spectrophotometer at 260nm (NanoDrop ND-1000, Thermo 
Scientific, Epson, UK). 
cDNA synthesis was carried out following the Ambion 1
st
 Strand cDNA synthesis kit 
(RETROscript®Ambion, Warrington, UK) using 1µg of RNA previously extracted. 
Briefly, using 1µg of RNA, random decamers and nuclease-free water was added to 
make up a volume of 12µl before centrifugation at 10,000rpm for 30 seconds. The 
mixture is then denatured at 80
o
C for 3 minutes and cooled for up to an hour at 4
o
C, 
after which they were centrifuged and placed on ice whilst the matermix containing 
dNTPs, RT buffer, RNAse inhibitor and MMLV-RT enzyme were added. The cDNA 
synthesis was then carried out at 42
o
C for 1 hour followed by the inactivation of the 
enzyme at 92
o
C for 10 minutes. 
3.7 Real-time Quantitative Polymerase Chain Reaction (qPCR) 
All qPCRs were carried out using the MESA Blue qPCR SYBR assay kit (Eurogentec, 
Hampshire, UK) following the manufacturers protocol. All primers were acquired from 
Qiagen and are listed in Table 3.1 and all reactions were set up using an Eppendorf 
Master cycler Realplex machine for reaction incubation and analysis. The total reaction 
volume was 20µl containing 1µl of cDNA and each measurement was taken in 
triplicates. The following PCR conditions were used: 95
o
C for 5 minutes, followed by 
40 cycles at 95
o
C for 15 seconds and 60
O
C for 2 minute. This was followed by another 
stage at 95
O
C for 15 seconds followed by a cool down process at 60
O
C for 15 seconds 
and incubation at 95
O
C for 15 seconds. All samples were normalised to an endogenous 
housekeeping gene (β-actin) and relative quantification carried out using a protocol 
previously published (Pfaffl et al., 2001). This equation uses expression levels of a 
housekeepiung gene as a standard to provide ratios of target gene expression, thus 
giving a fold increase or decrease of  expression of target genes. 
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Table 3.1: A list of qPCR primers used for analysis. 
Gene Name Symbol Transcript Detected Catalogue Number 
Actin, Beta ACTB NM001101 QT01680476 
Orthodenticle homeobox 2 OTX2 NM021728 QT00213129 
Six homeobox 3 SIX3 NM005413 QT00211897 
Paired box 6 PAX6 NM000280 QT00071169 
Visual system homeobox 2 VSX2 (CHX10) NM182894 QT00221081 
Retina and anterior neural fold 
homeobox RAX (RX) NM013435 QT00212667 
Cone-rod homeobox CRX NM000554 QT01192632 
Neuralretina leucine zipper NRL NM006177 QT01005165 
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4 Characterisation of Shef3 hESCs 
4.1 Introduction 
In 1998, Thompson and his group were the first to isolate the world’s first hESC lines 
from the inner cell mass of the human blastocyst. The group also created essential 
characterisation criteria that would define a hESC. If a cell was able to maintain (i) in an 
undifferentiated state of proliferation for a prolonged period and (ii) was able to hold a 
stable potential to form derivatives of all three germ layers even after prolonged culture 
then this would characterise that cell as a pluripotent hESC (Thompson et al.,1998). 
These very properties of hESCs make them the ideal candidates for the development of 
novel cellular therapies, with the potential to treat a vast number of degenerative 
diseases as potentially, these cells could be directed to form any cell of the body. 
1.7.1 4.1.1 Aim 
The aim of this investigation was to identify whether human embryonic stem cells 
(Shef3-hESCs) fulfilled all the characteristics that governs a cell to be a pluripotent 
stem cell. 
4.2 Morphology of undifferentiated Shef3-hESCs 
Although numerous techniques are available in order to identify whether cells comply 
with the criteria described above, several classic cellular surface markers have been 
found to identify hESCs in the undifferentiated state. Stage-specific embryonic antigens 
(SSEA)-3, SSEA-4, TRA-160 and TRA-181 have all been found to be expressed in 
hESCs whilst they are in an undifferentiated state (Carpenter et al.,2003).  
By raising antibodies against these markers, immunocytochemistry is commonly used to 
identify undifferentiated hESCs (Thompson et al.,1998). Similarly, transcription factors 
Oct 4, Nanog and Sox2 have been identified in the presence of pluripotent hESCs and 
thus using the same technique, whereby antibodies are raised against these markers, 
pluripotent hESCs can also be easily identified (Loh et al., 2006).  
Typically hESCs are cultured in the presence of a mouse embryonic fibroblast (MEFs) 
feeder layer, in order to aid with maintenance of cells in a pluripotent state in culture. 
As this process introduces the cross contamination of species it is not viable for use in a 
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clinical environment (Mallon et al.,2006). For this reason a range of feeder- free 
culturing systems have now become available whereby commercially available 
extracellular matrices (ECM) replace the need of MEF feeders as.  
 Human embryonic fibroblasts (HEF) have also now become available to maintain 
culture of hESCs on a feeder culture system that does not introduce cross contamination 
(Amit et al., 2003; Hernandez et al., 2011). 
In this investigation, Shef3 hESCs were co-cultured with MEFs, inactivated with 
Mytomycin C in order to maintain cells in an undifferentiated state. Within three days 
of culture cells were observed to be tightly compacted displaying the characteristic flat, 
rounded morphology of hESCs colonies (Figure 4.1).  
The colonies were also found to abundantly express pluripotent and undifferentiated 
markers Oct4, TRA-160 and SSEA-3 (Figure 4.1). SSEA recognise defined 
carbohydrates on epitopes of lacto and globo-series glycolipids and are involved in the 
control of cell surface interactions during development (Zhao et al., 2012). Both SSEA3 
and SSEA4 are synthesised during oogenesis and thus is expressed in hESCs whilst they 
remain in an undifferentiated state (Zhao et al., 2012). The TRA-1-60 antibody reacts 
with a part of a proteogylcan that is sensitive to neuraminidase (Zhao et al., 2012). 
Neuraminidase is a group of enzymes which cleave glycosidic linkages in neuraminic 
acids.  
TRA-160 and SSEA-3 are both cell surface markers and it is clearly visible from the 
immunocytochemistry results for these markers that cells express these markers 
abundantly across the whole population. Comparisons between the fluorescence 
exhibited by the markers and the DAPI staining are visually identical; suggesting that 
the expression observed is a true reflection of expression of these markers and not 
residual fluorescence from improper washing steps during the staining process. 
Oct4, as the name suggests, is a member of the POU family of transcription factors and 
plays important roles in the regulation of pluripotency and differentiation in hESCs 
(Zhao et al., 2012). The expression of Oct4 is maintained in the inner cell mass of the 
blastocyts and is restricted mainly to pluripotent and germ line cells (Zhao et al., 2012). 
 In the case of transcription factor Oct4, results again exhibit a high expression of this 
marker throughout the population of cells suggesting that this population of hESCs is 
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truly pluripotent (Figure 4.1). Once again, results for Oct 4 expression is almost 
identical to that of the DAPI staining and phase image of cells, suggesting that all cells 
visible in this population are in fact also pluripotent. This clearly suggests that this 
population of cells were characteristic hESCs and therefore those cells used in other 
investigations also held the same properties as they were initially retrieved from this 
very population of cells. 
 
 
Figure 4.1: Immunocytochemistry results of pluripotency markers Oct4, TRA-160 and SSEA-3 for 
Shef3 hESCs. Top row shows expression of various markers of undifferentiation and pluripotency; 
second row shows nuclear staining with DAPI and bottom row shows phase constrast microscopic 
images of cells. 
 
Once pluripotent hESCs are plated onto a MEF feeder layer, cells were found to attach 
to the MEF feeder layer. These cells then continued to proliferate in an undifferentiated 
manner. Morphologically these cells appear as well rounded cells, displaying a 
prominently large nucleus (Figure 4.2A). Occasionally in a population of 
undifferentiated cells, more than one prominent, dark structure is often visible in one 
cell. This is more than likely a result of a cell undergoing mitosis, whereby the cell 
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proliferates and divides into two cells  and thus the number of organelles are doubled at 
this point (Figure 4.2A). 
As cells proliferate within colonies, the peripheral edges of colonies appear phase-bright 
and distinct. Whilst colonies continue to grow, the feeder layer surrounding these 
colonies appears as whorls around these colonies (Figure 4.2B). 
 
 
 
Figure 4.2: Morphology of healthy undifferentiated cells.A:A high magnification of 
undifferentiated Shef3 cells. Arrow indicates an example of a cell containing two dark structures 
most likely to be nuclei. This is an example of a cell most likely to be undergoing mitosis. B: A 
typical colony of undifferentiated hESCs. 
 
500µm 
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4.3  Differentiation of  Shef3 hESCs 
As differentiation sets in this also results in the loss of the bright periphery of the colony 
(Figure 4.3A). Figure 4.3 A shows the morphology of undifferentiated Shef3 hESCs on 
the left of the image whilst differentiated cells, forming rosette like structures are visible 
towards the right of the same image. A change in shape in these cells is notable, with 
cells losing their characteristic well rounded shape as differentiation occurs. It is also 
difficult to identify the large nucleus in the centre of the cell, which usually appears as a 
very prominent structure in  undifferentiated cells.  
 
 
Figure 4.3: Morphology of Shef3 hESCs undergoing differentiation. A: Image of cells remaining in 
a state of undifferentiation (left) and differentiation (right) within a population of cells. B: 
Morphology of cells at the beginning of differentiation within a colony. Areas where a break in the 
phase-bright periphery are areas where differentiation is taking place. 
 
With the onset of differentiation hESCs have been found to express a cell surface 
marker SSEA1, which is not expressed by hESCs in the undifferentiated state. 
Immunocytochemistry can be employed to identify cells undergoing differentiation 
(Figure 4.4). As is visible from the image below, cells within a population or colony of 
cells differentiate at various time periods. Some cells within the colony express a high 
intensity of SSEA1 whilst expression levels are very low in other parts of the cells. This 
suggests that, as expected, differentiation is not one uniform process that occurs within 
one population of cells, but instead individual cells undergo differentiation at various 
points. Once a particular cells starts differentiation however, it is also then capable of 
contributing in the direction of surrounding cells through the same process or 
encouraging surrounding cells to continue through the same process via inter cellular 
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signalling processes. This could be one explanation to the abundance of fluorescence 
emitted by single cells in a population surrounded by cells only emitting low levels of 
expression. 
 
 
 
 
Figure 4.4: Immunocytochemistry results for cell surface marker SSEA1 on a population of hESCs. 
A: Microscopic image of cells. B: SSEA1 results for the same population of cells in image A. 
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4.4 Formation EBs from pluripotent Shef3 hESCs 
One commonly used strategy to encourage undifferentiated hESCs down a specific 
lineage is through the formation of embryoid bodies (EBs) in suspension. Cells are 
dissociated from the monolayer and cultured in specific supplemented media in a 
suspended manner. These cells then make cell to cell adhesions in suspension via 
adhesion receptors and form small aggregates called EBs (Bratt-Leal et al., 2009). 
These EBs are typically formed over a period of days or weeks and are found to form 
spheres of aggregated cells. Aggregates are usually well rounded in morphology. This 
process is often employed to initiate a specific differentiation route of cells and is often 
followed by a classic attachment culture system once the period of suspended culture 
has occurred. An example of EBs formed after 5 days of static suspended culture is 
shown below (Figure 4.5). As is evident from the image  pluripotent hESCs form 
aggregates within the suspension. These 3D aggregates are darkened in colour when 
analysed under an electron microscope due to the dense makeup of cells within the 
aggregate. The size of aggregates are not uniform in this particular investigation as they 
are highly dependent on the number of cells which have come together in order to form 
the EB, which in this case, is dependent on location of the cells in suspension (the main 
reason for heterogeneous EB size and shape of is due to a limited control of the initial 
size of hESCs colonies at the beginning of  suspension culture, not location of the 
colonies in suspension).  
Technology has however progressed for this process, whereby culture plates with 
minute wells force equal numbers of single hESCs into EBs, making this process more 
uniform throughout investigations. One such culture plate is called the AggrWell 
produced by StemCell Technologies. As mentioned before in chapter 1.8.1 this plate has 
a number of micro wells built into the plate and as a single cell culture suspension is 
added to the plate, after centrifugations cells settle to the bottom of the micro well. 
Culturing of cells then proceeds as normal but allows the formation of EBs in a uniform 
and reproducible manner. 
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Figure 4.5: Image of EBs formed from Shef3 hESCs after 5 days of suspended culture. 
 
4.5 Karyotype analysis of Shef3 hESCs 
The ultimate goal for clinical therapy is to differentiate pluripotent stem cells into target 
cells which can then eventually be transplanted into humans to treat the disease that is 
deficient of those target cells.  
Pluripotent stem cells have enormous potential as mentioned previously due to their 
potential to follow any lineage to become potentially any cell in the body. Whilst 
pluripotent hESCs are capable of remaining in an undifferentiated state for prolonged 
periods of time in culture, this leaves cells prone to genetic changes. This, for obvious 
reason poses a challenge for application in therapy as this has potential to lead to 
tumour progression (Loring et al.,2007). 
 Thus, it is very important to ensure that cells contain normal number and structure of 
chromosomes before any hESCs are used for investigative purposes. Cells with 
chromosomal abnormalities could lead to tumour progression if incorporated into 
regenerative medicine. 
Karyotyping results for a sample of the pluripotent Shef 3 hESCs shows normal number 
and structure of chromosomes (Figure 4.6). The karyotype investigation was carried out 
by a third party. 
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Figure 4.6: Cytogenetic analysis of Shef 3 hESCs. Image shows results of karyotyping of these cells. 
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5 Differentiation of Pluripotent Human Embryonic Stem 
Cells using the Lamba protocol 
5.1 Introduction 
The degeneration of rod and cone photoreceptors is a major cause of blindness, 
affecting millions of people around the world. Unfortunately, current treatment only aim 
to slow down the process of degeneration but no cure is presently available for ocular 
diseases that result in blindness. Human pluripotent stem cells (hESCs) have given new 
hope for some degenerative diseases such as Retinitis Pigmentosa (RP). The generation 
of retinal progenitor cells (RPCs) from these hESCs have been shown to integrate and 
function once transplanted into the sub-retinal space of mature mice (Lamba et al., 
2006; MacLaren et al., 2006).  
A range protocols are now available, each using various combinations of growth factors 
which aid in inducing growth of primarily the forebrain. Some of these growth factors 
include: Dkk1 (Wnt signalling pathway anagonist), Lefty A (Nodal pathway anagonist) 
and Noggin (BMP pathway antagonist).  Each protocol has varying time periods and 
efficiencies of target cells (Lamba et al., 2006; Osakada et al., 2008; Hirami, Osakada et 
al., 2009; Meyer  et al., 2009). 
Lamba et al., generated over 80% of Pax6 expressing cells and over 70% of Chx10 
expressing cells. A small percentage (~5%) of cells expressing the photoreceptor 
precursor gene Nrl was also recorded. This particular protocol included the shortest 
timeframe, to date, of 21 days. It should be noted that target yields can vary 
significantly depending on pluripotent stem cell lines (Osakada et al., 2009). 
The Lamba protocol was followed in this investigation. This was because after taking 
into consideration of timeframes, number of soluble factors required for the 
differentiation as well as target yields, this protocol provided the most efficient process. 
As this protocol involves the formation of EBs, the terms “EB differentiation” and “EB 
incorporated differentiation” have been widely used in this study in reference to the 
whole process of this differentiation method. 
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5.1.1 Aim 
The aim of this investigation was to reproduce the Lamba protocol and generate RPCs. 
As this chapter contains the control data, any benefits of optimisations of the protocol 
are comparative to these results. 
 
5.2 Differentiation of Shef 3 hESCs following the protocol devised by 
Lamba 
In accordance with the Lamba protocol, Shef3 hESCs were mechanically dissected from 
the feeder layer with Collagenase IV. Cells were then cultured in suspension for a 
period of 3 days with media supplemented with the following growth factors: DKK1, 
Noggin and IGF-1. During this period of suspended culture, colonies began to form 
floating aggregates similar to EBs. These EB-like structures did not appear as well 
rounded spheres commonly reported in literature (Figure 5.1). By definition, an EB is 
an aggregate of cells, containing cells from all three germ lines. Visually cells appeared 
as aggregates, but verification that these aggregates were EBs would require a test 
confirming the presence of cells from all three germ lines.  
After day 1 of suspended culture, large aggregates were observed with areas of densely 
populated cells. In some cases aggregates were observed to have combined to form very 
large sized aggregates (Figure 5.2). Although the mechanical dissection using 
Collagenase IV does not produce single cells, many single cells were observed in the 
suspension around the EB-like structures (Figure 5.2B). Many of these cells were 
observed to migrate and attach onto other cell aggregates. In some cases smaller EB-like 
structures were observed to migrate and attach to either bigger aggregates or form 
smaller aggregates (Figure 5.2B). 
 A small population of debris was also observed in the suspension appearing as small 
dark specks in comparison to live cells which exhibited a bright appearance.  
By day 3 of the suspended culture, aggregates were observed to have become very 
densely populated with cells. This gave aggregates an extremely dark morphology. At 
this point in the investigation a visibly larger population of cell debris was also 
observed in comparison to that observed on day 1 of the suspension culture (Figure 
5.2F).  
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Figure 5.1: Morphology of EBs. A: Typical EB formed from suspension culture of WA09 hESC 
line. Image taken from Luzzani et al., 2011. B: EB formed on day 3 of the differentiation protocol in 
this study. 
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Figure 5.2: Morphology of cell aggregates formed from cells mechanically dissected with 
Collagenase VI at various time points in the differentiation process. A: Aggregates formed after 
day 1 of suspension culture. B: Enlarged image of the area indicated in image A. Image shows 
various sized aggregates migrating towards each other. White arrow indicates example of a live cell 
and the black arrow indicates an example of cell debris. C: EB-Like structures formed on day 2 of 
suspension culture. D: Enlarged image of area indicated in image C. E: EB-like structures formed 
on day 3 of the suspension culture. F: Enlarged image of area indicated in image E. Area indicates 
an example of cell debris which appear as black specks. The arrow indicates an example of a live 
cell. 
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After 3 days of suspended culture, EBs were plated down onto matrigel (day 4 of the 
differentiation process) coated 6-well plates and maintained in media supplemented 
with N2 supplement and bFGF (KOSR was omitted in this media) until day 21. Media 
changes were maintained every 48 hours.  
Cells became adherent by day 5 and the point at which each cell aggregate had attached 
resulted in the formation of a colony of cells (Figure 5.3). Whilst cells located in the 
centre of the colony remained tightly compacted, those located on the edge of the 
colony exhibited signs of migration and differentiation (Figure 5.3B). 
Several morphologies were observed. Some cells appeared more flattened with nodules 
sprouting out towards the surrounding (Figure 5.3 C & E). Others exhibited a more 
elongated morphology, with the elongation narrowing out into smaller elongations 
(Figure 5.3 F). These cells resembled the morphology of neural cells; the elongated 
centre was similar to an axon which progressed into smaller partitions resembling 
dendrites. 
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Figure 5.3: Morphology of cells on day 5 of the differentiation of Shef 3 hESCs. A: Colonies of cells. 
Area indicates a population of differentiating cells. B: Enlarged image of A. Morphology of 
flattened cells. C: Colony of cells with differentiating cells located on the edges of the colony. D: 
Enlarged image of indicated area on C showing morphology of differentiating cells. White arrows 
indicate example of circular cells. E: Colony of differentiating cells. Indicated area shows 
morphology of another cell type. F: Enlarged image of indicated area on E. Arrow indicates the 
presence of neural-like cells. 
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By day 6 of the differentiation process, cells had migrated outwards from their 
respective colonies although the reminiscence of the colonies was still visible (Figure 
5.4 A). Cells located in the centre of these colonies still remained compacted but those 
located on the peripheral edges exhibited visual signs of differentiation. Amongst these 
tightly packed colonies of cells, populations of triangular cells were observed (Figure 
5.4 B).  These cells resembled epithelial cells in morphology (Nie et al., 2008).  
Some of these cells were more elongated in appearance than others whilst others 
exhibited small spindle-like structures. Cells containing spindle-like structures were 
mainly located on the edge of these populations of differentiated cells. Cells on the edge 
of these regions migrated and evolved to become more elongated by day 7 with the 
development of more spindle-like structures. Some cells displayed a star-like 
morphology common to astrocytes with small spindles sprouting out from a central 
body (Figure 5.4 D). These cells resembled fibroblast cells in appearance (Liu et al., 
2007). 
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 Figure 5.4: Morphology of cells on days 6 and 7 of the differentiation process. A: Cells on day 6 of 
the differentiation process. Area indicates example of triangular cells. B: Enlarged image of 
indicated area in image A. Epithelial-like cells. Arrows indicate an example of spindle-like 
structures. C: Cells on day 7 of the differentiation process. D: Enlarged image from indicated area 
on image C. 
 
By day 10 of the differentiation process cells had become very compacted and had 
reached approximately 70% confluency. Amongst the compacted sheet of cells, colonies 
of epithelial-like cells were observed to have proliferated (Figure 5.5 A).  
Larger numbers of these epithelial-like cells were observed. Some of these cells were 
found to have lost their triangular shape but remained as large cells in comparison to the 
compacted cells present in the overall population. Surrounding these regions of large 
cells, networks of intertwined spindle-like structures were observed (Figure 5.5B). 
Observations made using a higher magnification revealed that these spindle-like 
structures were beginning to pan over central regions of these large cells. These spindle-
like structures were predominantly located on the edges of these cell groups (Figure 5.5 
C). 
A 
Day 6 
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By this point of the investigation, cells were observed to begin to proliferate and/or 
differentiate in multilayered structures in some areas of the culture vessel (Figure 5.5 
A). This is often observed in the differentiation processes after attachment of EBs. 
Often as EBs attach, cells in the centre of the aggregate remain attached to other cells in 
the aggregate resulting in the formation of multi-layered structures after the attachment 
process. 
 
 
 
Figure 5.5: Morphology of cells on day 10 of the EB incorporated differentiation process (A). Area 
indicates a population of spindle-like structures. Arrows indicate a population of cells growing in 
multilayers. B: Enlarged image of indicated area in image A. C: Morphology of spindle-like 
structures. 
 
 
 
 
      
 
106 
 
By day 11 of the differentiation process, much of the same cell types were observed as 
mentioned above. Cells continued to migrate, proliferate and differentiate abundantly. 
Areas of compacted cells, were however, observed to have a change in morphology. 
Cells in these regions were so compacted that it was no longer possible to identify the 
morphology of single cells. All that could be visualised were a vast population of very 
small darkened specks (Figure 5.6 A). Magnified observations of these regions revealed 
the appearance of occasionally two darkened pigments in close proximity of each other 
and a vague shape resembling the number “8” in some cases (but not in all) (Figure 5.6 
B).  
An increase in small single cells was also observed in the cell population. Single cells 
appeared more distinct in areas of cells with a less defined morphology than cells with a 
triangular morphology. In some regions of large cells, cells were observed to have 
migrated, creating an appearance of more available space surrounding these cells 
(Figure 5.6 C) in comparison to the group of triangular cells observed previously. This 
migration of cells was not observed in all regions of large cells but only in some areas 
of these cells. 
On day 12 of the investigation, these regions appeared larger in size with an increase of 
such cells. This suggested that these cells had proliferated during the 24 hours in culture 
(Figure 5.6 D). Some cells in these areas had also become more elongated and spindle-
like structures were once again observed. Over the next 7 days of culture, cells became 
more compacted and formed multi-layered structures. Webs of spindle-like connections 
were observed across cell population in areas of large cells (Figure 5.6 E). 
By day 19, cells had become extremely compacted with only a few regions containing 
large cells, the morphology of which was still vaguely evident amongst the mass of 
cells. In many areas, multi-layered structures had formed over the monolayer of cells 
and it was very difficult to identify specific cell types in the cell population (Figure 5.6 
F).  
By day 20, cells had become so over confluent that in some very densely compacted 
areas, the monolayer was observed to detach from the matrigel coating (Figure 5.7). 
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Figure 5.6: Morphology of cells during days 11, 12, 13 and 19 of the differentiation process. A: 
Image of cells on day 11 of the differentiation process. Area indicates example of compacted cells 
with mildly visible darkened specks. B: Enlarged image of area indicated in image A. C: Image of 
migrated, large cells on day 11. D: Cell morphology on day 12. E: Image of network of spindle-like 
structures on day 13 of the differentiation process. F: Cell morphology on day 19 of the 
differentiation process. 
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Figure 5.7: Cell monolayer detachment from the matrigel coating on day 20 of the differentiation 
process. White arrow indicates detachment of cells from the matrigel coating. 
 
5.3  Generation of Early RPCs  
Immunocytochemistry results revealed expression of neural retinal progenitor markers 
Pax 6 and Chx10 after 21 days of differentiation. 
In the case of Pax6 expression, fluorescence was mainly observed in groups of 
compacted cells, although low levels were also observed in surrounding areas of these 
cells (Figure 5.8). Chx10 expression was observed to be more widespread in 
comparison to Pax6 (Figure 5.8).  
The absence of Chx10 expression was most prevalent in areas where cells were not very 
compacted. Some of these Chx10 negative cells appeared fairly large and elongated. 
DAPI staining confirmed the presence of many cell nuclei in these areas providing 
further evidence that these cell types were negative in expressing Chx10. Additionally 
this also gives evidence that the fluorescence observed in these cells was specific.  
After making comparisons between Pax6, Chx10 expression and DAPI staining, it was 
possible to conclude that this investigation was in fact successful in directing 
pluripotent hESCs down the retinal lineage.  
 
B 
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This was because, as expected, not all areas where cells were present expressed a 
marker for retinal precursors. Additionally those areas exhibiting fluorescence coincided 
with the presence of differentiated cells suggesting this was a true display of cellular 
expression. 
It must however be noted, that although retinal progenitor markers Pax6 and Chx10 
were observed, overall, only low levels of expression were visualised. As ICC data only 
provides visual results thus quantitative PCR was used to confirm these findings (Figure 
5.9). 
 
 
Figure 5.8: Generation of Pax6 and Chx10 positive cells from Shef3 cells differentiated using the 
EB incorporated differentiation protocol. 
 
qPCR results confirmed low expression of early eye field genes Pax6, Six3 and Rx. 
Expression of Rx however, was found to be mildly more increased in comparison to 
Six3 and Pax6 (Figure 5.9).  
In the case of Pax6 expression, this finding was in line with ICC data discussed above, 
as only low levels of fluorescence was observed for Pax6. Also in line with the ICC 
data, only low levels of Chx10 expression was observed although qPCR data revealed 
the expression of Chx10 was mildly more increased than Pax6. Only a 2 ½ fold increase 
of Chx10 expression was observed in comparison to the housekeeping gene β-actin 
(Figure 5.9).  
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Over a 5 fold expression of the later eye field gene, Nrl, was observed in comparison to 
the housekeeping gene (Figure 5.9). Nrl is a marker for photoreceptor precursor cells, 
confirming the presence of photoreceptor precursor cells in this differentiated 
population.  
This confirms that this investigation was very successful in its aim in differentiating 
pluripotent Shef3 hESCs towards the retinal lineage. The significantly increased 
expression of Nrl, in comparison to other early eye field genes, is an indication that by 
the end of this differentiation process, a larger population of photoreceptor precursor 
cells was present than other early eye field cells.  
In order to determine the efficiency of the protocol however, further investigations are 
required in order to calculate the percentage of eye field cells relative to the overall 
population of cells.  
 
 
Figure 5.9: qPCR analysis of retinal gene expression of cells mechanically dissected with 
Collagenase IV. These cells were then differentiated into RPCs using the EB incorporated 
differentiation process. 
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5.4 Optimisation of  the Lamba  Differentiation Process 
 
5.4.1 Aim 
Although the protocol devised by Lamba and his group was successful in directing 
pluripotent hESCs into the retinal lineage, it was thought that optimisation of the 
protocol was still necessary in order to devise a more efficient and cost-effective 
protocol. As in most protocols, a vast numbers of avenues could be investigated as part 
of the optimisation. Such avenues included (but not exclusive): dissociation method 
type, cell seeding density, ECM protein coating type, buffer pH, oxygen percentage 
exposure amongst others.  
In the first instance it was decided to investigate the method of dissociation of cells. 
This was because the dissociation of cells is involved right at the beginning of the 
process. If the method used to dissociate cell resulted in a negative effect on the 
differentiation capacity of pluripotent hESCs, then this would have a knock on effect on 
the retinal differentiation process. If pluripotent hESCs are damaged in the dissociation 
process at the beginning of the differentiation protocol, then this would result in a lower 
population of target cells at the end of the process. For this reason, Accutase and 
TrypLE Express were tested in order to investigate whether these methods of 
dissociation could impact the expression of RPC markers compared to the original 
mechanical dissection method with Collagenase IV. 
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5.4.2 Differentiation of Shef3 hESCs using dissociation enzyme 
Accutase and dissociation reagent TrypLE Express  
In order to make precise comparisons the method of differentiation was followed as 
mentioned above (Chapter 5.2) with the exception of using Accutase or TrypLE Express 
in the cell dissociation stage. In short, cells were initially dissociated with either 
Accutase or TrypLE Express and maintained in suspension for a period of 3 days with 
media containing growth factors: DKK1, Noggin and IGF-1. 
At this stage of the process both dissociation methods resulted in a high population of 
single cells in comparison to cells dissociated in the control investigation. Those 
dissociated enzymatically with Accutase were observed to produce a higher population 
of single cells than using TrypLE Express (Figure 5.10 A & C). TrypLE Express was 
found to have dissociated cells as a mixture of cells groups as well as single cells. 
Both dissociation methods were observed to produce aggregates of cells during the 
period of suspension culture. Similar to what was observed in the mechanical dissection 
using Collagenase IV (the control), in this investigation aggregates were not well 
rounded EBs as often reported in literature.  
After day 1 of the differentiation process, cells dissociated with TrypLE Express had 
formed fairly large aggregates in comparison to those formed by cells dissociated with 
Accutase (Figure 5.10). In the case of cells dissociated with Accutase, a large 
population of cell debris was observed. These appeared as small darks specks in the 
suspension, giving the appearance of a reduced population of cells in the wells. 
Aggregates formed by cells dissociated with Accutase were observed to be visibly 
smaller in size than those formed by cells mechanically dissected with Collagenase IV 
and TrypLE Express, at the same time point. Aggregates formed by TrypLE Express 
had a very darkened appearance as these were very densely packed with cells in 
comparison to the smaller, lighter aggregates formed by cells dissociated with Accutase. 
In some cases, aggregates formed by cells dissociated with TrypLE Express were 
observed to attach to other aggregates (Figure 5.10).  
 
      
 
113 
 
By day 4, cells dissociated with TrypLE Express continued to form dark aggregates in 
comparison to cells dissociated with Accutase. In the later of these a larger population 
of single cells was observed to remain in the suspended culture (Figure 5.11).  
Observations made at this point of the investigation found that of the three dissociation 
methods investigated, Accutase best favours cells to remain as single cells rather than in 
aggregates. In the case of Collagenase VI and TrypLE Express, these methods suited 
cells to remain in culture as aggregates. Although both Accutase and TrypLE Express 
produced a large population of single cells at the dissociation stage, cells dissociated 
with TrypLE Express continued to form many large aggregates whereas those 
dissociated with Accutase remained predominantly as single cells. Cells dissociated 
with Accutase also exhibited the largest population of cell debris in comparison to cells 
dissociated with TrypLE Express and mechanical dissection with Collagenase IV.  
At this stage of the differentiation process it was unclear whether the formation of 
smaller aggregates or the presence of a high single cell population would have an effect 
on retinal gene expression at the end of the process. Although morphologically 
aggregates resembled EBs, in order to verify this cells would have to be tested in order 
to confirm the presence of cells from all three germ layers.   
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Figure 5.10: Morphology of day 1 aggregates formed from cells dissociated with Accutase and 
TrypLE Express. A: Aggregates formed by cells dissociated with Accutase. Area indicates area of 
cell debris. B: An enlargement of area indicated in image A. Arrows indicate examples of cell debris 
appearing as dark specks. C: Aggregates formed by cells dissociated with TrypLE Express. 
 
Figure 5.11: Morphology of day 4 aggregates. A: Aggregate formed from cells dissociated with 
Accutase. B: Aggregates formed from cells dissociated with TrypLE Express. 
      
 
115 
 
 
These cells were then transferred onto matrigel coated well plates and maintained in 
culture media supplemented with N2 supplement and bFGF until day 21 with media 
changes every 48hrs. 
As a large population of single cells were present in cells dissociated with Accutase and 
TrypLE Express, care was taken to transfer all cells present from these cultures to 
ensure potential RPCs were not discarded. 
As observed in the control investigation (mechanical dissection with Collagenase IV), 
cells dissociated with both Accuatse and TrypLE Express adhered and migrated well by 
day 5 of the differentiation process. In line with the control investigation, cells appeared 
to form colonies at the point at which the aggregate had attached to the coating (Figure 
5.12A & C). Differentiation was also readily observed in cells dissociated with both 
TrypLE Express and Accutase. Cell appeared compacted towards the centre of the 
colonies whilst those located on the peripheral edges of colonies were observed to 
migrate outwards from the colony and differentiate (Figure 5.12). This was true for cells 
dissociated with both TrypLE Express and Accutase.  
In the case of cells dissociated with Accuatse, differentiated cells were elongated but 
flattened in appearance, often with spindle-like structures sprouting out from the main 
body. These cells resembled fibroblasts (Figure 5.12B). Cells with the same 
morphology were also observed in cells dissociated with TrypLE Express. In addition to 
these cells, more cell types were observed in cells dissociated with TrypLE Express.  
In some areas of the wells, very elongated, thin cells were observed with ends dividing 
into further spindle-like structures resembling dendrites. These cells also contained a 
cell body within the main elongation and resembled the morphology of nerve cells 
(Figure 5.12D). The nucleus was difficult to identify in these cell types. 
As cells dissociated with Accutase only produced small aggregates in size, it was no 
surprise that the colonies of cells observed after the attachment were also small in size 
in comparison to those observed in cells dissociated with Collagenase VI and TrypLE 
Express.  
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Figure 5.12: Morphology of cells on day 6 of the differentiation process. A: Morphology of cells 
dissociated with Accutase on day 6. Area indicates differentiated cells. B: Enlarged image of 
indicated area of differentiated cell from image A. C: Morphology of cells dissociated with TrypLE 
Express on day 6 of the differentiation process. Area indicated differentiated cells. D: Enlarged 
image of differentiated cells indicated in image C. E: Morphology of another cell type from cells 
dissociated with TrypLE Express. Area indicates cells with similar morphologies to neural cells. F: 
Enlarged image of indicated area in image E. Arrow indicates location of cell body-like structure. 
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By day 7, in both buffer types tested cells had continued to migrate and differentiate. In 
the case of cells dissociated with TrypLE Express, in some areas of the vessel cells were 
observed to form multi-layered structures. In some areas of compacted cells, large cell 
and spindle-like structures were observed. In these cells were located amongst 
compacted cells. The area surrounding these large cells appeared to have a cleared area 
around these cells (Figure 5.13). Occasionally these spindle-like structures were 
observed to connect with other cells. These cell types were also observed in the control 
investigation but were not observed in cells dissociated with Accutase. 
By day 10, whilst cells continued to migrate, proliferate and differentiate some cells in 
compacted areas were observed to have become more visible. Cells located in these 
areas seemed to have migrated outward creating more space between cells. These cells 
appeared large with undefined peripheral edges. In some cases these cells appeared to 
be attached resembling the figure “8” (Figure 5.13D). Although only small colonies 
were observed in cells dissociated with Accutase by this point of the investigation cells 
were still observed to proliferate in multi-layered structures (Figure 5.13C). 
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Figure 5.13: Morphology of cells during different time points of the differentiation process. A: 
Morphology of cells dissociated with TrypLE Express on day 7. Area indicates clearing around 
cells amongst compacted cells. B: Enlarged image of area indicated in image A. C: Morphology of 
cells dissociated with Accutase on day 7. Area indicates mitotic-like cells. White arrow indicates 
example of multi-layered structure. D: Enlarged image of indicated area on image C. 
 
By day 11, large cells located within colonies of compacted cells were observed to have 
proliferated, in cells dissociated with TrypLE Express. These cells types were found to 
have expanded creating a large area occupied by these cells (Figure 5.14A). A closer 
analysis revealed a network of tubule-like structures spanning over the area of these 
large cells (Figure 5.14B). In addition to these tubule-like structures a web of smaller, 
spindle-like structures were also observed to interconnect cells within these regions of 
cells.  
 
      
 
119 
 
At this point of the investigation, proliferation of these large cells was observed in cells 
dissociated with Accutase (Figure 5.14C). In addition to this, cells from areas of 
compacted cells were observed to be more visible with some cells appearing more 
elongated. By day 12, an increase in population of these elongated cells were observed 
(Figure 5.14D). As was observed in those cells dissociated with TrypLE Express, in 
cells dissociated with Accutase, a network of spindle-like structures was not visualised. 
As a lower population of cells had attached to the matrigel coating at the initial stages of 
attachment, a larger surface area was still available to these cells to continue down the 
differentiation or proliferation route. 
 
 
Figure 5.14: Morphology of cells dissociated with TrypLE Express and Accutase on days 11 & 12 of 
the differentiation process. A: Day 11 of cells dissociated with TrypLE Express. Area indicates 
region of tubule-like structures. B: Enlarged image of indicated are in image A. White arrows 
indicate examples of tubule-like structures. C: Image of cells on day 11 of the differentiation 
process of cells dissociated with Accutase. D: Morphology of cells dissociated with Accutase on day 
12 of the process. 
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Cells continued to proliferate and differentiate until day 19; by this point of the 
investigation cells dissociated with TrypLE Express had become over confluent. Wells 
were observed to be extremely compacted. Many multi-layered structures were visible 
predominantly located in regions of compacted cells although some were also observed 
to be positioned in areas of elongated, neural-like cells (Figure 5.15A). As cells 
continued to proliferate cell detachment was also observed in some areas of the wells by 
day 20 (Figure 5.15B). These areas of detachment were mainly observed in peripheral 
regions of small compacted cells. The detachment resulted in a sheet of cells rolling 
towards the centre of the cell population. 
 
 
Figure 5.15: Morphology of cells dissociated with TrypLE Express on day 20 of the investigations. 
A: Morphology of cells on day 20 of the investigation, arrows indicates examples of multi-layered 
structures. B: Phase image of cell detachment on day 20 of the differentiation process, arrows again 
indicate examples of multi-layered structures.  
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5.4.3 Generation of early RPCs 
On day 21 of the investigation cells were fixed with paraformaldehyde for 
immunocytochemistry investigations looking for expression of early eye field markers 
Pax6 and Chx10.  
Immunocytochemistry results revealed low level expression of Pax6 in cells dissociated 
with Accutase, expression of Pax 6 was mainly observed in areas of multi-layered 
structures with almost no expression observed elsewhere in the wells (Figure 5.16). It 
was difficult to conclude whether this was a true reflection on Pax6 expression or 
whether the stain had become trapped between layers of the multi-layered structures 
resulting in an accumulation of the stain in these areas.  
Pax6 expression was observed in cells dissociated with TrypLE Express and visually 
the intensity of expression was very mildly reduced in comparison to cells dissociated 
with Accutase. In cells dissociated with TrypLE Express, expression was mainly 
observed in areas of compacted cells in comparison to cells dissociated with Accutase 
and Collagenase where Pax6 positive cells remained in groups of cells. 
Overall Pax6 expression was observed in both dissociation buffers investigated with 
those cells dissociated with TrypLE Express expressing slightly lower levels than cells 
dissociated with Accutase.  
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Figure 5.16: Pax 6 expression of cells dissociated with Accutase and TrypLE Express. Arrows 
indicate examples of multi-layered structures. First coloumn shows expression of Pax6, second 
coloumn shows nuclear staining with DAPI and third coloulm shows phase images of cells. 
 
Similar to the immunocytochemistry results observed for Pax6, cells dissociated with 
Accutase exhibited very low levels of Chx10 expression with the majority, once again, 
observed in multi-layered structures (Figure 5.17). Whilst some expression was 
observed in areas of compacted cells, the intensity of expression was visibly lower in 
these cell types than that observed in areas of multi-layered structures. It is difficult 
conclude whether the intensity of fluorescence is a true reflection of Chx10 expression. 
In this case it is likely that the dye had become trapped between multi-layered structures 
leading to an excess of the stain resulting in the intense fluorescence but low intensity 
fluorescence observed in other cells may in fact be a reflection of on the Chx10 
expression within the population of cells. 
In cells dissociated with TrypLE Express a similar observation was made in that the 
intensity of fluorescence was greatly increased in areas of multi-layered structures 
(Figure 5.17). Again, this is more than likely not to be a true reflection of Chx10 
expression in this population. Visually, expression of Chx10 was found to be more 
widespread across compacted cells in this population, in comparison to the population 
of cells dissociated with Accutase. This suggests the presence of a larger population of 
Chx10 expressing cells in cells dissociated with TrypLE Express than those dissociated 
by Accutase but qPCR results are required to confirm this statement. 
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Figure 5.17: Immunocytochemistry results of Chx10 Express from cells dissociated buffers 
Accutase and TrypLE Express. Arrows indicate examples of multi-layered structures. First 
coloumn shows exoression of Chx10, second coloumn shows nuclear staining with DAPI and thirs 
coloumn shows phase images of cells. 
 
Once qPCR results had been analysed, of all the dissociation methods tested, retinal 
gene expressions from cells dissociated with Accutase consistently produced the lowest 
expression. For this reason the expression of genes from these cells were set as a 
baseline to which the expression from cell dissociated with the remaining two methods 
could be compared against including results from the control investigation. 
The expression of Six 3, a marker for eye field cells was recorded in cells dissociated 
with all three methods. In cells dissociated with TrypLE Express, a 20 fold increase in 
expression of this gene was noted in comparison to cells dissociated with Accutase 
(Figure 5.18). In cells mechanically dissected with Collagenase VI, Six 3 was found to 
express less than a 10 fold compared to those cells dissociated with Accutase (Figure 
5.18). Although another early eye field marker, Rx1, was also investigated, no 
expression of this marker was noted in cells dissociated with Accutase and therefore it 
was not included in the qPCR data displayed in Figure 5.18. This was because 
comparisons of expressions could not be calculated for the remaining two buffer types. 
Expression of Rx1 was however recorded in cells dissociated with TrypLE Express and 
mechanical dissection with Collagenase VI. 
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In accordance with immunocyctochemistry results, Pax 6 expression was recorded in 
cells dissociated enzymatically and mechanically with Accutase and Collagenase IV 
respectively. No expression of this eye field marker was recorded from cells dissociated 
with TrypLE Express contrary to ICC analysis. This suggests that the fluorescence 
observed in the ICC analysis may be due to nonspecific staining. Together with Pax 6, 
Chx10 is a marker for neural retinal progenitor cells and expression of this marker was 
consistent to immunocytochemistry results.  
qPCR analysis revealed an over 70 fold increase in expression for this neural retinal 
progenitor marker in cells dissociated with TrypLE Express, with the expression of the 
same marker only being recorded at less than 10 fold with those cells mechanically 
dissected with Collagenase VI in comparison to cells dissociated with Accutase (Figure 
5.18). 
One of the most exciting markers to be investigated was that of Nrl as this is a marker 
for photoreceptor precursor cells. It was interesting to note that over a 110 fold increase 
in expression for this marker was recorded from cells dissociated with TrypLE Express 
in comparison to those dissociated with Accutase. The mechanical dissection with the 
Collagenase VI control was only found to have a less than 10 fold increase in Nrl 
expression to those cells dissociated with Accutase.  
qPCR data analysis clearly revealed that cells dissociated with TrypLE Express 
exhibited a significant increase in retinal gene expression in comparison to the other 
dissociation methods tested in this investigation. 
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Figure 5.18: qPCR analysis of retinal gene expression in cells dissociated with Accutase, TrypLE 
Express and mechanical dissection with Collagenase. Gene expression in each condition was 
normalised to gene expression in the Accutase samples, as expression levels were lowest here and 
are therefore regarded as baseline values. 
 
5.5 Discussion 
Since the discovery of human pluripotent stem cells an array of protocols have been 
developed in order to exploit their properties to generate specific cell types for potential 
therapeutic treatment. The efficiency of protocols is however cell line dependant. 
Lamba and his group developed one of the first successful protocols to generate RPCs 
from the H1 cell line in 2006. This cell line was one of the first pluripotent human stem 
cells to be created by Thompson and his group in 1998. The protocol devised by Lamba 
involved a two-stage differentiation process consisting of a phase of suspended culture 
followed by a plated culture system for a period of 21 days in total.  
The first phase of this protocol consisted of the formation of EBs in suspended culture 
in the presence of growth factors DKK1, noggin and IGF1- all of which have been 
found to hold important roles in the induction of forebrain development in early 
mammalian embryogenesis (Lamba et al., 2006). The second phase of this protocol 
involves the attachment of the EBs formed and maintenance of culture in media 
supplemented with N2 and B27 in addition to the growth factors previously mentioned. 
Following the Lamba et al., 2006  protocol, this group found ~70% of H1 hESCs to co-
express retinal progenitor markers Pax6 and Chx10. 
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This chapter successfully followed the Lamba protocol to generate RPCs from a 
pluripotent Shef 3 cell line and also investigated the effect of Accutase, Collagenase VI 
and TrypLE Express on the differentiation process.  
At the dissociation stage it was very apparent that both Accutase and TrypLE Express 
both dissociated cells as single cells in contrast to that of mechanical dissection with 
Collagenase VI. Although a large population of single cells was created by both 
Accutase and TrypLE Express, those cells dissociated with TrypLE Express were found 
to form large aggegrates. This was similar to those produced by the mechanical 
dissection of cells with Collagenase VI.  
These aggregates were large and dark in appearance due to the presence of a large 
population of cells. In contrast to this, those cells dissociated with Accutase only formed 
small aggregates with a light appearance- again reflecting the size of the cell population 
present in these aggregates.  
Although a large population of single cells were also visible in both groups of cells 
dissociated with TrypLE Express and Accutase, towards the end of the EB phase a 
lower population of these cells were observed in cells dissociated with TrypLE Express 
than that of Accutase. A higher population of cell debris was also observed in cells 
dissociated with Accutase in comparison to those dissociated with TrypLE Express and 
mechanical dissection with Collagenase VI. These were dark in appearance with a less 
apparent cell membrane. 
Common to all dissociation buffer types investigated, all aggregates formed did not 
have a typical well rounded appearance commonly reported as EBs. Although in 
appearance aggregates formed resemble EBs, in order to confirm this further tests are 
required to ensure cells from aggregates are capable of forming cells from all three germ 
lines. 
After the initial phase of the differentiation process it was evident that the enzyme 
Accutase was more suited to dissociating cells as a single cell population but was not 
the preferred method of dissociation  in order to create cell aggregates in suspension. 
This may be a factor which contributed to the increase in cell debris.  
Cell to cell signalling plays a vital role in cell maintenance especially the case of 
suspension culture. When cells aggregate these signalling systems are undisturbed 
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aiding cellular functions to continue as usual. When cells do not form aggregates and 
remain as single cells in suspension, inter-cell  signalling pathways are disturbed which 
then in turn could have a knock-on effect on the intra-cell signalling system. This could 
result in the diversion of the differentiation or proliferation process of the cell into 
apoptosis. In mouse stem cells especially it has been found that the location of cells 
within aggregates play important roles in the direction of cellular process taken such as 
differentiation and apoptosis (Murray and Edgar, 2004). 
Both conditions where cells had formed large cell aggregates, in this investigation, 
contained a lower population of cell debris in comparison to those cells which remained 
predominantly as single cells. Additionally, only cells that remained as single cells 
progressed into cell debris.The control of EB size and shape could have a significant 
impact on retinal differentiation. Some studies have found a controlled EB method to 
increase the production of photoreceptor precursor cells (Yanai et al., 2013). Briefly, the 
study carried out by Yanai and his group focussed on size controlled EB differentiation 
of hESC into retinal cells. This group found that by controlling EB size to 1000 cells, 
Crx positive cells (photoreceptor precursor cells) could be recorded as early as day 17.  
In the second phase of this differentiation, cells from all conditions tested were 
observed to adhere well onto the matrigel coated vessels. Cells were observed to adhere 
within a colony at the location where the attachment of the aggregate had occurred and 
this was common to all conditions investigated. Another common factor to all cells 
investigated was the appearance of these colonies of cells. Those cells located in the 
centre of these colonies were observed to be very compacted whilst those located on the 
outer boundaries were found to migrate and differentiate. As expected those cells 
dissociated with Accutase were only found to display small colonies in comparison to 
cells dissociated with TrypLE Express and those mechanically dissected with 
Collagenase VI. This was no surprise as these cells also produced small aggregates of 
cells and therefore as only a small population of cells were present in these aggregates a 
large colony after attachment was not expected. 
  By day 5 of the investigation, all cells tested were found to display signs of 
differentiation. Commonly to all dissociation methods investigated, cells with an 
elongated, flattened morphology with spindle-like structures were observed in all cells 
investigated. In those cells mechanically dissected with Collagenase VI, cells 
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resembling astrocytes were also observed in addition to those cells mentioned 
previously. In cells dissociated with TrypLE Express very thin, elongated cells 
resembling neural cells were recorded.  
By day 10 cells has become very confluent, more common to those cells mechanically 
dissected with Collagenase VI and dissociated with TrypLE Express. Those cells 
dissociated with Accutase appeared to have a lower population of live cells, this again 
was no surprise. Towards the middle (Day 12) of the differentiation process, cells were 
observed to form multi-layered structures presumably due to the lack of space available. 
It was interesting to note that although space had become very limited due the vast 
population of cells, proliferation and differentiation was still taking place. By this point 
of the investigation, cells mechanically dissected with Collagenase VI and dissociated 
with TrypLE Express were found to also display a network of tubule-like structures 
interconnecting areas of cells. This network of tubules was not observed in cells 
dissociated with Accutase. As cells had become over crowded by the end of the 
investigation cell detachment was observed in some areas of over confluency. 
It was evident that those cells dissociated with Accutase displayed less varied cell 
morphologies in comparison to the other two dissociation buffers investigated. It was 
also interesting to find that, although initially dissociation with TrypLE Express 
produced a fairly high population of single cells this did not in any way hinder the 
formation of aggregates or differentiation in these cells as was the case in cells 
dissociated with Accutase.  
Overall qPCR results revealed a clear advantage to using TrypLE Express as a 
dissociation buffer for the purpose of this investigation in comparison to both Accutase 
and Collagenase VI. The latter of which was used to mechanically dissect cells in the 
original protocol produced by Lamba and his group in 2006. Cells dissociated with 
TrypLE Express produce an exceptionally high expression of RPC genes in comparison 
to cells dissociated with Accutase and Collagenase VI. Dissociation with Accutase 
consistently produced very low level expression of all RPC genes investigated with no 
expression of Rx detected although expression of this gene was detected in cells 
dissociated with TrypLE Express and mechanical dissection with Collagenase VI.  
The qPCR results of Pax 6 and Chx10 expression of cells dissociated with Accutase was 
consistent with the immunocytochemistry results as only very low levels of these genes 
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were detected. This was also the case with those cells dissociated with TrypLE Express 
as it was difficult to confirm the presence of Pax6 expression from the 
immunocytochemistry results but this was confirmed from the qPCR results as no 
expression was present for this gene in these cells.  
As over a 100 fold expression of Nrl, a marker for photoreceptor precursor cells was 
observed in cells dissociated with TrypLE Express it was clear that those cells contained 
a larger population of cells that had been directred towards the retinal lineage.  
A high population of cell loss as a result of the formation of EBs was observed in this 
investigation. This prompted the investigation of a monolayer differentiation system, in 
order to reduce the population of cells lost during this process. 
 
5.6 Conclusion 
The aim of this investigation was initially to follow the protocol produced by Lamba 
and his group in 2006 to generate cells expressing RPC genes and was successful in its 
aim.  
Secondly, it aimed at optimisation of the protocol whereby three dissociation methods:  
(mechanical dissection) Collagenase VI, Accutase and TrypLE Express were 
investigated in order to detect whether the dissociation methods could have a significant 
effect on directing pluripotent Shef 3 cells into RPCs. The results of this investigation 
were again successful in its aim and found  cells treated with TrypLE Express to 
consistently have a significant increase in RPC gene expression. The results also 
confirmed Accutase was not favourable to direct pluripotent Shef3 cells into RPCs as 
these cells consistently produced very low levels of RPC gene expression. In 
accordance with the results from this investigation using TrypLE Express to dissociate 
cells at the start of the differentiation process can aid significantly to direct Shef 3 cells 
down the RPC lineage. 
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6 Monolayer Differentiation of Human Pluripotent Stem Cells 
6.1 Introduction 
One of the key hurdles that exist in introducing pluripotent hESCs clinically is the 
efficiency of the differentiation protocols. Without an efficient protocol, production and 
maintenance of cells would not be clinically viable. Current protocols rely on the EB 
differentiation system in order to direct pluripotent hESCs into the retinal lineage. This 
method cannot be used to create a highly efficient differentiation system as a large 
population of cells are lost during the EB stage at the early stages of the process.  
A monolayer differentiation protocol was first devised by Lamba and his group in 2010 
to direct iPSCs into retinal cells with successful results. Within three weeks over 70% of 
cells were found to express the early eye field marker Pax6, with over 11% of cells 
expressing the photoreceptor precursor marker Crx (after two months of induction). 
These results show clearly that a monolayer differentiation could be successful in 
directing iPSCs towards the retinal lineage and that differentiated cells incorporate well 
after induction. The advantage of this protocol is that a reduction is made to the number 
of cells lost during the initial stages as cells no longer have the need to aggregate for 
survival before once again attaching onto the monolayer. 
The difference in cell type and differentiation success varies greatly as mentioned 
previously but if this protocol could be used to direct the differentiation of pluripotent 
hESCs, omitting the EB stage of the protocol, it could provide a step in the right 
direction for cell maintenance and productivity for clinical trials. 
6.2 Aim 
This chapter aims at directing pluripotent Shef 3 hESCs into RPCs following the 
protocol established by Lamba et al., (2010). 
 
6.3 Monolayer Differentiation of Shef-3 hES cells 
Following routine cell culture of pluripotent Shef 3 hESCs using Collagenase VI for 
mechanical dissection, cells were transferred onto Mef feeder cells. For a period of 3 
days cells were maintained in media supplemented with growth factors noggin, Dkk1 
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and IGF-1, in accordance with the protocol established by Lamba and his group in 
2006.  
By day 1, cells had adhered well to the MEF feeder layer and remained in small 
colonies at the point of attachment. Cells appeared to be well rounded with many large 
nuclei observed, characteristic of undifferentiated hESCs (Figure 6.1). A low population 
of un-attached cells were also observed.  By day 3 of the protocol cells had proliferated 
well covering approximately 60% of the surface (Figure 6.1). Cells appeared very 
compacted and in some cases were losing the characteristic well rounded morphology of 
undifferentiated cells, especially on the peripheral areas of smaller colonies (Figure 
6.1D). 
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Figure 6.1: Morphology of Shef-3 hESCs on day 1(A & B) and day 3 (C & D) of the monolayer 
differentiation. 
 
By day 4 of the differentiation process, cells had become over confluent with cells 
appearing to be extremely compacted (Figure 6.2). In some areas of the vessels, cells 
were observed to have formed multi-layered structures due to the lack of space available 
and appeared dark in colour. Some cells appeared to have an elongated morphology 
showing signs of differentiation (Figure 6.2). These cells were prominently visible in 
peripheral areas of colonies as the centre of colonies was often too compacted to 
distinguish individually differentiated cells. By this point of the investigation feeder 
cells were becoming increasingly difficult to distinguish within the population of 
migrating cells. A high population of compacted cells were also found to contain large 
cells (Figure 6.2B). 
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Figure 6.2: Morphology of differentiated Shef 3 hESCs on day 4. A: Image of compacted cells with 
a lower magnification (x4). Arrow indicates example of multi-layered structure. B: A magnified 
image of differentiated Shef3 cells on day 4 of the process (x20).  
 
By day 5 and 6 cells had become extremely compacted and over confluent. This made it 
very difficult to both distinguish specific cells and also to clarify whether cells were 
continuing to undergo differentiation and proliferation (Figure 6.3). The presence of 
multi-layered structures was also observed to have increased and it was very apparent 
that the lack of space was going to be detrimental to the differentiation process. 
Although there were some signs of differentiating cells, these cells would not be able to 
continue to their full potential if left in this state (Figure 6.3). For this reason on day 7 
on the differentiation process, cells were cultured so that a lower density of cells were 
replated on a new layer of MEF cells using mechanical dissection with Collagenase VI, 
and maintained in the same supplemented media as mentioned above. During culture, a 
portion of the cells was pelleted for further analysis.  
 
Figure 6.3: Shef-3 hESCs at various points of the monolayer differentiation. A: Image of cells taken 
on day 5 of the differentiation process. B: Image of Shef3 hESCs take on day 6 of the process. 
Arrow indicated example of areas containing multi-layer structures.  
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On day 10 of the process, cells were found to still be recovering from the culture 
process to reduce the cell population. Although a large population of cells had attached 
well onto the monolayer and an abundance of space was now available for 
differentiation to take place by this point in the investigation, a healthy population of 
undifferentiated, well rounded cells with a strong cell membrane and large nucleus were 
not observed. A large population of cells appeared small and dark in colour with no 
prominent cell membrane or morphology (Figure 6.4A). These small cells were located 
across the monolayer and were also observed to be suspended in the media. 
Cultured cells were observed to have again formed colonies at the point of attachment 
and differentiation of cells within these colonies was observed once again (Figure 6.4 
B). Generally differentiated cells had a flat and elongated morphology occasionally with 
protrusions (Figure 6.4 C). A large population of large cells with a rounded appearance 
were also observed. Some of these cells contained a large dark structure whilst other did 
not.  
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Figure 6.4: Images of Shef 3 hESCs on day 10 of the monolayer differentiation process. A: Image at 
a lower magnification of cells taken on day 10. B: A high magnification of cells taken on day 10. 
Area indicates an area of differentiate cells. C: Enlarged image of area indicated in image B. This 
image shows the morphology of differentiated cells on day 10. 
 
Notable changes in morphology of cells were observed on day 11 of the differentiation 
process. An obvious decrease in the population of small, dark, cell debris was visible 
and various other morphologies were also exhibited. Overall cells had a much less 
defined cell membrane giving the appearance of a mass of amalgamated cells (Figure 
6.5A). In addition to the cell morphologies described above, more elongated cells were 
also observed. A closer analysis revealed a number of very small protrusions similar in 
morphology to spindles, inter-connecting cells creating a web-like network were 
observed on these cells (Figure 6.5B). These networks of tubules were observed to pan 
across the whole population of cells (Figure 6.5C). 
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Figure 6.5: Images of Shef3 hESCs on day 11 of the differentiation process. A: A low magnification 
image of Shef3 cells. B: A higher magnification image of Shef3 hESCs on day 11 of the 
differentiation process. The network of tubules is clearly visible. C: A higher magnification of the 
network of tubules observed in these cells. 
 
During days 12 and 13 much of the same cell morphologies described previously were 
observed (Figure 6.6A). Very occasionally rounded cell morphology was also observed; 
these cells appeared to have a very large dark structure prominently located into the 
centre of the cell, almost like a cell nucleus. These cells were found to be slightly 
increased in size in comparison to all other cells observed in the population (Figure 
6.6B). Cells were also found to have become fairly compacted by day 13 with many 
colonies observed to be tightly surrounded by highly differentiated cells with a network 
of tubules (Figure 6.6C).  
By day 14 cells were once again observed to have become over confluent with no 
vacant area available for further differentiation and development. Colonies of cells were 
very compacted and appeared dark in colour as cells predominantly formed multi-
layered structures over areas of the colonies. In general, cells within colonies appeared 
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very compacted making it very difficult to identify individual cells. In the areas between 
these colonies a mass of differentiated cells without a prominent cell membrane were 
observed (Figure 6.6D). Generally these cells had a darkened structure which morphed 
into an elongation. 
 The outermost edges of the colonies were also observed to be slightly brighter in colour 
almost like an outline. A magnified image analysis of this region revealed the presence 
of cells with a very thin elongated morphology surrounding these colonies (Figure 
6.6E). As there were still a number of days remaining for the investigation to be 
completed, it was once again decided that it would be in the best interest of the 
investigation to dissociate cells mechanically with Collagenase VI in order to reduce the 
density of cells for the remaining of the investigation. The culture was carried out in the 
same way as previously explained with a small portion pelleted for further analysis. 
Whilst a vast majority of cells were observed to have attached onto the monolayer, a 
large population of cells were also observed to remain in suspension a day after the 
process was carried out. 
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Figure 6.6: Images of Shef3 hESCs at various time points of the differentiation. A: Image of Shef3 
hESCs on day 12 of the differentiation process. B: A magnified image of Shef3 hESCs on day 12 of 
the differentiation process. Arrows indicate examples of rounded cells with a darkened structure 
located in the centre of the cell. C: Image of Shef3 hESCs on day 13.  Arrow indicates example of 
compacted colonies surrounded by a high population of differentiated cells and tubular network. D:  
Image of Shef3 hESCs on day 14 of the differentiation process. White arrows indicate example of 
brightened edges of colonies. E: Magnified image of cells located on the periphery of colonies on 
day 14 of the differentiation process. 
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By day 17 cells had adhered well onto the monolayer. Cells located between colonies, 
those with less prominent cell membranes, were observed to have migrated well giving 
the appearance of more available space around each cell. The spindle-like elongations 
of these cells were also more prominent (Figure 6.7 A). A closer analysis of these cell 
types revealed the presence of yet more network-like connections panning across the 
monolayer (Figure 6.7B). Cells within colonies became more apparent with individual 
cells becoming more visible. Within these colonies some large cells with a less 
prominent cell membrane were recorded.  
 
Figure 6.7: Image of Shef3 hESCs on day 17 of the differentiation process. A: Image of cells at a 
lower magnification on day 17. B: Magnified image of cells on day 17 of the differentiation process. 
Arrows indicates example of tubular network.  
 
By day 18 cells had become very confluent with some areas of the vessel observed to be 
darker in colour in comparison to other areas of the vessel. These areas had a growth of 
cells in multi-layered structures (Figure 6.8A). In contrast to the availability of space 
between cells observed the day before, by this point of the investigation cells were 
observed to have once again become very compacted. Networks of tubule-like 
structures were also visible across the monolayer of cells but due to the vast number of 
compacted cells it was difficult to identify individual cells (Figure 6.8A).  
By day 19 only one type of cell morphology was observed as cells were very compacted 
(Figure 6.8B). These cells were elongated with spindle-like structures. A closer analysis 
revealed cells to have a darkened bulb like mass which narrowed into an axon or 
spindle-like structure (Figure 6.8C). As expected, cells were observed to have become 
very compacted towards the end of the investigation although on day 20, some parts of 
the vessel were observed to display a darkened structured within the cells. These large 
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cells with a less prominent cell membrane were located within the reminiscence of 
colonies whilst those cells surround these colonies appeared to have a less defined cell 
membrane as described before (Figure 6.8D).  
 
Figure 6.8 Images of Shef3 hESCs at various time points of the differentiation process. A:  Cells on 
day 18 of the differentiation.  Arrow indicates example of cell growing in multi-layered structures. 
B: Cells on day 19 of the investigation. C: A magnified image of cells taken on day 19 of the 
differentiation. Arrows show example of cells containing a morphology similar to axons sprouting 
from a bulb-like mass D: Image of cells on day 20 of the investigation.  
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6.4 Differentiation of Retinal cells on various ECMs 
On day 21 cells were pelleted for further analysis and cultured onto plates coated with 
the following extracellular matrix proteins (ECM): laminin, matrigel, fibronectin, 
gelatin and Poly-D-Lysine (PDL) with one left uncoated. Cells were then passaged onto 
these plates and maintained for a further 6 days in differentiation media with media 
changes given every 2-3 days in order to identify any ECMs that may benefit the 
differentiation process 
Cells were found to have attached well onto the various ECM coatings with the 
exception of PDL. Cells were also found to have adhered well onto the uncoated vessel, 
although a high population of cells were also observed in suspension. A higher 
population of multi-layered structures were also observed in uncoated vessel (Figure 
6.9A). In the case of those cells located in the PDL coated vessel, cells had the 
appearance similar to cell debris. These cells appeared very small with an undefined cell 
membrane and more than 90% of the population of cells were in suspension (Figure 
6.9B). A few larger aggregates were also observed in this vessel again in suspension, 
these aggregates were not in a rounded formation as are EBs but instead took various 
formations most likely dependant on the number of cells and location where cells had 
become attached to the aggregate.  
In general, the population of cells observed in gelatin were visibly lower in comparison 
to all other coated vessels. Cells contained in the PDL coated vessels had an unhealthy 
morphology but the population of cells in these vessels still remained high as the 
majority of the population remained in suspension. With exception of cells cultured in 
PDL coated vessels, all other ECM contained cells, were of the same morphology and 
in fact were also the same as those observed during the initial differentiation process for 
the first 21 days.  
In summary the morphology of cells was flat and elongated with long tubule-like 
structures. A closer analysis also revealed the presence of a network of tubule-like 
structures interconnecting cells. These cells also maintained the same morphology as 
those observed during the initial differentiation process. A large population of cells with 
a very prominent structure in the centre of the cell (possibly a nucleus) were also 
observed but these cells did not have a distinctive cell membrane (Figure 6.9D). In 
comparison to these cell types described above, a smaller population of cells with a faint 
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structure located in the centre of the cell (again, possibly a nucleus) and a faint cell 
membrane were also observed (Figure 6.9F). Cells cultured in the gelatine coated 
vessels were found to hold a large population of elongated cells without any tubule or 
spindle-like structures and differing slightly in morphology to those elongated cells 
described previously (Figure 6.9H). 
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Figure 6.9: Image of cells on day 25 of the differentiation process on various ECM coatings. A: 
Image of cells cultured on the uncoated surface. B: Cells cultured on the PDL coated surface. C: 
Cells cultured on the laminin coated surface. Area indicates example of large cells. D: Enlarged 
image of indicated areas shown in image. C. E: Cells cultured on fibronectin. Area indicates 
example of large cells. F: Enlarged image of indicated area in image E. G: Cells cultured on 
Matrigel coated surface. H: Cells cultured on gelatin coated surface. 
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6.5 Generation of Early RPCs Using a Monolayer Differentiation 
On day 27 of the investigation, cells were fixed in paraformaldehyde in order to identify 
the presence of early RPCs using immunocytochemistry. 
β-III Tubulin plays an important role in neuronal development and is heavily involved 
in the health and maintenance of neuronal circuits  (Tischfield and Englel, 2010). It is 
thus a marker for the presence of neurons and neurites.  
Immunocytochemistry results for β-III tubulin showed good expression of the marker 
within cell cultures on the uncoated vessel, with expression also found in both the main 
body of cells as well as the network of tubules present in this population (Figure 6.10). 
A high expression of β-III tubulin was also observed in cells cultured on fibronectin and 
gelatin coated vessel (Figure 6.10). A closer analysis of these cells revealed the 
morphology of positive cells to predominantly be exhibited in large cells with a faint 
cell membrane (Figure 6.10).  
Visually a lower intensity of fluorescence was observed in cells cultured on laminin and 
matrigel coated vessels, but the DAPI staining reveals the presence of a high population 
of cells suggesting that it is more than likely that the fluorescence was not a true 
reflection of the expression of β-III-tubulin in these cells. 
Although only low levels of expression was observed in cells cultured on matrigel in 
comparison to those cells cultured on laminin, visually matrigel cultured cells had a 
slightly increased population of positive cells (Figure 6.10). Cells cultured on uncoated 
vessels were also found to have low levels of β-III-tubulin positive cells with the 
exception of areas of heavily aggregated cells (Figure 6.10A). The intensity in 
surrounding areas was similar to that displayed by cells cultured on laminin. In 
comparison to intensities displayed by cells cultured on fibronectin and gelatin, cells 
cultured on the uncoated vessel only exhibited low levels of β-III-tubulin expression.  
Although on most ECMs investigated, cells expressed at least low levels of β-III 
tubulin, cells cultured on PDL coated vessels displayed extremely low levels of 
expression although in some cases specks of expression could faintly be matched to the 
presence of a cell from the DAPI staining (Figure 6.10). The expression exhibited by 
these cells was so low that visually it was very difficult to identifiy whether any 
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expression was present at all. Even expression in aggregated areas was of only low 
intensity in these cells. 
 
Figure 6.10: Immunocytochemistry for β-III-Tubulin, DAPI Staining and phase images for cells 
cultured on various ECMs. 
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Overall, expression of early eye field marker Pax6 was only observed at low levels on 
all ECM coatings investigated with the exception of the uncoated vessel where no 
expression was recorded (Figure 6.11). Cells cultured on the PDL coated vessel were 
observed to express extremely low levels of Pax6 but as the intensity of expression was 
so low and visually very difficult to identify whether the fluorescence was in line with 
the location of cells displayed by the DAPI staining. This is highly likely to be a result 
of non-specific expression (Figure 6.11). Although low Pax6 expression was observed 
on all other ECMs investigated a particularly low intensity of expression was found in 
cells cultured on gelatin coated vessels in comparison to all other cells investigated 
(with the exception of PDL and the uncoated cultured cells) (Figure 6.11).  
True to all ECMs tested in this investigation, Pax6 expressing cells were predominantly 
observed in small groups of attached cells rather than single cells (Figure 6.11). These 
groups of Pax6 positive cells took a morphology that was visibly similar to grapes 
emitting a strong intensity of Pax6 expression within the group of cells making a clear 
distinction between positive and negative cells (Figure 6.11).  
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Figure 6.11: Immunocytochemistry for Pax6, DAPI staining and phase images for cells cultured on 
various ECMs. 
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As was observed with Pax6 expression, in general, only low levels of neural retinal 
progenitor marker Chx10 was recorded. This was true of all cells tested in this 
investigation (in all culture vessels) with the exception of those cells cultured on gelatin 
coated vessels.  
In the case of cells cultured on gelatin, a widespread expression of Chx10 was observed 
across the vessel with a high intensity of expression (Figure 6.12). Expression was not 
limited to specific aggregates of cells or specific cell types as was observed previously 
with Pax6 positive cells. Instead expression was found to be more widespread. DAPI 
staining revealed the presence of a high population of cells in these vessels the location 
of which was consistent with  Chx10 expression (Figure 6.12).  
Some expression was also observed in cells cultured on uncoated surfaces although this 
expression was mainly confined to groups of compacted cells with very low expression 
surrounding these areas in comparison to the expression observed in gelatin cultured 
cells (Figure 6.12). Expression exhibited by cells cultured on fibronectin coated vessels 
was observed to be extremely low; so low, that it was difficult to visually estimate 
whether expression was present at all (Figure 6.12). This was also true in the case of 
cells cultured on both laminin and matrigel coated vessels (Figure 6.12). The expression 
of Chx10 exhibited by cells cultured on PDL coated vessels was again so low that it was 
very difficult to commit to whether fluorescence was present at all (Figure 6.12). A 
closer analysis revealed the location of Chx10 positive cells to mimic the location of 
cells exhibited by the DAPI staining.  
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Figure 6.12: Immunocytochemistry results for Chx10 for monolayer differentiated Shef3 cells 
cultured on various ECM coatings. 
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qPCR results were supportive of immunocytochemistry results in that Pax6 and Chx10 
expression was also found to be low in this investigation.  
qPCR results revealed that on day 7 of the differentiation period, very low Pax6 
expression was observed and in fact was found to be visually almost half of that of the 
control on the same day (Figure 6.13). On day 7, Chx10 expression was very slightly 
improved in that expression was found to remain slightly increased in comparison to the 
control (EB differentiation). 
Expression of photoreceptor precursor marker Crx was in fact observed to be increased 
by over 10 fold in comparison to that of the control on day 7. qPCR analysis of samples 
taken on day 14 of the differentiation process revealed a very slight increase in Pax6 
expression in comparison to day 7 with expression remaining lower than that of the 
control sample (Figure 6.13). Chx10 expression was also observed to be increased on 
day 14 with an increase of over 2 fold in comparison to that of the control. Differing to 
the pattern of expression of Pax6 and Chx10 on days 7 and 14, Crx expression was 
found to be greatly reduced on day 14 (Figure 6.13). 
In comparison to the excess of 10 fold increase in expression observed on day 7 of Crx, 
on day 14 this had reduced to only a ~6 fold increase in expression in comparison to the 
control. Within 7 days of differentiation a decrease of over 4 fold in expression had 
been recorded. qPCR results for expression of all retinal markers investigated was found 
to be even more greatly reduced on day 21.  
On day 21, both Pax6 and Chx10 expression was found to be less than half the 
expression of that of the control with the greatest reduction in expression exhibited by 
Crx; where expression was found to drop to lower than that of the control (Figure 6.13). 
In comparison to the Crx expression levels observed on day 7, expression was found to 
have reduced by over 10 fold standing just under that of the expression exhibited by the 
control sample. 
In general qPCR results revealed a decrease in expression of retinal markers over time 
in this investigation.
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Figure 6.13: qPCR results for monolayer differentiation of pluripotent Shef 3 hESCs samples taken 
at various time points during the differentiation process. 
 
6.6 Discussion and Conclusion 
A major issue in the differentiation of photoreceptors from pluripotent stem cells is that 
predominantly the process is carried out in two stages, where initially EBs are formed 
which are then transferred to the second stage of the process. This process however 
immediately disposes off a high population of cells with the potential to differentiate 
into target cells. This can be a limiting factor, a bottleneck for the success of 
differentiation techniques, as the efficiency of any protocol is dependent on the time and 
yield of the process.  
Whilst Lamba and his group were successful in eliminating this EB stage of the 
differentiation of photoreceptor cells in 2010 with their monolayer differentiation 
technique using iPS cells, this technique has not yet been completely investigated using 
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other pluripotent cell lines such as the Shef 3 cell line. Adult somatic cells can be 
reprogrammed into pluripotent iPS cells with the induction of Oct3/4, Sox2, c-Myc and 
Klf4 (Takahashi and Yamanaka, 2006).  As characteristically iPS cells are in fact cells 
that have been reprogrammed to become pluripotent stem cells, as is the case with any 
cell line, they vary in differentiation efficiencies. 
The first day of the differentiation process where pluripotent Shef3 hESCs were 
exposed to the initial supplemented media, cells were found to have adhered well 
forming many healthy colonies at the point of attachment as would be observed in any 
healthy population of cells. As days progressed it was evident cells were proliferating 
and differentiating and were found to become compacted and reached confluency by 
day 3. Following the over confluent nature of these cells, cells were sub-cultured in 
order to provide more available space and nutrients as a long period of differentiation 
was still ahead. After the initial culture maintenance, although a high population of cells 
remained to be healthy and found to adhere onto the monolayer a large population of 
cells were also found to be suspended in the media. This was an initial sign that the 
whole population of cells did not recover well from the initial maintenance procedure as 
suspended cells had a less rounded morphology as well as a darkened appearance. Cells 
were then found to have recovered and differentiation was observed amongst these cells 
with mainly an elongated and flat morphology observed at this point of the 
investigation. Some rounded cells with a large prominent nucleus were also observed in 
this population of cells whilst some others with a less prominent nucleus were also 
observed. A large nucleocytoplasm ratio is characteristic of pluripotent stem cells and as 
a result of this the presence of a large nucleus is also characteristic of undifferentiated 
pluripotent hESCs (Oh et al., 2005). Therefore the observation of those cells with large 
nucleus is more than likely to be undifferentiated hESCs. 
By day 11 cells were observed to have visually recovered from the initial cell 
maintenance process as the proportion of cell debris had visibly decreased and the 
remaining population had a healthy morphology.  
Various other cell morphologies were also observed suggesting that a high population 
of cells were in fact undergoing differentiation. Although the exact lineage of the 
differentiation taking place was not predictable at this stage of the investigation, the fact 
that differentiated cells were displaying spindle-like protrusions and interconnecting 
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web-like tubule networks were observed across the monolayer was encouraging as these 
are similar in morphology to other neuronal cells- a step in the right direction .  
Cells were observed to continue to proliferate and differentiate as by day 13 space had 
once again become restricted leading to another maintenance process on day 14. After 
the process visually cells were found to have adhered well onto the monolayer and 
continue down the differentiation and proliferation process with cellular morphologies 
displaying spindle-like outgrowths and interconnecting tubules as described previously.  
qPCR results revealed an increase in Pax6 and Chx10 expression after this process. This 
suggests that the maintenance process may in fact have aided early eye field cells. This 
is because in comparison to the expression of these markers on day 7 as expression was 
found to be slightly improved on day 14. As cells were extremely compacted this may 
have limited the proliferation and differentiation of Pax6 and Chx10 positive cells 
resulting in the lower expression of these markers observed on day 7. The maintenance 
process may have however aided in the proliferation and differentiation of these 
particular cells resulting in the increase of Pax6 and Chx10 expression on day 14.  
In the case of Crx expression however, qPCR results revealed a reduction in expression 
on day 14 in comparison to day 7. This shows that a small population of cells had in fact 
differentiated into photoreceptor precursor cells by day 7 from pluripotent Shef3 
hESCs. It also suggests that the mechanical dissection with Collagenase IV may have 
been detrimental to the differentiation of these cells as a reduction in expression of Crx 
was observed. This also suggests the reduction in photoreceptor precursor cells. 
Mechanical dissection of cells is a harsh process and at this stage cells could not be 
individually isolated. This would have therefore resulted in the distortion and breakage 
of many cells in the population. This breakage may have disrupted intercellular signals 
which hold an important role in cellular differentiation. As inter-cellular signalling 
processes were disrupted this may have had a knock on effect on the proliferation of 
these cells as well as other cells differentiating into these cell types. This may have 
resulted in the reduction of these photoreceptor precursor cells as cells no longer have 
the initial communication between cells to progress down the same lineage. Breakage of 
cells could have also resulted in cell death of these cells again reducing the population 
of Crx positive cells. 
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The increase in expression of Pax6 and Chx10 positive cells after day 7 and the 
reduction of Crx positive cells after the same day suggests that early eye field cells may 
have been less prone to disruption than late eye field cells or photoreceptor precursor 
cells. It may be a fact that late eye field cells may rely more heavily on inter-cell 
signalling processes than early eye field cells. Additionally, further investigations to 
isolate Crx positive and early eye field positive cells may give a clearer understanding 
to the likelyhood of late eye field cells to be physically more prone to damage during 
manual culturing methods. For example if Crx positive cells were found to have a 
morphology possessing a large number of tubule-like connections intertwined within 
other cells in comparison to early eye field cells then these cells would most definitely 
be more prone to physical damage during mechanical dissection in comparison to other 
cells with less/no protrusions.  
Although visually cells were found to recover well from the maintenance processes 
carried out in this investigation and continued to differentiate, proliferate and migrate 
this process was detrimental to the differentiation process. qPCR results clearly revealed 
a reduction in eye field marker expression with time and it is highly likely that the 
maintenance process contributed highly to this. Although early eye field marker Pax6 
and Chx10 were initially observed to have a slight increase, expression was found to be 
heavily reduced over time.  
Additionally cell recovery may have been prolonged over time either due to cell age or 
due to the time weakened cells takes to recover. Recovery of cells could be reduced 
depending on the number of times cells have been exposed to environmental and 
possibly physical stress, in the case of this investigation. If cells had not recovered fully 
this could also affect the differentiation status and thus again limit the differentiation 
and proliferation potential. If cells were affected in this way early on in the process then 
this would have resulted in a limitation of eye field positive cell proliferation reducing 
the population of target cells. As pluripotent cells continue to differentiate the repetitive 
manual maintenance process could have affected these cells in the same way again 
limiting cell differentiation towards the retinal lineage and possibly directing cells down 
a different lineage.  
It is well known that ECMs can play a large part in many cellular processes including 
differentiation offering various forms of support to various cell types. Therefore the 
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ECM type on which cells are cultured during a differentiation process has the potential 
to play a large role in directing pluripotent cells down a specific lineage.  
Visually it was very apparent that PDL did not support the growth of differentiated cells 
in this investigation. Cells cultured on this ECM where mainly found to be very small in 
appearance. Additionally the majority of cells were found to remain in suspension, 
suggesting that PDL did not support adherence of cells to the monolayer. It is accepted 
that if the coating process with PDL is not carried out efficiently with all washing steps 
carried out efficiently any residues left could be toxic to cells. In this investigation 
however it is not clear whether this may have been the underlying issue for the lack of 
cell support on this matrix. 
 A population of cells were also found to have adhered onto the uncoated surface 
although a fairly high population were also observed to remain in suspension. This 
suggests that a small population of cells did not in fact require an ECM coating to aid 
adherence to continue to differentiate and proliferate. As these cultures require regular 
media changes to maintain the health of the culture, any cells in suspension were lost 
during the process immediately reducing the efficiency of the process. For this reason, it 
is clear that an ECM coating is in fact required.   
Cells cultured on all other ECMs were found to have adhered well onto the monolayer 
and continued along the cellular paths. The population of cells cultured on gelatine 
coated surfaces were found to visually have a lower population of cells in comparison to 
all other cells cultured. Overall visually the growth of cells was most supported by 
laminin, matrigel and fibronectin, as cells cultured on these ECMs were found to have 
adhered well on the monolayer as well as maintain a high cell population. In general the 
morphology of cells observed in these cultures were similar to those mentioned 
previously. Various cell types were observed in each culture system.  
In the case of cells cultured on gelatine coated surfaces, visually a high population of 
elongated cells with no tubule-like protrusions were observed in comparison to all other 
cells investigated. Cells cultured on this system were also found to exhibit high 
expression of β-III-Tubulin and chx10 in comparison to all other ECMs investigated. 
Although an extension of 7 days was added to the initial differentiation process it was 
interesting to find that this had no real effect on the expression of early eye field 
      
 
156 
 
markers Pax6 and Chx10. In line with the results exhibited by qPCR results, 
immunocytochemistry results also revealed, generally, a low expression of Pax6 and 
Chx10. This suggests the extension period did not have a large impact on early eye field 
cells already present in the population to proliferate. This is because qPCR results were 
carried out on cells samples taken on day 21, whilst immunocytochemistry analyses 
were carried out on cells at the end of day 28. In this period if there were a large 
increase in early eye field cells, then a large increase in fluorescence for these markers 
would have been observed. As this was not the case in this investigation, this suggests 
that there was a lack in support in directing cells down the retinal lineage. One reason 
behind this issue may have been the mechanical dissection carried out on day 21. As 
mentioned previous it is clear that this process is harsh on cells introducing cell 
breakage and cell death into the population of differentiated cells. Additionally, it must 
be taken into consideration that a very large population of cells which continued to 
differentiate on various ECMs had already be processed through the maintenance 
process twice. Therefore these cells may have had to go through the recovery period 
following this process several times. As mentioned previously, the recovery time of 
cells after the maintenance period may increase with the number of processes cells have 
undergone as it may have “weakened” the ability to recover.  
qPCR results have clearly revealed the maintenance process to be detrimental to cells 
undergoing differentiation in this investigation. In light of this, it may be the case that 
the final maintenance process had resulted in a particularly increased recovery time of 
cells resulting in the lack of progression of cells down the retinal lineage despite the 
time extension given to these cells. It was also interesting to observe that although Pax6 
expression may have only been observed at low levels, expression was mainly located 
in groups of aggregated cells. A number of repetitions and further investigations are 
however required in order to conclude whether the morphology of Pax6 cells is in fact 
confined to these cell types. 
Although early eye field markers were found to be expressed at low levels it was 
encouraging to note that a high expression of β-III-tubulin was exhibited by these cells. 
This is encouraging as β-III-tubulin is a marker of neuronal cells and plays an important 
role in the health and maintenance of these cells suggesting that the remaining 
population of cells held a high population of neuronal cells which is a step in the right 
direction.  
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Although a high efficiency of RPCs were not observed, this investigation was still 
successful in mimicking the Lamba et al., 2010 protocol using pluripotent Shef3 hESCs 
to produces early RPCs. Detection of early eye field markers Pax6 and Chx10 along 
with photoreceptor precursor marker Crx is evidence of the presence of pluripotent 
hESCs being differentiated down the retinal lineage using the monolayer differentiation 
protocol.  
Although this investigation has proved that a monolayer differentiation system is 
feasible to produce RPCs the efficiency of the protocol is still too low to use in clinical 
supply.  
A major issue brought to light by this investigation is the initial seeding density which 
may play a large role in the optimisation of this particular protocol. This investigation 
clearly shows the detrimental effects of mechanical dissection of cells during the 
differentiation process which may be omitted if the optimal seeding density is 
calculated. This seems to be the downside of this investigation. If mechanical dissection 
had not been employed during the differentiation process, cells may have had the 
opportunity to differentiate efficiently into RPCs and a reduction in expression of retinal 
markers may have not been observed. 
It was exciting to note that detection of photoreceptor precursor marker Crx was 
recorded as early as day 7. If optimal conditions were met, there may be an opportunity 
to reduce the photoreceptor differentiation protocol by a vast number of days. In terms 
of use in therapy, this could hold a major advantage as this immediately has the 
potential to increase efficiency of the protocol by reducing cost of production.  
As overall, no particular ECM type had profound advantages for the purpose of this 
investigation, this may also be another optimisation route to investigate as various 
combinations may contribute to the differentiation efficiency. This investigation 
however concludes that neither PDL nor an uncoated surface is optimal for the 
differentiation of Shef3 hESCs into RPCs. 
Overall, this investigation shows that a monolayer differentiation protocol could be 
successful provided initial seeding densities of cells could be calculated. Along with 
other optimal conditions the time period of the protocol may also be heavily reduced. A 
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complete optimisation of the protocol could give better scope for cells to be used in 
regenerative medicine. 
 
 7 Concluding Remarks and Future work 
7.1 Summary of results 
Investigations into the following areas were made during this study: i) the 
characterisation of the Shef3 hESC line, ii) the differentiation of Shef3 hESCs into 
RPCs following a pre-existing protocol, iii) the effect of different dissociation buffers 
on the pre-existing protocol, iv) the effect of a monolayer differentiation system on RPC 
production and v) the effect of different ECMs on RPC maintenance. 
In chapter 4, this study sought to characterise the Shef3 hESC line. The ability of the 
cells to remain undifferentiated and pluripotent for a prolonged period of in vivo culture 
was investigated. Expression analysis of intercellular (Oct4) and surface (TRA-1-60 and 
SSEA-3) pluripotent markers revealed that a large proportion of these cells remained 
pluripotent over a  long period of time (refer to Figure 4.1).   
Additionally, karyotyping was employed to ensure no abnormalities were present at the 
genetic level.  This is important as chromosomal abnormalities could potentially lead to 
tumourigenesis once cells are injected into the patient. As discussed in chapter 4, the 
Shef3 line was shown to have a normal karyotype. 
In chapter 5, the ability of Shef3 hESCs to differentiate into RPCs was investigated, 
using a protocol devised by Lamba and colleagues in 2006. Following this established 
protocol, it was demonstrated that Shef3 hESCs could successfully generate RPCs. 
Immunocytochemistry results revealed the expression of neural RPC marker Chx10 in 
these cells after 21 day of differentiation (refer to Figure 5.8).  
Having confirmed the ability of Shef3 hESCs to generate RPCs using the Lamba 
protocol, the protocol was then further optimised through an investigation of the impact 
of dissociation buffers on RPC production. It was shown that the TrypLE Express 
dissociation buffer was by far the best buffer for use in this differentiation protocol. In 
comparison to cells dissociated with Accutase, cells dissociated with TrypLE Express 
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revealed an approximate 110-fold increase in photoreceptor precursor marker Nrl. In 
comparison to cells dissociated with Collagenase VI, as used in the Lamba protocol, the 
expression of Nrl was also increased by approximately 100-fold, in those cells 
dissociated with TrypLE Express ( refer to Figure 5.18). This investigation highlighted 
the importance of process optimisation, and revealed a clear advantage for using the 
TrypLE Express dissociation buffer in the production of RPCs. There was however, a 
high degree of cell death observed during the EB investigation, and, thus, an alternative 
monolayer differentiation protocol was investigated in the following chapters. 
In chapter 6, the effect of a monolayer differentiation protocol was investigated on the 
ability of Shef3 hESCs to produce RPCs. This protocol had been established by Lamba 
and colleagues in 2010, whereby iPSCs were successfully differentiated into RPCs. This 
study revealed that a monolayer differentiation protocol could be successful in directing 
Shef3 hESCs into RPCs. Indeed, qPCR analysis revealed more than a 10-fold increase 
in expression of photoreceptor precursor marker Crx, compared to the standard EB 
protocol (refer to Figure 6.13). This increased expression was observed as early as day 
7. 
This study revealed a decrease in retinal markers over time and highlighted the 
importance of not carrying out mechanical dissection of cells during the differentiation 
process. This reduction in retinal gene expression is most likely to be a result of cell 
degeneration due to damage and stress caused from the breaking up of cells during 
maintenance procedures.  
The study also investigated the impact of the ECM on the growth and differentiation of 
RPCs. Visually, immunocytochemistry results indicated that cells cultured on gelatin 
exhibited higher Chx10 expression in comparison to all other ECMs investigated. 
In conclusion, this study has been successful in its aim to contribute to the optimisation 
of the photoreceptor differentiation protocol. Results from this investigation have 
demonstrated a clear advantage to using TrypLE Express for the dissociation stage of 
this protocol. Additionally, it has also been shown that the differentiation period could 
potentially be vastly reduced, with expression of photoreceptor precursor cells detected 
as early as day 7 in the optimised protocol. In light of research that has found the 
successful integration of precursor cells for the treatment of blindness this hold great 
potential. The study has also provided some evidence that the differentiation of cells on 
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gelatin, could also have a positive impact on protocol with the presence of slightly 
increased RPC markers. 
 
7.2 Future Work 
Although this study has successfully investigated its initial aims, there are further 
investigations that could be carried out to  support these findings.  
A more comprehensive characterisation of the Shef3 cell line could further benefit 
investigations. Although important aspects of Shef3 characterisation were carried out, 
the majority of this concentrated on immunocytochemistry analysis for markers of 
pluripotency and the undifferentiated state. In addition to this, it would be prudent to 
allow cells to undergo spontaneous differentiation as EBs to confirm their multi-lineage 
potential. Markers such as Nestin (ectoderm marker), Brachyury (mesoderm marker) 
and Sox17 (endoderm marker), could then have been utilised to identify cells from all 
three germ layers.  
A more rigorous method of confirming pluripotency is the transplantation of hESCs into 
immunodefficient (SCID) mice which form teratoma-like structures. These structures 
can then be analysed for multi-lineage differentiation.  
Due to ethical reasons and limitation within the lab, this process was not employed in 
this study. 
Many studies have reported the successful differentiation of hESCs into RPCs (Lamba 
et al., 2006; Osakada et al., 2008; Hirami et al., 2009; Meyer et al., 2009; Osakada et 
al., 2009). Although success has been widely reported, a major hurdle remains the target 
cell yield, which has been consistently very low. With such low efficiencies, the process 
will not be clinically or financially viable for the treatment of patients.  
Therefore a major hurdle is present at the very beginning of this differentiation process. 
In order to rectify this issue, optimisation of initial stages of the protocol is clearly 
required. Optimisation of initial processes in the differentiation system would increase 
efficiencies of target yield. 
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The EB differentiation system was shown to successfully direct Shef3 hESCs into 
retinal cells, as shown by qPCR analysis of gene expression (refer to Figure 5.18). 
Dissociating cells with TrypLE Express was shown to be extremely favourable over 
other buffers in this study, as indicated by increased retinal gene expression. A more 
comprehensive analysis of this effect could be obtained through the measurement of 
actual numbers of cells expressing retinal cell markers. By using flow cytometry, the 
precise proportion of the cell population expressing the various eye field genes could be 
established and compared. This would give increased support to the evidence for using 
TrypLE Express as a dissociation buffer for this differentiation. Additionally repetitions 
of this investigation would also give further supportive evidence. Repeating these 
investigations in another cell line would also add strength to the data set, whilst 
providing evidence for both generic and specific optimisation requirements for each cell 
line. Such investigations could also give insight into specific cell lines that may be more 
efficiently differentiated into RPCs. 
This study observed a high degree of cell loss during the initiation of differentiation 
through EBs. This is likely to contribute to the low target efficiencies reported, and, 
thus, the potential loss of target cells at this stage must be minimised.  
A monolayer differentiation system would be an ideal alternate solution to the EB 
system, aimed at combatting the high cell losses. 
 The results of this study showed the potential for the employment of a monolayer 
differentiation system. For monolayer system to be beneficial, optimisation of initial 
cell densities is required. Initial seeding densities used in this investigation heavily 
impacted the outcome of the result. It was clear that a lower seeding density would have 
been more beneficial to this study. The seeding density used in this investigation 
resulted in an over-confluency of cells early on in the differentiation period. An attempt 
to reduce this density of cells manually, during the differentiation process, had 
detrimental effects on the expression of retinal genes.  
A more comprehensive investigation would involve the optimisation of the seeding 
density for the monolayer differentiation. Care would have to be taken not to dissociate 
cells for maintenance during the differentiation period. Allowing cells to remain in 
culture, undisturbed, may hold the key to greater efficiencies of target cells. By 
establishing optimal initial seeding densities the timeframe for the differentiation of 
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hESCs into RPCs could potentially be significantly reduced. Additionally, this could 
also aid in the isolation of target cells. Over-confluent cells, having formed multi-
layered structures, cannot be physically separated without causing damage to cells. This 
can lead to cell death, as exhibited in this study. An optimal seeding density could allow 
for the use of FACS (Fluorescence Assisted Cell Sorting), whereby markers for target 
cells could be identified to sort cells from a single cell solution. The original protocol 
produced by Lamba and colleagues in 2006, set a timeframe of 21 days for the 
production of RPCs. In this study, photoreceptor precursor marker Crx was observed as 
early as day 7.  
In terms of production of RPCs for therapy, a considerable reduction in the timeframe 
could greatly aid the formation of a cost effect production line.  
Photoreceptor development can be separated into a number of stages which include: 1) 
the withdrawal of progenitor cells from the cell cycle to adopt a photoreceptor cell fate; 
2) physical changes resulting in the morphology of inner and outer segments; 3) 
production of synapses with interneurons of the retina; 4) maintenance of 
photoreceptors (Hunter et al., 2004). This process is highly organised with intrinsic 
controls monitoring the various developmental stages.  
The retinal microenvironment is thus comprised of a range of factors which all play a 
part in the fine control of photoreceptor development (amongst other functions). One 
such set of components are the ECMs, secreted macromolecules which play vital roles 
in directing many aspects of photoreceptor development including: 1) the initiation, 
continuation and stop of cell division; 2) the timing of differentiation; 3) the location of 
migration; 4) locations at which synapses should be formed (Hunter et al., 2004).  
 One type of retinal ECM is Laminin, which plays important roles in retinal 
differentiation. There are several members of the Laminin family but those containing 
the β2 chain have been found to play key roles in the maintenance of rod photoreceptor 
phenotype and bipolar cells (Hunter et al., 2004).  
Another component of the retinal ECM is Wnt- inhibitory factor 1 (WIF-1). WIF-1 has 
been found to be bound by many molecules including Wnt and LPR6, the Wnt 
pathways have been discussed in further detail in chapter 1.9.2. 
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Other small, soluble molecules can also interact with ECMs to promote or demote 
specific roles. For example FGF-2 has been found to promote rod photoreceptor 
generation whilst TGFβ has been found to inhibit this process (Hunter et al., 2004). 
Acidic FGF (αGF) and basic FGF (βFGF) receptors have been found to be present in 
optic vesicles (Ramsden et al., 2013).  
There are many pathways that are vitally important for various development stages in 
the retina, which can be impacted by a range of ECM components. Notch signalling is 
involved in axis determination and appears later in retinal developmental (Ramsden et 
al., 2013). Nodal signalling determines left-right determination. Whilst sonic hedgehog 
(SHH) is involved in the division of the eye field; SHH knockout results in cyclopia, a 
congenital disease characterised by the incomplete division of eye orbitals into both 
cavities of the eye (Ramsden et al., 2013). The importance of ECMs in mimicking the 
retinal environment may hold the key to a successful RPC differentiation process.  
This study investigated the impact of several ECMs on the maintenance of potential 
RPCs. Of those ECMs investigated, this study found gelatin to be the most 
advantageous to the differentiation process of RPCs. These results were based on visual 
assessment of immunocytochemistry results. The use of qPCR gene expression analysis 
would provide a quantitative measurement of the effect of ECM components on RPC 
production, providing a more robust and conclusive data set to reinforce the ICC results.  
Additionally, this study investigated the impact of ECMs during an extension period of 
the differentiation protocol. In light of the fact that photoreceptor precursor cells were 
observed as early as day 7, an investigation whereby ECMs were studied during the 
differentiation process would have been more beneficial to the optimisation process. For 
example, a study could have been set up with various ECMs, following the same 
monolayer differentiation protocol, omitting the culture maintenance stage of the 
protocol observed in this study. Following the end of the process, qPCR analysis of 
expression of various retinal markers would have given a more robust result set 
exploring the advantage of specific ECM type for the production of RPCs. 
It is evident that the retinal microenvironment is tightly controlled, with various ECM 
components all playing significant roles in photoreceptor development. In light of this, 
once preliminary investigations of the most beneficial ECMs have been established, 
further studies could be employed to investigate optimal ECM combinations. Many 
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current protocols have used Matrigel for the production of RPCs, but the disadvantage 
of this is that Matrigel is not a well-defined matrix (Hughes et al., 2010). This poses 
variability issues in research. Additionally, the use of Matrigel for therapeutic use 
immediately flags numerous safety issues. For these reasons, optimal ECM 
combinations, omitting Matrigel, would be highly beneficial for creating an efficient 
RPC differentiation protocol. 
The key to creating an optimal RPC differentiation protocol, lies within mimicking the 
retinal microenvironment during embryogenesis. One factor that has been researched 
greatly in this process is oxygen concentration. It has been found that a state of hypoxia 
is present during embryogenesis. In ambient air approximately 20% of oxygen is 
present in comparison to the 2% of oxygen present during embryogenesis (Bae et al., 
2012). A study carried out by a group from our laboratory showed that Pax6 and Chx10 
expression is increased in hESCs differentiated in hypoxia (2% Oxygen) (Figure 7.1). 
Results from the study carried out by Bae et al, 2012 could be incorporated into the 
optimisation of the RPC differentiation protocol.  
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Figure 7.1: Quantification using flow cytometry for the differentiation of hESCs under normal and 
hypoxic conditions. Figure taken from Bae et al.,2012. 
 
In conclusion, an optimisation strategy for production of RPCs firstly requires the 
establishment of optimal seeding densities. Once this has been achieved, cells should be 
dissociated using TrypLE Express, as use of this buffer has been shown to increase 
efficiencies of target cell production. Next the optimal combinations of ECMs could be 
investigated and once established, the differentiation process could be carried at hypoxia 
in a monolayer differentiation process. Once the optimisation of these critical factors 
has been achieved, attention could be turned towards the addition of various soluble 
components, such as growth factors and small molecules that may further improve the 
protocol as a whole.  
An optimised protocol such as this could then be tested in a number of cell lines to 
identify those lines with an increased propensity for RPC differentiation. Additionally 
      
 
166 
 
qPCR and flow cytometry should be employed for quantitative analysis of marker 
expression. Once a fully optimised protocol has been identified target cells could be 
isolated using FACS, and then a secondary optimisation process could be investigated 
in order to identify ideal conditions to promote proliferation and growth of these RPCs. 
Photoreceptor progenitor cells could then undergo transplantation studies to investigate 
the functionality and integration of these cells. If cells are found to integrate well and 
mature into functional photoreceptors then the process would be successful in its aim 
and could then be used for therapy.  
A monolayer protocol would be highly beneficial in the scale-up process for supply in a 
clinical environment. Current strategies that employ EBs to initiate differentiation 
would result in a two-stage process. If cells were to be supplied for use as therapy 
currently, two set of machinery would have to be employed. For the initial EB stage a 
bioreactor system would have to be employed for example the DASGIP Parallel System 
or Cellmate (Tap Biosystems) for the maintenance of a suspended culture system. After 
this stage of the process another system for an attachment culture system could have to 
be employed such as for example SelecT (Tap Biosystems).  
By establishing a monolayer culture system, scale-up for clinical use would only require 
one system such as the SelecT (Tap Biosystems) to carry out the whole differentiation 
process. This process intensification would be a more cost-effect method of production, 
which also has the added benefit of standardising production lines. Cost-effective and 
efficient methods for the production of photoreceptor precursor cells would greatly aid 
in the treatment for the many sufferers of ocular diseases. 
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